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Abstract 
 
Over half of prescribed medications are not taken as prescribed, resulting in health and 
economic consequences.  Using constructivist grounded theory, 15 interviews were 
conducted to develop a theory on understanding the medication adherence choices of 
individuals, who were between the ages of 40 to 55, were diagnosed with a chronic condition, 
and taking three or more medications.  The results indicate that participants are engaging in 
self-management strategies, with massive variance in adherence behaviours.  Medications are 
sacrificed for personal and financial reasons, resonating with feelings of fear for the person’s 
current situation and future. Individuals are struggling with who they have become to who 
they once were, which becomes related to their medications.  Finally, individuals are citing 
the impact of their physician; citing barriers to communication and Canada’s health care 
system. Participants’ experiences provided an understanding of the meanings individuals 
associate with their medications and how this impacts their decision-making. 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
Acknowledgements 
 
To the individuals who took the time to share their experiences with me, thank 
you for taking the time to do so and to contributing your stories to this research study.  
This project would not have been possible or have been as impactful as it was on me 
personally had it not been for the stories that you have shared with me. 
To my supervisor, Dr. Jarold Cosby, I am beyond grateful for the mentorship you 
have provided me with.  You always were willing to sit and listen to me discuss this 
project in-depth and about life in general, you provided me with constant leadership and I 
am sincerely thankful for that.  You were not only my mentor but my friend – you 
provided continual expert advice and supported me throughout this experience.  This also 
includes my supervisory committee, Dr. Madelyn Law and Dr. Matthew Greenway, 
thank you for your continued support and commitment.  You have all contributed to my 
academic and personal growth throughout this process. 
 To my friends and family, thank you for being excellent listeners and always 
making the time to listen to me rave about my research even if this was not a care in the 
world, it was to me and you knew that.  I am forever grateful for the continual support, 
encouragement, and love I have received from you.  You reminded me of my goals and 
put life in perspective for me, always giving me the motivation to move forward 
throughout this experience, thank you.  
 
 
 
 
  
iv 
 
Table of Contents 
Abstract _______________________________________________________________ ii 
Acknowledgements ______________________________________________________ iii 
Chapter 1: Introduction __________________________________________________ 1 
Health Care Costs ...................................................................................................................... 3 
Individual Factors ..................................................................................................................... 5 
Patient-Physician Communication ........................................................................................... 6 
Canada’s Health Care System .................................................................................................. 6 
Medication Adherence Interventions ....................................................................................... 6 
Qualitative Inquiry .................................................................................................................... 7 
Purpose: ...................................................................................................................................... 8 
Research Questions: .................................................................................................................. 9 
Chapter 2: Review of Literature ___________________________________________ 9 
Health Care Costs in Canada ................................................................................................. 10 
Effects of policy: .................................................................................................................................. 10 
Health care expenses: .......................................................................................................................... 15 
Demographics ...................................................................................................................................... 17 
Individual Factors in Medication Adherence ........................................................................ 20 
Commitment to chronic condition: ...................................................................................................... 20 
The search for normality: .................................................................................................................... 22 
Patient identity and experience living with chronic condition(s): ....................................................... 25 
Patient-Physician Communication ......................................................................................... 29 
The effects of physician communication: ............................................................................................. 29 
Understanding the person with the chronic condition(s): ................................................................... 31 
The Health Care System in Canada ....................................................................................... 34 
Structural barriers: .............................................................................................................................. 34 
Treatment options: ............................................................................................................................... 35 
Evaluation of Medication Adherence Interventions ............................................................. 37 
Social and economical: ........................................................................................................................ 38 
Health care – oriented: ........................................................................................................................ 39 
Therapy – related: ............................................................................................................................... 42 
Patient – related: ................................................................................................................................. 44 
Chapter 3: Methods ____________________________________________________ 46 
Theoretical Framework: ......................................................................................................... 46 
Epistemological/ Paradigmatic Perspective: ......................................................................... 49 
Methodology: ........................................................................................................................... 52 
Interviews: ................................................................................................................................ 54 
Data Collection Procedures .................................................................................................... 56 
Sampling strategy: ............................................................................................................................... 56 
Sampling recruiting procedures: ......................................................................................................... 57 
Sample: ................................................................................................................................................ 58 
v 
 
Ethics: .................................................................................................................................................. 59 
Data analysis: ...................................................................................................................................... 60 
Chapter 4: Results _____________________________________________________ 65 
Ability to ‘self-manage’ chronic conditions and multiple medications ............................... 66 
Origins of chronic condition(s): .............................................................................................. 67 
The impact of others to self-manage condition and medication use: ................................................... 68 
The ‘success’ and ‘failure’ associated with self-management: ........................................................... 70 
The ability to continue to work and maintain privacy: ........................................................................ 73 
The choice of sacrificing medication use ............................................................................... 76 
‘Meds are very important but...’: ......................................................................................................... 76 
The fear of living with a chronic condition ........................................................................... 77 
The fear of the future: .......................................................................................................................... 78 
The fear of dependency on medications: .............................................................................................. 81 
Identity dilemma of the ‘old normal’ to the ‘new normal’ .................................................. 84 
Emotions associated with being first diagnosed: ................................................................................. 84 
Moving to a new ‘normal’: dependence vs. the imagery of a warrior: ................................................ 86 
Prescribing experiences _________________________________________________ 91 
The awareness of being on multiple medications: ............................................................................... 91 
Patient-physician communication .......................................................................................... 93 
The role of the patient and the physician: ............................................................................................ 94 
Canada’s Health Care System ................................................................................................ 97 
Barriers and facilitators to care: ......................................................................................................... 97 
Chapter 5: Discussion __________________________________________________ 99 
Strengths and Limitations: _____________________________________________ 112 
Chapter 6: Conclusion _________________________________________________ 117 
Future Implications: __________________________________________________ 122 
Summary Conclusions _________________________________________________ 128 
Chapter 7: Bibliography _______________________________________________ 131 
Chapter 8: Appendices _________________________________________________ 144 
Appendix A: Semi-structured interview guide ................................................................... 144 
Appendix B: Inclusion and exclusion criteria ..................................................................... 147 
Appendix C: Summary of research project ........................................................................ 148 
Appendix D: Telephone script 1 ........................................................................................... 150 
Appendix E: Letter of invitation .......................................................................................... 153 
Appendix F: Informed consent form ................................................................................... 155 
Appendix G: Supporting quotations .................................................................................... 157 
Emotions associated with being first diagnosed ................................................................................ 160 
Moving to a new ‘normal’: dependence vs. the imagery of a warrior ............................................... 160 
The awareness of being on multiple medications .............................................................................. 160 
 
vi 
 
List of Figures  
 
Figure 1. Factors affecting medication adherence (pg.3) 
Figure 2. Effects of daily medication use on adherence behaviours (p.22) 
Figure 3. How the condition impacts ‘the person’ and ‘the patient’ (p.26) 
Figure 4. Patient-physician communication (pg.32) 
 
 
  
vii 
 
List of Tables 
 
Table 1. Participant Bios (pg.58) 
 
 
1 
 
Chapter 1: Introduction 
 
To understand a patient’s decision to not adhere to a medication, there needs to be 
an evaluation of the use of prescription medication as a treatment option.  Over half of 
prescribed medications are not taken as prescribed (Osterberg & Blaschke, 2005), 
questioning the effectiveness of medication as a treatment option.  Non-adherent behavior 
is higher in those with chronic conditions as opposed to those with acute conditions 
(Gibson, Ozminkowski, & Goetzel, 2005; Osterberg & Blaschke, 2005).  Medication 
adherence in those with chronic conditions has been found to be affected by the 
frequency of the dose- a higher medication frequency is associated with poor medication 
adherence (McDonald, Garg, & Haynes, 2002; Peterson, Takiya, & Finley, 2003; 
Townsend, Hunt, & Wyke, 2003).  This provides some explanation of why those with 
chronic conditions exhibit higher rates of non-adherence based on dose frequency.  This 
was reflected in a recent study by the World Health Organization (WHO) which found 
that adherence was only around 50% for those who with a chronic condition in developed 
countries and approximately 16% of patients fail to fill a new prescription (Golay, 2011; 
Kreps et al., 2011; Peterson et al., 2003).  Townsend et al. (2003) concluded that those 
with chronic conditions who were required to take multiple medications viewed their 
drug regimen as a central component to their lives, which resulted in drug regimens being 
viewed as complex, demanding, and restricting.   
The term ‘adherence’ is the extent to which the patient’s behavior coincides with 
medical advice or recommendations (Kaufman & Birks, 2009; Golay, 2011; McDonald et 
al., 2002; Osterberg & Blaschke, 2005; Peterson et al., 2003).  The term adherence 
recognizes the difficulties of following a drug regimen and there is no blame placed on 
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the prescriber, the patient, or the treatment (Kaufman & Birks, 2009; McDonald et al., 
2002).  ‘Adherence’ considers physiologically and empirically what optimal care should 
entail however this term fails to recognize the patient’s concerns and how decisions are 
made in adhering to a prescribed drug regimen.  This becomes problematic since the 
physician is then unable to conceptualize why patients are choosing not to follow 
treatment recommendations.  
It is essential to evaluate non-adherence when poor adherence can lead to disease 
progression, complications, side-effects, and in extreme cases death (Townsend et al., 
2003; Wang et al., 2011).  As a result of poor adherence, treatment outcomes are often 
impaired and health care costs are increased (Golay, 2011; Kennedy & Morgan, 2006).  
Barriers have been recognized in adhering to multiple medications such as associated 
medication costs (Demers et al., 2008; Gibson et al., 2005; Grootendorst, 2002; Kennedy 
& Morgan, 2006; Law, Cheng, Dhalla, Heard, & Morgan, 2012; Schoen et al., 2007; 
Schoen et al., 2010), individual factors (Charmaz, 1994; Gallagher, Miller, Cronan, & 
Groessl, 1997; Holahan, Moos, Holahan, & Brennan, 1995; Kreps et al., 2011; Ledford et 
al., 2010; Pitmman, 1999), patient- physician communication (Ledford et al., 2010; Nair 
et al., 2002; Osterberg & Blaschke, 2005), and the structure of Canada’s health care 
system (Demers et al., 2008; Gibson et al., 2005; Golay, 2011; Grootendorst, 2002; 
Schoen et al., 2010).  Figure 1 provides a representation of this literature to summarize all 
the various factors acting as barriers to medication adherence.  This research project will 
evaluate how specific barriers (i.e. costs, individual factors, patient-physician 
communication, and Canada’s health care system) influence a patient’s decision-making 
capacity to adhere to a prescribed drug regimen. 
3 
 
Figure 1. Factors affecting medication adherence 
 
 
Health Care Costs 
 
When analyzing the effects of cost, individual circumstances need to be 
considered, specifically the person’s available drug coverage, household income, age, 
diagnosis and number of conditions, and perception of health.  In a sample of 3 505 
Canadians, 16.2% did not have any form of prescription coverage and were more likely 
than those with some health coverage to report cost related non-adherence (Kennedy & 
Morgan, 2006).  The Medical Care Act of 1966 and the Canada Health Act of 1984 did 
not mandate provincial coverage of prescription medications that are taken outside of the 
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hospital setting and Ontario only offers federal reimbursement to a limited number of 
groups such as those who have an income of less than $20 000 (Demers et al., 2008; 
Grootendorst, 2002).  This results in detrimental consequences for patient health and 
economical consequences for society.  If patients are unable to afford their prescribed 
medication, which may cause their condition to progress, patients may have no choice but 
to seek other self-management strategies such as alternative medicine.  This is concerning 
when adherence to medications for those with a chronic condition has been the primary 
means of reducing the risk of relapse or complications and is associated with better health 
outcomes (Gibson et al., 2005; Golay, 2011).   
When reflecting on what specific demographics are exhibiting non-adherence 
behaviours, it is clear that those with a lower household income are more likely not to 
adhere to a prescribed drug regimen because of cost restrictions (Golay, 2011; Kennedy 
& Morgan, 2006; Law et al., 2012; Schoen et al., 2007; Schoen et al., 2010).   However, 
Kennedy and Morgan (2006) found that 34.2% of Canadians in the lowest quintile of 
household income (approximately less than $20 000) reported non-adherence due to drug 
costs compared to only 7.6% in the highest quintile. Schoen et al. (2010) also concluded 
in a sample of 2 316 Canadians that 18% of individuals who were considered to have a 
‘below average’ income experienced a barrier to health care because of cost versus 6% of 
individuals who were considered to have an ‘above average’ income.  While Law et al. 
(2012) found in a sample of 10 898 Canadians that 10.5% who had an income of $40 000 
to $79 999 with some form of coverage reported cost related non-adherence compared to 
20.5% who had an income of less than $20 000 with no medical insurance.  
5 
 
It is evident that those with a lower household income are displaying higher rates 
of non-adherence due to costs but non-adherence was still taking place in those with a 
higher household income who have drug coverage to assist with health care expenses.  
The literature has been unable to provide a basis of why non-adherence is taking place 
among those who have the financial ability to afford their medication.  This provides a 
further rationale of the importance of evaluating the choices individuals of varying 
incomes are making in adhering to their prescribed drug regimen.  
Individual Factors 
 
Different reasons are cited by men and women in exhibiting non-adherent 
behaviors (Charmaz, 1994; Gallagher et al., 1997; Holahan et al., 1995; Pitmman, 1999).  
Despite the fact that some literature has been able to exemplify gender differences 
occurring in those with chronic conditions (Artinian & Duggan, 1995; Asbring, 2001; 
Charmaz, 1994; Gallagher et al., 1997; Holahan et al., 1995; Pittman, 1999; Sharpe et al., 
1991), both males and females will be included within this research study.  This will be 
explained in further detail within the methods section.   
The decision making process of individual’s with a chronic condition between the 
ages of 40 to 55 must be further evaluated in providing insight to the measures that 
should be taken to improve medication adherence.  It is essential to focus on this age 
group specifically because of the limited amount of literature available on this age 
bracket who are considered to be relatively young to be on multiple medications (Tinetti 
et al., 2004; Townsend et al., 2003).  Age will be considered in further detail when 
reviewing barriers associated with medication adherence.   
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Patient-Physician Communication 
 
A typically cited barrier pertaining to adherence rates is the ability of physicians 
to candidly communicate with patients and encourage medication adherence (Golay, 
2011; Kreps et al., 2011; Ledford et al., 2010; Osterberg & Blaschke, 2005).  However, 
this poses a challenge for physicians if patients are purposely choosing not to 
communicate with their physician, which limits the ability of physicians to understand 
the choices patients are making in adhering to their drug regimen.  Kennedy and Morgan 
(2006) concluded that patients are at greater risks for non-adherence if they have minimal 
interactions with their physician.  High quality and cost effective treatment will be best 
achieved if there is a partnership between the patient and the health care provider 
(Kaufman & Brinks, 2003).  
Canada’s Health Care System 
 
Finally, the structure of the health care system must be evaluated in determining 
the effectiveness of the availability of treatment and how this is impacting patient’s 
decisions regarding adherence to a drug regimen.  The choices made by patients have to 
be reviewed to ensure that health interventions can be modified according to the patient’s 
values and beliefs.   
Medication Adherence Interventions 
 
Health interventions that have been implemented to improve medication 
adherence have focused primarily on clinical outcomes and there has been minimal focus 
on understanding the decision-making process patients are making in choosing to adhere 
to their prescribed medications (Britten, 2003; Kreps et al., 2011; McDonald et al., 
2002).  Hypothetically speaking, if a patient were diagnosed with a chronic condition and 
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expected to take multiple medications over an extended period time, yet purposely chose 
to only adhere to certain medications, there needs to be an explanation of why this is 
occurring.  Golay (2011) has found that adequate adherence results in more cost-effective 
use of health care resources and an enhanced quality of life.  If there is an expectation to 
improve medication adherence, then interventions cannot be based solely on clinical 
outcomes.  Interventions need to be multidimensional in addressing the patient’s choices 
and providing a rationale of why non-adherent behaviour is occurring. 
Qualitative Inquiry  
 
To elicit patient’s experiences qualitative research is an ideal method.  The 
purpose of using qualitative research is it allows the researcher to focus on the 
experiences of participants to determine how meanings are constructed through and in 
culture, and to discover variables as opposed to testing variables (Corbin and Strauss, 
2008).  Qualitative data provides depth and details, which is best obtained through the use 
of interviews (Patton, 1990).  Qualitative interviewing is a useful approach within the 
health care setting and through the use of interviews it will allow participants to speak of 
their decisions regarding medication adherence, to learn their judgements, and “to capture 
the complexities of their individual perceptions and experiences” (Patton, 1990, p. 205).  
Therefore, a qualitative and subjective basis will be the most appropriate method used for 
understanding the choices made by individuals diagnosed with a chronic condition and as 
a result are required to take multiple medications.   
Grounded theory is an ideal approach, as it is a qualitative research method 
concerned with developing an explanatory theory of basic social processes (Creswell, 
2007; Moustakes, 1994; Patton, 1980; Patton, 2008; Starks & Trinidad, 2007).  
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According to Moustakes (1994) the final objective of grounded theory is to construct an 
integrated theory that is developed by focusing on elements of other’s experiences and 
from these elements a theory is developed that enables the researcher to understand an 
individual’s particular experience.  Interviews are an ideal choice for grounded theorists.  
Interviews elicit subjective worldviews and are very flexible in nature- the researcher can 
constantly modify the interview guide and pre-determine to some extent what is asked to 
focus on a certain phenomenon (Holstein & Gubrium, 2003).  Grounded theory also 
depends upon flexibility; grounded theory develops a framework through data collection 
and the researcher is constantly returning to the field to ask questions that are continually 
changing to fill in the gaps within the data until themes are clearly submerged within the 
categories (Holstein & Gubrium, 2003).  Thus, grounded theory is a logical method for 
investigating the decision-making process of individuals with a chronic condition who 
are required to take multiple medications.    
Purpose: 
 
The purpose of this study is to develop a theory of the process of decision-making 
in medication adherence.  Specific organizational and individual factors (i.e. the costs of 
health care, individuality, patient-physician communication, and Canada’s health care 
system) will be analyzed while investigating the influence these factors have on a 
patient’s ability to follow their physician’s recommendations.  A theory based upon the 
data will aid decision and policy makers in understanding how decision making works, 
why it works the way it does, and the impact it is has on patients as well health care as a 
whole (Patton, 1980).  Grounded theory analysis can provide physicians with alternative 
understandings of patient’s lay beliefs and actions compared to those offered within the 
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clinical setting (Charmaz, 1990).  Based upon data collection, with a focal point around 
individual experiences, it will aid in developing a framework for health care providers in 
understanding the context and the rationale behind a lay person’s decisions in adhering to 
prescribed medications.  Once a rationale has been provided for adherent or non-adherent 
behaviours, a hierarchy will be created exemplifying what factors are primarily affecting 
individuals while considering the demographic of the person (i.e. diagnosed condition, 
number of conditions, number of prescribed medications, gender, education, etc.). 
Research Questions:   
 
What factors influence the decisions of individuals between the ages of 40 to 55 who are 
prescribed 3 or more medications in adhering to a drug regimen?  Finally, how do these 
factors influence the decisions patients are making in adhering or not adhering to their 
prescribed drug regimen? 
Chapter 2: Review of Literature        
 
 The following section will review organizational and individual factors that can 
affect an individual’s ability to adhere to a prescribed drug regimen.  There have been 
specific barriers that have been recognized in non-adherent behavior, specifically health 
care costs, individual factors, patient-physician communication, and Canada’s health care 
system.  However, these specific barriers have only been considered as single entities, not 
as co-existing factors.  The literature was reviewed and will highlight the gaps within the 
current research that have failed to recognize the patient’s decision-making process in 
adhering to their physician’s prescribed medication treatment.  A review of medication 
adherence interventions was conducted to demonstrate the successes and failures of 
interventions that have been implemented in an attempt to improve medication 
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adherence.  By reviewing the inconsistencies within previously implemented 
interventions, the review will aid in providing a framework that can be used by decision 
and policy makers in understanding the choices made by patients in adhering to a 
prescribed drug regimen. 
Health Care Costs in Canada 
Effects of policy: 
 
Canada’s ability to mandate the pricing of prescription medications can affect an 
individual’s ability to adhere to a prescribed drug regimen by forcing Canadians to pay a 
certain amount for health care services.  Before discussing the foundations of drug 
coverage within Canada, it is important to understand key terms that are used when 
explaining health insurance.  ‘Beneficiary cost sharing’ is the direct charge to the patient 
while the patient’s insurer (assuming the patient has coverage) covers the remainder of 
the costs (Gibson, 2005; Grootendorst, 2002).  Beneficiary cost sharing can take several 
forms including: premiums, deductibles, copayments, and coinsurance.  ‘Premiums’ are 
payments made to receive drug coverage and have no relation to drug use while 
‘deductibles’ are the amount of health care costs the beneficiary is responsible for before 
the insurer has any payments (Gibson, 2005; Grootendorst, 2002).  ‘Copayments’ are a 
fixed amount paid by the insured as a result of deductibles and coinsurance (i.e. the 
patient pays $10 per prescription regardless of the prescription) and ‘coinsurance’ is a 
share of a fixed percentage of the drug costs paid by the beneficiary of the healthcare 
policy (i.e. the beneficiary pays 20% of the prescription costs) (Gibson, 2005; 
Grootendorst, 2002).   
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 In Canada there is no federal reimbursement or standardization for drug plans; 
thus each province funds and establishes some form of drug insurance program (Demers 
et al., 2008; Grootendorst, 2002).  This allows provinces to create their own terms and 
conditions.  For example, each province can regulate who is eligible for coverage, the 
specific medications that are covered, and the amount of beneficiary cost sharing for 
covered prescriptions (Grootendorst, 2002; Schoen et al., 2010).  The payments made by 
patients vary across the provinces since there is no standardization in prescription costs 
despite legislation in place that regulates some aspects of Canadian healthcare at the 
federal level. 
The Medical Care Act of 1966 and the Canada Health Act of 1984 do not 
mandate provincial coverage of prescription drugs that are taken outside of hospital care 
(Demers et al., 2008; Grootendorst, 2002).  This raises numerous concerns when Canada 
is basing prescription drug coverage on outdated legislation and is not considering that 
prescription medication is a primary means of treatment for patients.  Furthermore, 
patients are spending less time in hospitals (Schoen et al., 2010), which is forcing 
patients to pay for prescriptions that otherwise would have been administered within a 
hospital setting and thus covered.  It is necessary for Canada to update this piece of 
legislation when taking into account that in 2005, $20.6 billion was spent on outpatient 
prescription medications, which results in the second largest category of health spending 
in Canada after hospital expenditures (Demers et al., 2008; Morgan, 2004).  Furthermore, 
of the $20.6 billion, $4 billion is due to out-of-pocket expenses made directly by patients 
(Demers et al., 2008).  According to Law et al. (2012) most Canadians have some form 
of coverage yet are still forced to pay for necessary treatment.  These out-of-pocket 
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expenses may provide a rationale of why patients are not adhering to their drug regimen 
and sacrificing their health due to medication expenses.    
In an attempt to reduce prescription costs for patients, most provinces offer 
separate and more comprehensive coverage for certain medications (Grootendorst, 2002; 
Schoen et al., 2010).  However, Morgan (2004) concluded that provincial drug programs 
only fund approximately 40% of prescription drugs in Canada since only certain 
medications are patented and covered under provincial drug funding.  When taking into 
account those with a chronic condition who are required to take multiple medications, 
this provides minimal reassurance when this group of individuals are recommended to 
take numerous medications and not even half of their prescription costs are being 
covered.  Furthermore, all provinces have limited the coverage of brand name drugs but 
instead provide coverage on the lowest costing, interchangeable generic drug 
(Grootendorst, 2002).  If the person wants the brand name drug then he/she is responsible 
for the difference in costs (Grootendorst, 2002).  However, some brand name drugs have 
been proven to be clinically more effective than its’ generic counterpart (Andermann, 
Duh, Gosselin, & Paradis, 2007; Guberman & Corman, 2000; Sanyal & Datta, 2011).  
Patients then suffer by either having to pay the additional costs for the brand name or are 
aware that they are not receiving the best possible treatment by settling for the generic 
brand due to costs restrictions.  This may affect patient’s choices in adhering to a 
prescribed drug regimen and leave the patient questioning what is the ‘right’ decision? 
Provincial health programs have attempted to counter the increase in prescription 
medication expenditures by implementing higher copayments, reducing reimbursement 
levels, placing caps on the number of covered prescriptions, and restricting formularies 
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(Kennedy & Morgan, 2006).  However, this is not an optimal solution for those with 
chronic conditions who are required to take multiple medications, therefore already 
having higher associated costs.  Ontario has implemented more control mechanisms to 
limit drug use to more effective cost options (primarily generic drugs).  This may 
influence those who are diagnosed with a chronic condition in making decisions in 
determining what medication to take since the most effective cost option may not be the 
most effective health option. 
Since Canada does not have standardized provincial drug programs and restricts 
reimbursements to a limited number of groups, individuals are sacrificing their health due 
to the increasing costs of medications.  One of the guiding principles of Canada’s health 
care system is that ‘all Canadians should have equal access to health care benefits’ 
(Demers et al., 2008).  However, this is clearly not taking place when  it has been shown 
that beneficiary cost sharing can lead to poor health outcomes by forcing patients to pay a 
certain amount for a prescription (Grootendorst, 2002).  Direct charges disproportionately 
affect those with low incomes and the ‘working poor’ that have no form of drug 
coverage; as a result health is being sacrificed.  Finally, low income individuals have a 
larger modifiable burden of illnesses and thus face the consequences of direct charges 
more so than those with a higher income who are in better health (Grootendorst, 2002).  
Literature is citing that provincial drug plans are preventing individuals from taking their 
prescribed medication (Demers et al., 2008; Grootendorst, 2002; Schoen et al., 2010).  
However, there needs to be a further understanding of the extent to which an individual’s 
drug coverage is affecting the patient’s decision-making capacity to adhere to their 
medications. 
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People lacking insurance for prescription medications was associated with a more 
than fourfold increase in cost related non-adherent behaviors than individuals with some 
form of coverage (Law et al., 2012).  For example, 26.5% exhibited non-adherence who 
had no prescription drug coverage versus only 6.8% did not adhere who had partial 
coverage for prescription drugs (Law et al., 2012).  In a sample of 3 505 Canadians, 
16.2% did not have any form of prescription coverage and were more likely than those 
with some form of insurance to report cost related non-adherence (Kennedy & Morgan, 
2006).  Schoen et al. (2010) concluded that 10% of the general population had no form of 
health coverage and the rates of average coverage declined with household income 
resulting in cost related non-adherence.   
As previously outlined, provincial drug programs have been implemented to assist 
those who qualify for social assistance and who have a lower household income but this 
is not consistent with what is being said within the literature.  Cost is being cited as a 
barrier by those who do qualify for social assistance and who have a lower household 
income.  This leads one to question, why is cost being cited as a barrier to medication 
adherence if financial funding is being provided.  This further supports the importance of 
investigating the need to understand the decisions made by individuals with chronic 
conditions who may categorize themselves as having minimal coverage with a lower 
household income.  Grounded theory is an ideal method in generating a theory that will 
aid physicians in understanding the effects of medication costs (Charmaz, 1990; 
Charmaz, 1994), which has been exemplified in affecting individuals of varying incomes, 
available drug coverage, diagnosis of condition, and perceived quality of health.  
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However, to further understand the social processes of medication adherence and 
generate a theory that is integrated – individual factors need to be considered. 
Health care expenses: 
 
To understand a patient’s experiences, it is essential to consider the barriers in 
adhering to one’s medications.  Cost was viewed as a barrier to medication adherence and 
may be the most important factor that affects policy interventions (Gibson et al., 2005).  
Cost can impact the choices patients choose to make to adhere to a drug regimen because 
of the restrictions felt by the price of medications; specifically the perceived notion of the 
costs associated with generic versus brand name drugs.  However, the economy theory 
states that if an individual were aware of the benefits and adverse effects of a drug, one 
will consume an optimal amount of the drug based upon income constraints and 
knowledge of the drug (Gibson et al., 2005).  The economy theory further concludes that 
when individuals with a low income are faced with an increase in direct charges, this 
group will relinquish more drugs than those with a higher income (Schoen et al., 2010).  
This is subject to the physician’s ability to relay the importance of medication adherence 
while considering cost as a restriction when prescribing a medication specifically for 
those who have a minimal income.  If cost is affecting an individual’s ability to make 
decisions regarding adherence to a prescribed drug regimen, then there needs to be a 
better conceptualization of the effects of costs according to individual circumstances. 
In 2003, Canadians out-of-pocket expenses on prescription drugs totalled 
approximately $16 billion (Morgan, 2004).  In 2010, out-of-pocket payments totalled 
$4.6 billion or approximately 17.5% of total spending on prescription drugs in Canada 
(Law et al., 2012); the decline in spending can be partially attributed to the passing of Bill 
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102 in Ontario in 2006 which mandated the pricing of generic drugs.  However, 
Canadians are still spending a large amount of money on prescription drugs, providing 
cause for why medication adherence may not always be a viable option.  The out-of-
pocket payments made by Canadians may be affected by the need for a brand name drug 
over a generic drug based on literature outlining that brand name drugs can be more 
clinically effective then generic drugs (Andermann, Duh, Gosselin, & Paradis, 2007; 
Guberman & Corman, 2000; Sanyal & Datta, 2011).   
In 2001 to 2004 the mean copayments for generic drugs increased by 42.9% (from 
$7 to $10), preferred brand name drugs rose 61.5% (from $13 to $21) and non-preferred 
brand name drugs increased 94.1% (from $17 to $33) (Gibson et al., 2005).  Despite the 
increase in drug costing, there has been a resistance to generic drugs by patients.  Patients 
prefer brand name over generic drugs based upon the perception of increased quality and 
effectiveness in brand name drugs (Gibson et al., 2005).  Expenditure growth in Canada 
has been attributed to higher prescription rates resulting in an increase in medication use 
specifically brand name drugs, which are more costly options (Demers et al., 2008; 
Kennedy & Morgan, 2006; Morgan, 2004).  This is problematic since patients are 
restricting the consumption of their prescribed medications due to cost, yet are willing to 
pay more for a brand name drug sacrificing adherence in return.   
The importance of understanding patient’s individually is evident when reflecting 
on the effects of the costs of prescription medications.  One in 10 Canadians have not 
filled a prescription, renewed a prescription, or have tried to make a prescription last 
longer because of out-of-pocket expenses (Law et al., 2012).  Higher prices in 
medications results in lower consumption.  It has been demonstrated that patients will 
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look for substitutes for their medications and will be more inclined to take these 
substitutes instead of the prescription because of affordability (Gibson et al., 2005; Law 
et al., 2012).  If a strategy is developed that involves improving patient’s health while 
saving money, individuals may be more inclined to adhere.  It is apparent that the price of 
a drug regimen affects an individual’s ability to adhere to prescribed medications, 
especially those between the ages of 40 to 50 who are diagnosed with more than 2 
chronic conditions and perceive their health as being ‘poor’.   
Demographics 
Age: 
It is important to recognize individual differences when conceptualizing how the 
costs of medications can restrict a person’s decision to adhere to a prescribed drug 
regimen.  Law et al. (2012) conducted a study that included 10 898 participants from 10 
Canadian provinces and concluded that 9.6% of Canadians engaged in non-adherence due 
to cost.  This type of non-adherence varied with age, number of chronic conditions, 
perception of one’s health, household income, and drug coverage.  The prevalence of cost 
related non-adherence was highest in those between the ages of 35 to 44 at 11.4% and 45 
to 64 at 10.8% while only 4.8% of participants over the age of 65 did not adhere due to 
cost (Law et al., 2012).  Kennedy and Morgan (2006) also concluded in a sample of 3 
505 Canadians, that 17.7% of adults aged 35 to 55 and 16.7% aged 45 to 55 reported non-
adherence due to costs compared to only 8.2% of adults over the age of 75.   
The above findings are supported by Townsend et al.  (2003), who found that 
individuals between the ages of 40 and 50 were expected to be at the peak of their wage 
earnings; yet this group demonstrated the greatest sensitivity to cost when adhering to 
their drug regimen.  One may speculate that this specific age bracket is exhibiting cost 
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related non-adherence because of available drug coverage, as earlier indicated the 
‘working poor’ have too much income to qualify for social assistance but are employed in 
sectors that do not provide health benefits.  Furthermore, those between the ages of 40 to 
50 may not be prepared to recognize or accept being labelled as ‘ill’ and thus are more 
defiant against recommended treatments (Audulv et al., 2012; Charmaz, 1994).  When 
understanding the process of decision-making, it is necessary to examine the choices this 
specific group is making if cost is being viewed as a barrier despite the literature 
outlining that this group should be at the peak of their wage earnings. 
Diagnosis and perception of condition: 
Age is not the only individual factor that needs to be considered in relation to the 
costs of medication.  Grootendorst (2002) found that adults who reported chronic pain 
which limited activity were 29.9% more likely to report cost related non-adherence 
versus only 12.4% of adults with acute pain who reported cost as a barrier to adherence.  
Law et al. (2012) also concluded that individuals who have been diagnosed with more 
than two chronic conditions were 12.4% less likely to adhere to a drug regimen due to 
cost compared to 11.2% when diagnosed with one chronic condition and 8.2% when not 
diagnosed with a chronic condition.  Those who are diagnosed with more than two 
chronic conditions will most likely be required to take more prescribed medications and 
have more associated costs.  However, this specific group who are most in need of 
medication to manage various medical conditions are unable to do so because of the cost 
of medications.   
Finally, participants were asked to rate their perception of their own health.  
Those who classified their health as being ‘fair or poor’ had the highest cost-related non-
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adherence at 20.1% compared to ‘good’ at 10.4% and ‘excellent or very good’ at 6.9% 
(Law et al., 2012).  Grootendurst (2002) also had similar findings with adults who 
perceived their health to be ‘fair or poor’ were 29.9% more likely to report non-
adherence due to costs compared to only 12.4% of individuals who assessed their health 
as being ‘good, very good, or excellent’.  This is ironic since those who require health 
care the most are citing cost as a barrier and are significantly less likely to adhere to a 
drug regimen despite the need for it.  
Income: 
 
In 2000, medications for citizens in Ontario with social assistance and low annual 
income households (less than $20 000) had no premiums, deductibles, and no beneficiary 
contribution (Grootendorst, 2002).  Copayments and coinsurance were $2.00 per 
prescription if a person qualified for social assistance or had a household income below 
$20 000 (Grootendorst, 2002).  However, this system does not consider the ‘working 
poor’, who are individuals that make more then $20 000 but unfortunately are not 
employed by a company that provides healthcare benefits (Schoen et al., 2010).  Thus, do 
not qualify for the provincial drug plan; as a result they have no coverage (Schoen et al., 
2010).  Research has concluded that those who qualify for social assistance and have a 
household income of less than $20 000 (thus qualify for provincial drug assistance 
programs) are most affected by out-of-pocket payments of prescription drugs and limit 
drug use as result (Demers et al., 2008; Kennedy & Morgan, 2006; Law et al., 2012).   
Furthermore, a low household income was associated with an increase in cost related 
non-adherence compared to a high household income (Grootendorst, 2002; Kennedy & 
Morgan, 2006; Law et al., 2012; Schoen et al., 2007; Schoen et al., 2010).  Law et al. 
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(2012) found that annual household incomes of $20 000 or less were 20.5% more likely 
to not adhere to their prescribed medications due to cost versus household incomes of $40 
000 to $80 000 that were only 10.5% likely not to adhere to their drug regimen because 
of costs.  Kennedy and Morgan (2006) also concluded that household incomes within the 
lowest quintile were 34.2% to report non-adherence due to prescription costs compared to 
only 7.6% in the highest quintile who cited cost as a barrier to medication use.  This 
demonstrates that numerous groups are affected by Ontario’s provincial drug plan 
regardless if one qualifies for provincial drug funding or not, cost was still being cited as 
a barrier.  This is not only affecting a person’s abilities to make choices pertaining to 
medication adherence but limiting the choices to be made. 
Individual Factors in Medication Adherence 
Commitment to chronic condition: 
 
 After reviewing the effects of health care costs, it is evident that specific 
demographics can influence medication adherence behaviours.  To evaluate the factors 
that influence decision-making pertaining to medication adherence, barriers that directly 
affect the individual should be assessed.  For the patient with a chronic condition, 
adhering to a prescribed medication it is not a single decision but is a daily decision to 
which a commitment is extremely challenging.  Chronic conditions places a different set 
of demands on a patient than does an acute condition – living with a chronic condition 
requires continued decision-making and adjustments to changing circumstances for both 
the patient and loved ones (Ledford et al., 2010; Tinetti et al., 2004; Wagner et al., 2005).   
According to Kreps et al. (2011), Ledford et al. (2010), and Zhao, Villagran, and Kreps 
(2011) the two most common barriers to medication adherence were the concern about 
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the prescribed medication and the perceived need for the medication (medication 
commitment).   
Concern of one’s health was dependent on the side-effects and the impact it had 
on a patient’s daily life (Kreps et al., 2011; Ledford et al., 2010; Zhao et al., 2011).  As 
well, patients compared the side-effects with the symptoms experienced prior to 
treatment (Kreps et al., 2011; Ledford et al., 2010; Zhao et al., 2011).  57% of 
participants (n=17 males, 13 females; mean age of 46) reported moderate to strong 
feelings about the need for medications yet recognized their drug regimen as a barrier 
(Kreps et al., 2011).  Commitment to one’s drug regimen was dependent on the perceived 
need for the medication (diagnosis belief and perceived need for the prescribed therapy) 
and the effectiveness of the medication (treatment belief) (Ledford et al., 2010; Zhao et 
al., 2011).  Participants within Ledford et al. (2010) study spoke of not understanding 
why he/she were being prescribed medication that did not pertain specifically to their 
condition and did not see the point in taking it.  However, others recognized that if one 
went a few days without taking their medication he/she would experience pain but only 
then would he/she recognize the effectiveness of their medication and then be willing to 
take their medication (Ledford et al., 2010).      
When patients with a chronic condition make decisions about their medication 
use, there must be an optimal trade-off between the benefits and the harm within the 
context of the patient’s health priorities (Ledford et al., 2010; Tinetti et al., 2004).  
Medications are purposefully prescribed by health care professionals to aid in the 
management of a medical condition.  However, for some the side-effects of prescribed 
medications outweigh the benefits.  Furthermore, patients have raised concerns about 
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being prescribed multiple medications and the long-term effects this will have on their 
body, which has prevented individuals from adhering to their prescribed drug regimen 
(Asbring, 2001; Kralik, 2012; Ledford et al., 2010).  See Figure 2, which is based on an 
accumulation of what has been outlined in the literature (Asbring, 2001; Kralik, 2012; 
Kreps et al., 2011; Ledford et al., 2010; Zhao et al., 2011).    
Figure 2. Effects of daily medication use on adherence behaviors 
 
The search for normality:  
 
 Commitment and concern to a patient’s drug treatment was also dependent upon 
the person’s beliefs and values.  Audulv et al. (2012) concluded that patient’s beliefs and 
Dependent on 
complications 
with illness
Affects of a 
daily drug 
regime
Substitution for 
medications
Limited choices
Knowledge and 
perception of 
medications
Commitment to 
daily decisions
Perception of 
health
Patient’s 
commitment to 
decision and 
perceived health
Affect on well-
being
Balance between 
condition and 
person
Life goals
Enhanced 
quality of life
Affected by:
• Frequency of 
dose
• Complexity of 
drug regimen
• Perceived need 
for medication(s)
Options for self-
management
Avoidance of 
putting 
medications in the 
body
23 
 
values included the participants’ views of themselves (i.e. their abilities to manage their 
condition), normality, and how one “should” live with a chronic condition.  This study 
consisted of 21 participants who were diagnosed with ischemic heart disease, rheumatic 
diseases, chronic kidney failure, inflammatory bowel disease, multiple sclerosis, and/or 
diabetes often in conjunction with other long-term conditions (asthma, breast cancer, high 
blood pressure, heart conditions, chronic pain, or fibromyalgia).   
Many participants spoke of the need to be a “good patient”; for example, one 
participant spoke of how a “good” diabetic should live and the importance of balancing 
one’s own life within the condition (Audulv et al., 2012).  Yet research has been unable 
to exemplify to what extent individuals sacrifice certain life goals due to their condition.  
As a result, how this is affecting the choices individuals are making.  More importantly, 
how can health care professionals help their patients maintain a balance between the 
patient’s life goals while managing their condition?  If self-management strategies can be 
easily integrated into a patient’s life, an increase in medication adherence may be a viable 
option.  Wagner et al. (2005) concluded that self-management was an active process that 
requires patients to make day-to-day decisions to manage their medical condition and that 
these decisions play a vital role in managing chronic conditions.  The effectiveness and 
quality of integrating self-management strategies into one’s life is a strong determinant of 
health outcomes (Wagner et al., 2005).  This may be challenging for patients to achieve if 
there cannot be a balance between the person and the medical condition.   
 Participants within Audulv et al. (2012), Kralik (2002), and Townsend et al. 
(2003) studies also spoke of the search for “normality”.  Many participants purposely 
limited their search for information about their condition because he/she did not want to 
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identify themselves as an “ill” person.  For some, normality could only be achieved by 
following a complex drug regimen to relieve distressing symptoms (Townsend et al., 
2003), while some purposely did not want to follow a drug regimen because it was not 
possible to live a “normal” life (Audulv et al., 2012).  One participant spoke of how, “it 
[the rheumatism] takes up too much space as it is, without becoming an illness” (Audulv 
et al., 2012, p.341).  This was also exemplified within Asbring (2001) and Charmaz’s 
(1994) study of the importance of maintaining the life patients once had before being 
diagnosed with a medical condition. 
It is evident individuals within these studies who were diagnosed with a chronic 
condition were unable to accept their condition and are purposely choosing not to accept 
information about their condition in return for a ‘normal’ life.  However, individuals are 
then sacrificing their health and as previously outlined by not adhering to treatment, it 
will result in potential enhanced side-effects and poor disease progression (Golay, 2011; 
Townsend et al., 2003; Wang et al., 2011).  Thus, how can patients expect to achieve 
‘normality’?  Research has been unable to clearly document what normality is for those 
with multiple conditions who are between the ages of 40 to 55 and are already considered 
to be relatively young to be diagnosed with a chronic condition (Townsend et al., 2003).  
Grounded theory will aid in generating a theory that will help explain or provide a 
framework validating the influence that the search for normality can have on the 
decisions made by individuals who are required to take multiple medications (Charmaz, 
1990).  The search for normality may cause patients to question their identity since 
patients are trying to integrate their disease into a life one previously had, which may not 
be a viable option if medication adherence is going to take place.   
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Patient identity and experience living with chronic condition(s): 
 
Charmaz (1994) considered the effects of being diagnosed with a chronic 
condition, which requires multiple medications, can have on a male’s identity.  Charmaz 
(1994) found that when men experienced a chronic condition it threatened their identity 
especially in middle-aged men; this was also found by Asbring (2001) in middle-aged 
women diagnosed with a chronic condition. Men faced identity dilemmas such as risking 
activity versus forced passivity, remaining independent versus becoming dependent, 
maintaining dominance versus becoming subordinate, and preserving a public persona 
versus acknowledging private feelings (Charmaz, 1994).  It is evident that being 
diagnosed with a chronic condition can threaten a men’s masculine identity since they are 
not in complete control of something (i.e. personal health) that they once were.   
Asbring (2001) and Kralik (2002) also found similar findings to Charmaz (1994) 
in women living with a chronic condition.  Women within Asbring (2001) and Kralik’s 
(2002) study spoke of the loss of control they felt over life circumstances and the need to 
retain their previous identity, which as previously cited was also experienced by males 
diagnosed with a chronic condition.  Living with a chronic condition meant physical, 
psychological, social, and economic losses yet it also entailed taking calculated risks, 
surrendering security, making choices, and taking risks (Kralik, 2002).  Unlike findings 
from Charmaz (1994), women embraced their condition(s) and reconstructed their 
identity to gain a sense of empowerment and control, rather than being a ‘victim’ of their 
health (Asbring, 2001; Kralik, 2002).  However, it was never outlined how power and 
control was achieved within a participant’s life and to what extent this affected choices 
made in adhering to their physician’s recommendations. See Figure 3 for a summary of 
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the literature with a focal point in understanding the patient has a whole (Asbring, 2001; 
Charmaz, 1990; Charmaz, 1994; Kralik, 2002; Kreps et al., 2011; Ledford et al., 2010).  
By implementing grounded theory, it will allow individuals to reflect on their experiences 
of being ill and more importantly the diversity of each experience (Charmaz, 1990).  It is 
important to consider how a chronic condition and the management of comorbid 
conditions affect an individual’s identity.  This may indirectly affect the choices made by 
patients in adhering to their prescribed drug regimen.  
Figure 3. How the condition impacts ‘the person’ and ‘the patient’ 
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a chronic condition and who self-reported not adhering to their drug regimen.  The 
majority of participants became concerned if side-effects started to appear after being 
dependent on their medication for a longer period of time; this exemplified how patients 
were in tune with their health but would only take action when it directly affected their 
well-being.   
Patients who claimed that non-adherence was due to the medication side-effects, 
based this behaviour upon the impact their medications had on their day-to-day activities 
and if symptoms were present that pertained specifically to the patient’s diagnosed 
condition (Kreps et al., 2011; Ledford et al., 2010).  If symptoms were not manageable 
and patients experienced unacceptable side-effects, adherence decreased because of the 
negative experiences associated with the medication (Kreps et al., 2011; Ledford et al., 
2010).  This resulted in a reduced commitment to the therapy (Kreps et al., 2011; Ledford 
et al., 2010).  However, if symptoms were manageable then there was little concern about 
the side-effects of the medication.  Also, if a patient experienced no side-effects then the 
patient had a higher conviction that the medication was the ideal treatment and were more 
likely to adhere (Kreps et al., 2011; Ledford et al., 2011).  Prescribed medications play a 
key role in managing symptoms, allowing individuals to carry out everyday tasks that can 
become central to one’s identity (Townsend et al., 2003).  By not adhering to a prescribed 
drug regimen it not only will affect the individual’s ability to perform day-to-day tasks, 
but will indirectly affect the patient’s identity if they are unable to control their health and 
perform tasks that were once possible.   
There have been gaps within the literature that have not been able to clearly 
demonstrate the extent to which adherence is taking place and how decision-making 
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directly affects adherence.  Kreps et al. (2011) study had numerous limitations since 
participants reported purposely not adhering to their prescribed drug regimen, raising the 
question of how it can be concluded that participants became concerned about side-
effects over an extended period of time if adherence was not taking place.  Furthermore, 
there was no conceptualization if the decision to not adhere to one’s treatment was based 
solely on the medication’s side-effects or if other factors played a role in affecting 
adherent choices.  Lewis, Robinson, and Wilkinson (2003) and Townsend et al. (2003) 
concluded that other factors do play a key role in choosing to adhere to multiple 
medications – participants purposely did not adhere to their drug regimen to avoid putting 
“pills and potions” into their bodies, which was stemmed from fears of dependency, side-
effects, and interactions with other drugs.        
Specific factors have been recognized in explaining why patients’ haven chosen 
not to adhere to their medications yet research has failed to outline interventions that 
could be implemented to counter non-adherent behaviors (Kreps et al., 2011; Ledford et 
al., 2010; Townsend et al., 2003).  However, poor adherence is still affected by the 
severity and presence of the patient’s side-effects.  This could be improved if physicians 
explained the benefits and side-effects of the prescribed medication and would be an 
ideal intervention option (Golay, 2011; Kreps et al., 2011; Nair et al., 2002; Osterberg & 
Blaschke, 2005).  Also, patients must be willing to actively communicate with their 
physician about the side-effects experienced, providing physicians with the opportunity 
to outline the importance of the medication despite the side-effects associated with the 
prescribed medication.  Active communication between a patient and physician has been 
found to have positive associations with medication adherence (Gold & McClung, 2006; 
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Kreps et al., 2011; Ledford et al., 2010; Lewis, Robinson, & Wilkinson, 2003; Pittman, 
1999; Zhao et al., 2011).  However, there is conflicting literature citing communication 
with physicians has posed as a barrier to medication adherence for patients living with a 
chronic condition (Golay, 2011; McDonald et al., 2002; Osterberg & Blaschke, 2005; 
Wagner et al., 2005). 
Patient-Physician Communication 
The effects of physician communication: 
 
  Physicians must be able to communicate the effectiveness of a proposed treatment 
and explain to patients the negative side-effects that could occur due to poor adherence 
(Ledford et al., 2010; Osterberg & Blaschke, 2005).  Physicians should be asking patients 
about experienced side-effects, if the patient understands the purpose of their 
medications, and explain the benefits of the prescribed treatment (Ledford et al., 2010; 
Osterberg & Blaschke, 2005).  These specific questions can be a tool used by physicians 
to expose patient’s poor adherence and allow patients to raise any concerns regarding 
their treatment.  A study conducted by Nair et al. (2002) included 88 patients (mean age 
was 54; prescribed a minimal of 2 medications), who felt that they received minimal 
information about their medication and were frustrated that they were not provided with 
enough information regarding the side-effects and risks associated with their treatment.  
Participants felt if they had full disclosure about their condition, they could make more 
informed treatment decisions.  In a study of 2 500 respondents, 76.2% wanted full 
disclosure about all possible adverse effects of their medications (Nair et al., 2002).  This 
validates the influence physicians have in patient’s decision making and the importance 
of providing patients with information regarding their condition and treatment options. 
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Physician communication may indirectly affect patient’s poor adherence by not 
providing information regarding the patient’s condition.  Health care providers directly 
affect patient-related causes of poor adherence by prescribing complex drug regimens, 
being unable to address patient’s concerns about their illness and treatment options, not 
supporting the patient’s treatment decisions, and not considering the patient’s lifestyle.  
As a result, patients are intentionally missing appointments to avoid communication with 
physicians (Golay, 2011; McDonald et al., 2002; Osterberg & Blaschke, 2005; Wagner et 
al., 2005).   
It is ironic that patients are purposely missing appointments when the literature 
has cited the importance patients place in communicating with their physician and how 
physicians are typically the patient’s primary source of information (Gold & McClung, 
2006; Kreps et al., 2011; Ledford et al., 2010; Lewis et al., 2003; Pittman, 1999; Zhao et 
al., 2011).  This was also reflected in a study conducted by Audulv et al. (2012) where 
participants viewed physicians as their primary source of information and when patients 
asked their physicians for advice regarding their conditions and did not receive any 
suggestions, patients automatically concluded that the self-management strategies he/she 
were implementing were irrelevant.  Furthermore, health care providers only gave 
information about specific self-management strategies (i.e. medication and diet) rather 
than supporting the patient’s ongoing self-management integration (Audulv et al., 2012; 
Nair et al., 2002).  This is a hindrance to patients and affects the choices patients are 
making in following their physicians recommendations if the patient’s efforts are being 
dismissed. 
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Patients whose physicians communicated poorly were at a 19% higher risk of 
non-adherence than patients whose physicians communicated well (Ledford et al., 2010) 
and when appointments are often limited in time it is necessary for the physician to be 
able to communicate the importance of adherence (Wagner et al., 2005).  The 
effectiveness and perception of information may vary based on the physician’s role in 
managing the patient’s health.  Patients may be more inclined to share information with 
their family physician versus a specialist he/she is required to see.  Furthermore, access to 
varying health care providers was not the only barrier but access regarding the health care 
system was also a cited issue by patients.  Audulv et al. (2012) found that some 
participants were accustomed to the health care system while others described how their 
limited knowledge of the health care system posed difficulties in accessing treatments.  
Patient-physician communication is extremely influential in determining the extent that 
patients adhere to a drug regimen and should be considered when developing effective 
health interventions. 
Understanding the person with the chronic condition(s): 
 
 Through candid communication, the physician must tailor the treatment according 
to each patient while recognizing the values and beliefs of the patient.  According to the 
chronic care model (CCM) there needs to be an understanding of the illness and the 
person, not just the disease, which is necessary if patient-centred care is going to be 
achieved (Kaufman & Birks, 2009; Tinetti et al., 2004; Wagner et al., 2005).  
Unfortunately, most clinicians focus on disease-specific outcomes.  However, patient 
priorities are more variable, specifically for those with multiple health conditions (Tinetti 
et al., 2004).  When physicians prescribe a medication it is primarily based on the 
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benefits of the medication(s) but patients will base a decision to start or continue a 
medication on the side-effects experienced, the time required for the medication to be 
effective, convenience, and cost (Tinetti et al., 2004).  Physicians must be able to 
recognize the basis of the patient’s decisions and resolve the inherent tension of 
prescribing for the disease and prescribing for the patient.  Refer to Figure 4 for a 
summary of what has been outlined in the literature in patient-physician communication 
(Audulv et al., 2012; Charmaz, 1990; Golay, 2011; Kaufman & Birks, 2009; Law et al., 
2012; Nair et al., 2002; Osterberg & Blaschke, 2005; Tinetti et al., 2004; Townsend et 
al., 2003; Wagner et al., 2005). 
Figure 4. Patient-physician communication 
 
Lack of understanding 
between the patient 
and physician
Can result 
in..
Patients 
require and 
want…
Partnership between 
patient and physician
Physician supportive of 
patient's decisions
Communication of 
physician (Is it clear? 
Motivational? Relevant?)
If 
achieved
…
Increased medication 
adherent behavior
Full disclosure of 
medications to make an 
informed decision
Treatment tailored to the 
person
Patient’s role in 
management of health
Ability of physician to 
report medication benefits 
and side-effects
Patient not understanding 
the purpose of 
medications
Patient not communicating 
with physician
Unable to address 
patient’s concerns
Lack of support 
from physicianPhysicians ability to 
engage patient
Patient’s role is 
valued
33 
 
Furthermore, physicians need to take a holistic approach in understanding the 
patient as a whole, as previously exemplified individual factors impact a person’s ability 
in adhering to a prescribed drug regimen (Audulv et al., 2012; Charmaz, 1990; Golay, 
2011; Law et al., 2012; Osterberg & Blaschke, 2005; Townsend et al., 2003).  The 
physician should consider individual differences when determining the best method in 
presenting treatment options and in exemplifying the importance of the selected 
treatment; this can be reflected in the health care system’s ability to properly train 
physicians to elicit patient’s individual differences and then prescribe a treatment that is 
tailored to the individual.  Those with chronic conditions exhibited better rates of 
adherence, if one knew the medication was prescribed for them ‘personally’, rather than a 
standard medication used for anyone with that condition (Nair et al., 2002).  Recognizing 
the patient as an individual will aid the physician in prescribing medications and should 
be considered by healthcare as whole not collectively among physicians. 
Research has suggested that in order to improve medication adherence, it is 
essential that there be a realistic assessment of the patient’s knowledge, an understanding 
of the patient’s beliefs regarding treatment options, and communication needs to be clear, 
sensitive, and motivational when addressing barriers to medication (Kaufman & Birks, 
2009; Kreps et al., 2011; Svarstad et al., 1999).  Furthermore, overall better health 
outcomes have been found in patients who play an active role in the management of their 
health, in setting self-management goals with the aid of their physician, developing action 
plans, and are provided with support from their physician (Wagner et al., 2005).  To 
achieve improved health outcomes, certain variables must be considered by the 
physician.  For example, the cost of medication needs to be considered by physicians, 
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specifically how this barrier varies based upon individual differences. Physicians need to 
ensure the patient understands the importance of taking a prescribed medication and the 
rationale behind the treatment.  Physicians must be able to communicate the benefits of 
the medication(s) despite the associated risks and how the benefits outweigh the side-
effects or risks associated with the prescribed treatment.  However, despite the literature 
citing the importance of patient-physician communication it is still uncertain to what 
extent this impacts adherent behavior.  Furthermore, there is minimal literature that has 
been able to exemplify how various relationships with numerous health care providers 
(i.e. family physician, specialists, and pharmacists) effect a patient’s ability to follow a 
prescribed a drug regimen.  
The Health Care System in Canada 
Structural barriers: 
 
Canada’s health care system has been cited as a barrier to medication adherence 
and it is not understood to what extent this barrier affects individual’s choices to follow 
their physician’s recommendations.  Schoen et al. (2010) compared and contrasted the 
health care systems of 11 different countries, Canada being one of them.  3 302 Canadian 
participants were sampled and when adults were asked if they were able to see a doctor or 
nurse the same day care was desired, Canada was rated the lowest at 45% versus 93% of 
adults from Switzerland indicating that it was possible.  When adults were asked if they 
had to wait more than 6 days to see a physician, Canada had the highest percentage at 
33% compared to the United States where only 19% of adults had to wait more than 6 
days to see a physician when care was needed.  Finally, Canada had the highest 
percentage of 41% in having to wait more than 2 months to see a specialist versus 
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Australia where only 28% cited this as being an issue.  This study exemplified that 
Canada’s health care system was not easily accessible and may explain individual’s 
hesitancy in wanting to seek health care. When individuals avoid seeing their physician 
because of long wait times, patient’s decisions become limited due to increased severity 
and progression of their condition.   
Ledford et al. (2010) conducted a study that included 30 participants who were 
diagnosed with various chronic conditions who were over and under the age of 50.  The 
health care system posed a challenge to participants, specifically through difficulties in 
scheduling appointments, contacting their physician via telephone, and getting refills on 
prescriptions (Ledford et al., 2010).  However, Ledford et al. (2010) did not specify the 
mean age, the age range of participants, or the number of chronic conditions with which 
participants were diagnosed.  As previously illustrated, age and the number of chronic 
conditions patients were diagnosed with, directly affected adherence and the impact of 
barriers varied based on individual factors.  Specific variables within the health care 
system such as physician communication contributed to the patient’s ability to adhere to a 
drug regimen.    
Treatment options: 
 
Interventions need to be implemented that attempt to re-structure the health care 
system by improving the availability of physicians and the physician’s ability to 
communicate with patients.  If this solution is not attainable, then patients should be 
provided with alternatives, such as the increased availability of nurse practitioners to 
address immediate concerns the patient has and the use of pharmacists to refill 
prescriptions and be a source of information.  Kreps et al. (2011) and Nair et al. (2002) 
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concluded that although pharmacists were the most accessible source of information for 
patients, pharmacists are at a disadvantage in providing information to patients because 
they lack access to the diagnosis that engendered a prescription.  If pharmacists are 
unable to provide patients with immediate and credible information, patients have no 
choice but to seek information from other less reliable sources.  This may affect the 
patient’s ability to make informed decisions regarding their health.   By having the 
patient play an integral role in their own health and treatment, the patient may be more 
inclined to adhere to a drug regimen if the value of their role in improving their own 
health is clear.   
Kaufman and Birks (2009) and Lewis et al. (2003) concluded that it is necessary 
to incorporate the patient’s preferences and values into treatment decision making but the 
rationale behind a patient’s treatment decisions is poorly understood.  Research has 
emphasized the importance of patient-centred care, which is characterized by promoting a 
better understanding of the patient’s life, empowering the patients, and tailoring treatment 
to the patient’s needs and preferences (Golay, 2011; Tinetti et al., 2004; Wagner et al., 
2005).  However, the literature has been unable to exemplify how or if patient-centred 
care improves adherence and the affect it has on a patient’s decision making, specifically 
in those who are required to make decisions on a daily basis.  Through the use of 
grounded theory it will provide insight into the meanings patients attach to their treatment 
decisions and how their decisions are constructed (Corbin & Strauss, 2008; Patton, 1980).  
There has been minimal literature to demonstrate how choices are made over time when 
individuals are dealing with a condition on a daily basis.  However, it is still essential to 
evaluate medication adherence interventions and the strengths and pitfalls within the 
37 
 
interventions.  This will aid in designing a framework for physicians in understanding 
what needs to be done to improve patient adherence.           
Evaluation of Medication Adherence Interventions 
 
 When reviewing the barriers that have prevented individuals from adhering to 
their medications, interventions need to be implemented that target a specific population 
while considering individual differences.  It is important to develop interventions that 
increase adherence to prescribed medication to improve individual and public health 
(Golay, 2011; Kennedy & Morgan, 2006; Kreps et al., 2011).  However, there still is no 
direct link between effective interventions that result in improvements in clinical 
outcomes or the effect decision making has on adherence interventions (Golay, 2011; 
Kreps et al., 2011; Ledford et al., 2010; Zhao et al., 2011).  Interventions that have been 
deemed successful are typically complex and costly, yet there is no standardization in 
determining what is considered ‘adherent behaviour’ and thus, what classifies an 
intervention as successful.  For example, some clinical trials consider treatment outcomes 
to be considered effective if adherence is greater than 80% versus other trials that require 
95% adherence for the results to be significant and the intervention successful 
(McDonald et al., 2002; Osterberg & Blaschke, 2005; Peterson et al., 2003).  If there is 
no standardization in determining the successfulness of interventions then it is 
challenging to determine if one intervention is more effective then another.  However, 
interventions have been developed that specifically target the barriers that have been 
addressed by patients.  Interventions utilized to improve medication adherence can be 
social and economical, healthcare oriented, therapy-related, and patient-related. 
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Social and economical:  
 
 When measuring medication adherence, it should be cost effective, easy to use in 
the clinical practice, relevant, informative, and non-invasive (Golay, 2011; Wagner et al., 
2005).  However, no current intervention meets this criterion.  Devising an intervention 
that is relevant is challenging since, as previously outlined, adherence varies based upon 
the individual factors.  Interventions have been implemented that have attempted to 
address socio-economic factors associated with poor adherence.  Physicians have been 
trained to offer tailored explanations about treatment options to address illiteracy while 
considering the patient’s level of education (Golay, 2011; Svarstad et al., 1999; Tinetti et 
al., 2004; Wagner et al., 2005).  However, this is assuming that the physician is able to 
make appropriate conclusions about the patient’s level of education.  As previously cited 
patient-physician communication is a common barrier to medication adherence, 
questioning the effectiveness of using tailored communication as a means to improve 
adherence.   
Medical social workers have been provided to families who cite unemployment 
and unstable living conditions as a barrier (Golay, 2011).  By providing families with 
help, patients and their families are able to have access to social security, housing and 
other benefits (Golay, 2011).  Furthermore, social support has been associated with 
improved medication adherence.  Interventions have been developed that focused on the 
use of patient groups that allowed individuals to speak with others who experienced 
similar hardships (Audulv et al., 2012; Golay, 2011; Kaufman & Birks, 2009).  These 
interventions also served as an additional method for patients to discover other self-
management strategies (Audulv et al., 2012; Golay, 2011; Kaufman & Birks, 2009; 
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O’Neil & Morrow, 2001; Pittman, 1999).  Patient groups may help to improve knowledge 
and address social isolation, especially if the condition is rare.  However, when reviewing 
the interventions that have been implemented to address socio-economic factors, none of 
the interventions quantified the costs and consequences associated with the various 
methods utilized to improve adherence.  Furthermore, there was no assessment of 
reliability or validity in determining what interventions were effective or if there were 
any clinical outcomes associated with the interventions.  If socio-economic factors are the 
focal point for interventions, then cost and accessibility needs to be further considered to 
target the population that is primarily affected by this barrier.     
Health care – oriented:  
 
 To improve medication adherence, it is important to evaluate interventions that 
focus on one of the most crucial aspects of medication adherence – the health care 
system.  Research has demonstrated that adherence has improved based on the 
communication between the patient and the healthcare professional (Kreps et al., 2011; 
Ledford et al., 2010; Lewis et al., 2003; Pittman, 1999; Wagner et al., 2005; Zhao et al., 
2011); a meta-analysis of 48 studies found a statistically significant correlation between 
improved patient-physician communication and better medication adherence in those 
with a chronic condition (Gold & McClung, 2006).  Relationships between health care 
professionals and the patient should be built upon trust to facilitate open communication 
and engender a patient’s confidence in the professional’s recommendations (Golay, 2011; 
Ledford et al., 2010; Osterberg & Blaschke, 2005; Wagner et al., 2005).  Interventions 
have been developed that have provided health care professionals with high-quality 
training on how to educate patients about diseases and available treatments (Golay, 2011; 
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Kaufman & Birks, 2009; Svarstad et al., 1999).  Physicians were also trained on how to 
elicit the patient’s perspectives since patients were more likely to adhere to a drug 
regimen if one played a role in the treatment decision (Golay, 2011; Ledford et al., 2010; 
Lewis et al., 2003; Wagner et al., 2005).  This process is referred to as ‘patient centered 
care’ (PCC), which responds to the information needs and desires of the patient (Ledford 
et al., 2010; Tinetti et al., 2004; Wagner et al., 2005).  PCC was associated with higher 
levels of patient perceived satisfaction and has resulted in overall improved health 
outcomes (Ledford et al., 2010).  When evaluating PCC, Ledford et al. (2010) did not 
outline clinical outcomes.  Therefore, the results were not transferable, since the 
improved health outcomes and the beneficiaries were not specified.   
 Furthermore, Wagner et al. (2005) found that interventions that have been 
designed that encourage greater patient involvement have increased patient satisfaction 
and may positively impact health behaviours.  Yet the findings were mixed and it could 
not be concluded how effective PCC was.  Brehaut et al. (2003) also found that 
interventions designed to increase patient involvement have many benefits for patients, 
including greater confidence in treatment decisions, improved knowledge, more realistic 
expectations of the health outcomes, clarification of personal values, and improved 
feelings of support.  However, an issue with patient-centred interventions is if a poor 
health outcome occurs causing the patient to regret their decision; the patient will play a 
less active role in future treatment decisions and will be less likely to adhere to their 
medications because of their minimal involvement in their treatment choices (Brehaut et 
al., 2003). 
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 Interventions have also been implemented that have focused on re-structuring the 
health care system.  Systems have been developed to aid in reminding patients of their 
appointments specifically through the use of telephone and letter reminders, referred to as 
‘cue-dose training’ (Golay, 2011; Osterberg & Blaschke, 2005; Tinetti et al., 2004).  
Furthermore, clinics have re-structured the hours of operation, providing the option of 
evening appointments which has resulted in shorter wait times (Golay, 2011; Osterberg & 
Blaschke, 2005).  For example, clinical attendance rates and medication adherence 
improved in young adults with type 1 diabetes that had the option of evening 
appointments and were reminded of scheduled appointments via telephone, versus clinics 
that had conventional hours and did not proactively remind patients about appointments 
(Wills et al., 2003).  However, cost effectiveness was not considered for any of these 
initiatives and may not be feasible for clinics that do not have the resources to provide 
evening appointments or scheduled reminders; despite the proof that these factors 
improve medication adherence.  
 Finally, certain interventions have focused on using a multidisciplinary approach 
involving pharmacists, nurse practitioners, and physicians as a means to improve 
medication adherence.  Research has demonstrated that community pharmacists can help 
improve adherence by identifying non-adherent behaviors amongst patients and aid in 
implementing solutions (Nair et al., 2002; Raynor et al., 2000).  Non-adherent behaviours 
can be determined by reviewing pharmacy refill records and drug claims, which is an 
objective and inexpensive method of measuring adherence over an extended period of 
time (Svarstad et al., 1999).  Interventions have been implemented that have focused on 
the use of therapy management services for those with chronic conditions (i.e. offering 
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appointments to discuss therapy, offering personalized packaging, finding a peer sponsor, 
and regular telephone calls), which has resulted in improved adherence.  However, 
further research needs to be done in utilizing a multidisciplinary approach instead of 
focusing on each factor individually or claiming to use a multidisciplinary approach when 
this is not taking place.  For example, this approach should question: how can physicians 
communicate with community pharmacists in improving adherence amongst patients who 
clearly exemplify non-adherent behavior?  If physicians are unable to elicit the patient’s 
perspectives regarding treatment options, can a nurse practitioner be expected to do so?  
Each member of a multidisciplinary team will be able to offer solutions that could be 
effective if done individually however if health care professionals are able to work 
collectively together, medication adherence interventions may be more successful in 
catering to the patient’s needs and understanding the rationale of a lay person’s choices.    
Therapy – related: 
 
 The primary objective of therapy-related interventions is to modify the patient’s 
drug regimen according to their lifestyle.  However, this can only be achieved if patients 
are able to recognize that the treatment benefits outweigh the costs and adverse effects of 
the selected treatment.  Systems have been developed that have been aimed at reducing 
medication frequency while integrating medication schedules with the individual’s 
lifestyle (Golay, 2011; Peterson et al., 2003; Wang et al., 2011).  A systematic review of 
20 studies found that all trials reported higher medication adherence (based on electronic 
monitoring) with lower dosing frequency regimens (Kaufman & Birks, 2009; Saini, 
Schoenfeld, Kaulback, & Dubinsky, 2009; Wang et al., 2011).  Patients who were 
receiving once-daily regimens were 22% to 41% more adherent than those taking 
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medications three times a day and 2% to 44% more likely to adhere than those using 
twice-daily regimens (Saini et al., 2009).  However, this may not be a reliable 
comparison based on the large range between the percentages in determining adherent 
behaviour. Yet there was still improvement in adherence illustrating that by altering dose 
schedules it may be an effective intervention.   
Wang et al. (2011) formulated an intervention which focused on altering dose 
schedule that were ‘less rigid’ and coincided with daily times (8:00 a.m., 12:00 p.m., 6:00 
p.m., and 10:00 p.m.); with some fluctuations, give or take an hour.  There was an 
improvement in medication adherence, however the results did not outline to what extent 
adherent behavior was exhibited or the characteristics of the sample involved in the 
study; as previously exemplified, adherent behaviour can vary based on individual factors 
especially for those who are diagnosed with a chronic versus an acute condition.  
Furthermore, the objective of the intervention was to provide a ‘less rigid’ schedule yet 
times were predetermined indicating when medication should be taken.  If patients are 
being told when to take their medications, then their individual lifestyle is not being 
considered.  McDonald et al. (2002) conducted a scientific review and concluded that 
when considering interventions for those with chronic conditions, implementing changes 
to dose schedules was relatively simple, convenient, cost-effective, and has been 
somewhat effective in improving medication adherence.  Research has been able to 
exemplify improvements in adherent behavior by modifying the patient’s drug regimen.  
However, further research needs to investigate the use of low dose frequency regimens 
that can produce significant clinical outcomes while evaluating patient decision making.     
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Patient – related: 
 
 When developing interventions that are focused directly on the patient, there 
needs to be an emphasis on formulating treatment options that patients feel they have 
some control over and want to implement (Asbring, 2001; Charmaz, 1994; Kaufman & 
Birks, 2009; Kralik, 2002).  Patients need to feel a sense of control over something since 
those with a chronic condition can only control their condition to a point.  Interventions 
have been implemented that focus on improving dose schedules by using pill boxes to 
organize doses (Dosette boxes), simplifying the regimen to daily doses, and cues 
provided to remind patients to take their medications (Golay, 2011; Osterberg & 
Blaschke, 2005; Peterson et al., 2003; Tinetti et al., 2004).  In combination with this the 
physician should address any lay beliefs about the disease(s) and provide the patient with 
education on the pathology and the importance of treatment.  Also, periodic monitoring 
and reinforcement should be consistently conducted to help patients in overcoming 
intentional and unintentional poor adherence (Golay, 2011; Osterberg & Blaschke, 2005; 
Tinetti et al., 2004).  The framework of a patient-oriented intervention was reviewed by 
Golay (2011) and Osterberg and Blaschke (2005); however, the effectiveness of the 
intervention or who the intervention was specifically targeting was never outlined. 
 Interventions have also been implemented that focused on helping patients 
recognize non-adherent behaviour, which was measured through the use of pill counting 
and patient diaries.  Pill counting and patient diaries are relatively straightforward to use 
in measuring adherence, are inexpensive and convenient, but are extremely subjective 
(Golay, 2011; Osterberg & Blaschke, 2005; Svarstad et al., 1999).  Pill dumping and 
patient diaries can produce misleading results due to patients’ under-reporting non-
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adherence (Golay, 2011; Osterberg & Blaschke, 2005; Svarstad et al., 1999).  However, 
to counter the issue of pill counting, Medication Events Monitoring System (MEMS) was 
developed as an innovative method to monitor non-adherence.  MEMS is a 
microprocessor that records the date and time of each bottle opening, with each opening 
counting as a dosage (Golay, 2011; Svarstad et al., 1999).  This tool may be effective in 
improving medication adherence but may benefit the patient more if used in combination 
with a self-reported measure such as patient diaries since patients can dispose of the 
tablet with the device still measuring that the medication was taken.  There have been no 
interventions implemented that have focused on the use of MEMS to improve medication 
adherence in those with chronic conditions between the ages of 40 to 55 who are required 
to take more than three medications.  However, research may benefit by investigating the 
use of this tool with other subjective measures.            
 When creating interventions, there are numerous options that can be the focal 
point in ensuring medication adherence.  By using a socio-economic approach, additional 
resources such as the use of a medical social worker and social assistance are provided to 
the patient to aid in adhering to their drug regimen.  Furthermore, interventions could 
focus solely on re-structuring the healthcare system and provide physicians with training 
that emphasizes the importance of PCC.  If patients are required to take multiple 
medications, the use of low dose frequency schedules may improve adherence.  Patients 
are not always aware of non-adherence and this behavior can be unintentional.  The 
implementation of devices (i.e. pill counting, MEMS, Dosette boxes, calendar packs, 
patient diaries, etc.) will help the patient in recognizing when medication is not being 
taken and when it should be taken.  However, when reviewing the various approaches to 
46 
 
medication adherence interventions, it is evident that no approach clearly produced 
clinical outcomes or exemplified how patients are making choices to adhere to their drug 
regimen.  Many of the strategies outlined that adherent behavior was improved but never 
to what extent or who specifically exemplified this behavior.  This demonstrates the gaps 
in current research and the importance of developing a process-evaluation plan that 
considers each step of the intervention needed to evaluate the experiences of individuals 
diagnosed with a chronic condition (Charmaz, 1990).  This justifies the importance of 
evaluating the choices made by individuals between the ages of 40 to 55 who are 
prescribed more than 3 medications.  The literature available has been unable to provide a 
rationale of the decisions a lay person is making pertaining to their health.  
Chapter 3: Methods 
 
Theoretical Framework: 
 
 According to Corbin and Strauss (2008) theoretical frameworks are essential in 
providing a justification for research and serve as a guide throughout the research 
process.  The purpose of this research is to provide health care providers with a 
framework to aid in understanding how patient’s decisions are made in medication 
adherence, the rationale behind these decisions, and the meanings patients associate with 
these decisions.  Symbolic interactionism is a theoretical framework that bests supports 
this purpose.   
 Symbolic interactionism is ‘the study of human beings interacting symbolically 
with each other and with themselves, and in the process of that symbolic interaction it 
involves making decisions and directing their streams of action’ (Charon, 1989, p.140).  
There is not a focus solely on individuals interacting but also what is happening within 
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the person – the person acts according to a world he/she defines, which is influenced by 
the interaction with others and how one defines themselves (Charon, 1989; Soloski & 
Daley, 1978).  However, there is a constant, variable interaction between the self and 
others.   
‘Altercasting’ involves casting people into a role that ‘we’ want so that the person 
starts to think of themselves in that manner and behave in that way (Charon, 1989).  
Previous literature has exemplified how individuals who are diagnosed with a chronic 
condition struggle with their identity and over-compensate in roles previously held to 
avoid being labelled as ‘ill’ (Asbring, 2001; Audulv et al., 2012; Charmaz, 1994; Kralik, 
2002; Townsend et al., 2003).  This may be explained through the concept of 
‘presentation of self to others’, which outlines that one acts around others according to 
the identity he/she has claimed and chooses to represent to others (Charon, 1989).  Not 
only is the person labelling themselves but is assuming that others are labelling them.  
Thus, this influences what ones does and how one acts.  By considering ‘altercasting’ and 
‘presentation of self to others’, it may provide insight during data analysis in rationalizing 
how medication choices are being made and the direct effects of healthcare decisions on 
self-identity.   
A key tenet of this theoretical framework is humans purposely act towards 
objects/others by the meanings associated with it and human acts are intended to 
communicate a message (Charon, 1989; Schou & Hewison, 1998; Soloski & Daley, 
1978).  The acts people communicate become symbols and in turn other’s actions are 
interpreted and viewed as intentional communication, which becomes a ‘significant 
gesture’ (Charon, 1989).  Meaning to the person then becomes generated based upon the 
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social interaction with others (Schou & Hewison, 1998).  This is necessary to consider in 
relation to how patients choose to base decisions according to their physician’s 
recommendations.  By not adhering to one’s drug regime, a message is being 
communicated to the physician.  However, it is not understood the basis of this message 
especially if adherence to other medications are taking place.     
A symbolic interactionist perspective suggests that humans focus on what is 
relevant and useful directly for that person; ‘perspectives, facts, definitions, and ideas are 
all judged by the individual in terms of applicability’ (Charon, 1989, p.27).  If the 
communication aids the person in achieving their goals, then the information is applied 
(Charon, 1989; Soloski & Daley, 1978).  However, if it is not applicable then one will 
choose to alter the information or will choose to forget (Charon, 1989; Soloski & Daley, 
1978).  This then impacts the meaning individuals construct.  The meanings of objects 
vary according to the person and the purpose of the object determines the object’s 
meaning (Charon, 1989; Holstein & Gubrium, 2003).  When considering medication 
adherence, it has been previously outlined that a lay person will associate different 
meanings to their drug regimen (Audulv et al., 2012; Charmaz, 1994; Kralik, 2002; 
Townsend et al., 2003).  A drug regimen to some may be viewed as necessary in an effort 
to achieve normality or to retain one’s previous identity.  Others may view their drug 
regime as controlling or demanding and choose not to adhere to their physician’s 
recommendations.  Thus, the meaning behind adhering to one’s prescribed medications 
alters according to the person.   
Symbolic interactionism considers how multi-faucet people are and recognizes 
that decision-making is a continual process that is impacted by the interaction with 
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others, objects, and one’s self-identity.  This aligns with this research project, which aims 
to further understand the decision-making process patients are making regarding their 
personal health.  Also, the objective of this research study is to provide health care 
professionals with a better understanding of a patient’s decision in adhering to his/her 
prescribed drug regimen.         
Epistemological/ Paradigmatic Perspective: 
 
When considering what methodology to utilize it is important to situate oneself 
within a worldview, which will affect one’s epistemological perspective.  Epistemology 
is ‘the study of nature of knowledge and justification’ (Carter & Little, 2007, p.1317).  
Objectivism refers to reliable, checked, and controlled knowledge that is not distorted by 
personal bias or prejudice (Kvale & Brinkman, 2009).  The researcher and researched are 
independent from each other, with the ideal being that neither have an influence on the 
research process (Alvesson & Deetz, 2000).  Traditionally grounded theory, which will 
be the methodology utilized within this research, has been based upon objectivity 
(Denzin & Lincoln, 2011).  However, it would not be realistic to situate the researcher or 
the objectives under study within this epistemological perspective.  The researcher is not 
searching for a single, external truth and more importantly those involved within this 
study would not be viewed as “researched” but participants, recognizing that there is no 
relational hierarchy.  Therefore, the epistemological view would be within subjectivism.   
Knowledge is created within subjectivism through the interaction between the 
researcher and the participants (Alvesson & Deetz, 2000; Holstein & Gubrium, 2008).  
The researcher is connected to participants and creates the findings as the research 
process proceeds (Alvesson & Deetz, 2000; Holstein & Gubrium, 2008).  Subjectivity is 
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utilized as a pathway to deeply understand the human dimensions of the world in general 
as well as the phenomenon being examined (Patton, 2002).  Furthermore, the 
methodology serving as a basis for this project, constructivist grounded theory, 
recognizes the researcher’s role and the focus shifts away from the traditional grounded 
theory roots of objectivity and positivist to subjectivism and relativism (Denzin & 
Lincoln, 2011; Holstein & Gubrium, 2008).  The purpose of using constructivist 
grounded theory is to provide an increased understanding of the social structures within 
the health care industry and this can only be done through individual’s subjective 
experiences (Denzin & Lincoln, 2011). 
  It is vital that subjectivity serve as a basis throughout this research project since 
it is concerned with multiple truths that will be individualistic.  In order to gain rich 
descriptions, participants must be able to recognize the researcher as someone he/she can 
trust and share their personal experiences with.  By situating oneself within subjectivism 
it will reshape the interaction between the researcher and the participant; meaning will be 
co-constructed instead of focused solely on the participant (Mills, Bonner, & Francis, 
2006).    Given that the researcher will be maintaining a subjectivist perspective it seems 
appropriate that the worldview be situated within the context of the interpretative 
paradigm.   
 A paradigm is a perspective that aids in drawing out contextual factors and 
identifying relationships between context and process (Corbin & Strauss, 2008). The core 
belief of interpretivism is the reality that we know is socially constructed (Esterberg, 
2002; Gilboe, Campbell, & Berman, 1995; Willis, 2007).  The method the researcher will 
be utilizing (semi-structured interviews) relies on individual’s lived experiences and how 
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participants socially construct these experiences in relation to medication use.  Semi-
structured interviews are the best data collection method to use within this paradigm, 
since it seeks input from participants to create a representation of the individual’s reality 
(Gilboe et al., 1995).  What individuals say will determine the depth, richness, and 
authenticity of the research results.   
 The purpose of conducting research within this paradigm is to look for an 
understanding of a particular context (Willis, 2007).  There is no search for universal 
laws or rules (Willis, 2007).  This paradigm allows for flexibility and theory 
development, which is dependent on the researcher’s views and learning about the worlds 
of others (Creswell, Hanson, Clark, & Morales, 2007; Wuest, 2011).  This is also 
exemplified within the research methodology, constructivist grounded theory, which will 
be outlined in greater detail later.   
Interpretivism is based upon rationalism and relativism and since constructivist 
grounded theory will be used, which is concerned with the complexities of particular 
worlds, views, and actions (Creswell et al., 2011), it is beneficial to consider relativism in 
further detail.  Relativism is the reality that one perceives is conditioned by one’s own 
experiences and culture (Willis, 2007).  This is further influenced by anti-
foundationalism, which outlines that there is no secure foundation that humans can use to 
decide what is true and what is not (Willis, 2007).  This view of recognizing that there is 
no divine truth but that reality is shaped by experiences will serve as a basis during the 
analysis phase of my data collection.  An interpretative and subjective perspective will 
serve as a basis for this research project and provide further reasoning for selecting 
constructivist ground theory as the methodology.   
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Methodology: 
 
According to Creswell et al. (2007) and Moustakes (1994), grounded theory is 
used to generate an explanation or theory of a process, action, or interaction that is 
created through the voices of individuals.  Theory construction is based upon issues that 
are relevant to people’s lives and generated through the process of inductive research 
(Charmaz, 1995; Corbin & Strauss, 2008; Denzin & Lincoln, 2011; Mills et al., 2006; 
Patton, 1980).  Since the focus is on people’s individual experiences, grounded theory 
acknowledges multiple realities and truths.  The methodology is consistent with an 
interpretive worldview – the interpretations must include the perspectives and voices of 
the individuals being studied while recognizing the researcher’s role (Mills et al., 2006; 
Wuest, 2011).  The purpose of this research project is to provide a better conceptual 
understanding of the decision-making process for individuals who are required to take 
multiple medications.  Thus, it is important that participant’s views and voices become an 
integral part of the research process, which is why constructivist grounded theory will be 
an appropriate methodology to utilize.   
 Constructivist grounded theory focuses on the context, positions, discourses, 
meanings, and actions (Denzin & Lincoln, 2011).  The purpose is to learn how situations 
are defined and how power, oppression, and inequities affect individuals (Denzin & 
Lincoln, 2011).  Participants reconstruct their personal experiences and experiences are 
then used to show the complexities of particular worlds, views, and actions, which are 
rendered into theoretical interpretations (Creswell et al., 2007; Mills et al., 2006; Schou 
& Hewison, 1998).  As previously exemplified within the literature, medication 
adherence interventions have failed to recognize individual experiences (Britten, 2003; 
53 
 
Kreps et al., 2011; McDonald et al., 2002), which are extremely complex when 
considering the barriers that have been recognized in preventing patients from adhering to 
their prescribed drug regimen.  A constructivist approach assumes that reality is multiple 
and constructed under specific conditions (Creswell et al., 2007; Holstein & Gubrium, 
2008).  By using this approach as a guide each participant’s social constructions will be 
outlined with the intention of presenting emerging themes based upon the co-construction 
of meaning between the researcher and the participants.     
 Schou and Hewison (1998) outlined the importance of using constructivist 
grounded theory with chronic conditions.  By using grounded theory, the focus shifts 
away from the pathology and coping strategies when reviewing patient’s health accounts 
to instead a focus on self-stories and an exploration of experiences containing many and 
sometime contradictory voices (Schou & Hewison, 1998).  The literature has outlined the 
complications individuals with a chronic condition face, including the ability of one to 
accept their condition while finding a balance between the challenges with their health 
and their self (Asbring, 2001; Charmaz, 1994; Kralik, 2002; Tinetti et al., 2004).  This 
methodology recognizes that medication forces people to account for their condition and 
the handling of it in daily life and to legitimize one’s decisions to avoid societal backlash 
(Schou & Hewison, 1998).  Participants may have that commonality of being diagnosed 
with a chronic condition yet there may be differences in their experiences with living 
with a chronic condition.  This is why it is important when constructing interpretations to 
locate it within the participant’s experience (Schou & Hewison, 1998).  A constructivism 
approach to grounded theory makes the assumption that human beings each have their 
own diverse world that is shaped by the person’s views, beliefs, feelings, assumptions, 
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and ideologies (Creswell et al., 2007), which is consistent with this research project in 
recognizing each participant individually.      
 The purpose of using a constructivist grounded theory approach for this study was 
for several reasons.  This specific approach accounts for variations in behaviors (Wuest, 
2011).  This is necessary to consider if a patient’s individual experiences are going to be 
used to formulate a theory or framework for health care providers in understanding the 
decision-making process of a patient.  Furthermore, it will assist health care professionals 
in conceptualizing what is significant to the person and the ways that social and structural 
conditions influence how people manage their lives (Patton, 1980; Wuest, 2011).  Kathy 
Charmaz (1995) outlined that constructivism grounded theory is most suitable ‘for 
studying individual process, interpersonal relations, and the reciprocal effects between 
individuals and larger social processes’ (p.96).   Finally, this is an ideal methodology to 
use to generate a theoretical framework that could change individual practices, alter 
procedures, and shift policies (Patton, 1980; Wuest, 2011).  Thus, it is ideal to implement 
constructivist grounded theory if this purpose of the research is to be achieved.      
Interviews: 
 
 If a framework is going to be developed that will aid health care professionals in 
understanding a patient’s decision-making process then patients must be able to speak 
directly of these experiences.  Schou and Hewsison (1998) emphasized the importance of 
using a method that allowed the researcher to hear participant’s social accounts and view 
the person as a member of a social world who could contribute to changes in practices 
within the healthcare industry.  In order for participant’s voices to be heard, semi-
structured interviews are an ideal method. 
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 By using constructivist grounded theory as the methodology, interviews are an 
ideal choice because interviews explore and examine participant’s concerns.  This also 
gives the researcher control to continually develop and modify questions around these 
concerns, subsequently speaking to the participant’s experiences (Creswell et al., 2007; 
Holstein & Gubrium, 2003).  Holstein and Gubrium (2003) further outlined the 
importance of using in-depth interviewing with constructivist grounded theory because 
the interviewee has more direct control over the construction of the data compared to 
other methods such as ethnography or textual analysis.     
 Control of the data is a key variant of constructivist grounded theory but the 
participant’s experience must prevail.  The researcher must enter the interested 
phenomenon and work together with the participant to co-construct the data through 
interaction, which is best achieved through multiple, in-depth interviews (Denzin & 
Lincoln, 2011; Mills et al., 2006).  Therefore, the researcher should conduct multiple 
interviews when using a constructivist grounded theory approach since the interviewer 
may have to go back to the participant and ask additional questions to provide further 
theoretical insight (Holstein & Gubrium, 2003).  New questions are developed to provide 
insights that may have been missed during previous interviews and strengthen emerging 
themes within the data (Holstein & Gubrium, 2003).  However, based on time and 
financial constraints, one interview was conducted with participants. 
To guarantee that certain subject areas will be examined (i.e. specific barriers that 
have prevented patients from adhering to their prescribed drug regimen), an interview 
guide was used to allow for greater flexibility during the interview (refer to Appendix A).  
The interview guide was developed based on common questions exemplified in the 
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literature, specifically using the methodology of constructivist grounded theory while 
interviewing individuals who had a chronic condition.  Moreover, the interview guide 
was also piloted tested with five individuals, which resulted in alterations to the interview 
guide to allow individuals to speak more to the decisions they have made regarding their 
medication as well as an opportunity to develop comfort and trust with the lead 
researcher through the inclusion of icebreaker questions.  The interview guide was not 
only piloted on five individuals yet was reviewed numerous times by the researcher 
before each interview to ensure questions were consistent as participants were only 
interviewed at one point in time.  As interviews progressed, the order of questions were 
altered as well as questions were erased that resulted in repetition of responses.  Based on 
the researcher’s experience it became apparent that individuals concluded they were on 
medication based on certain experiences; thus, there was a focus on participants’ 
experiences related to them first being prescribed their medications. As Patton (2002) 
outlined, an interview guide serves as a basic checklist to ensure all relevant issues are 
covered and the same basic lines of inquiry are pursued with each participants.  This was 
the focus for the researcher as questions were never worded exactly the same yet there 
were common themes asked of each participant.  
Data Collection Procedures 
Sampling strategy:  
 
 Purposive sampling was used to recruit participants to gather information rich 
cases.  According to Carter and Little (2007), Esterberg (2002) and Patton (2002), 
purposive sampling is seeking rich experiences of a phenomenon of interest and is 
targeting a certain group with specific characteristics.  By using this sampling strategy, it 
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will provide an in-depth understanding of a specific phenomenon rather than result in 
empirical generalizations (Patton, 2002).  Theoretical sampling is typically used in 
accordance with grounded theory.  This form of sampling does not take place at a single 
point in the inquiry process but is a recurrent feature and at various times the researcher 
must go back to participants to collect more information around settings, events, and 
people (Hammersley, 2006).  However, by using a constructivist approach it does not 
require the researcher to follow certain guidelines or stringencies that are utilized in 
grounded theory such as theoretical sampling (Holstein & Gubrium, 2008).  Furthermore, 
theoretical sampling was not possible within the context of this research study as 
participants were interviewed at one point in time.   
Sampling recruiting procedures: 
 
Participants were recruited through various methods within the Niagara and 
Halton region.  Participants were recruited through referrals from a primary care office in 
Niagara, through Niagara Region Public Health, a physiotherapist office based out of 
Halton, and finally by the researcher through word of mouth.   
All participants in some capacity were provided with a summary of the research 
project (refer to Appendix C) and if interested the researcher’s contact information.  This 
led to participants contacting the researcher via telephone or email expressing further 
interest in the project.  The first conversation involved the researcher introducing the 
project, their background, and if the person met the sampling criteria (refer to Appendix 
D).  All participants agreed to participate during the first conversation.  If the person met 
the criteria, a letter of invitation (refer to Appendix E) was sent to the potential 
participants via email or provided before interviews began, which allowed the participant 
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to understand their rights as a participant, the purpose of the project, the implications of 
the project, and the requirements of participation.  Once this was reviewed, the potential 
participated agreed to participate either through email or telephone and a location and 
interview time was determined that met the needs of the participants.   
 Although each participant agreed to participate by signing an informed consent 
form (refer to Appendix F), they were verbally reminded that for whatever reason if they 
chose not to participate, to notify the researcher in advance of the interview time.  This 
affirmed their rights as a participant and respecting their choice to participate. 
Sample: 
 
 The researcher recruited 15 participants who met the sampling criteria.  This 
included: individuals between the ages of 40 to 55, currently taking three or more 
prescribed medications, and diagnosed with a chronic condition.  The recruitment of 
these participants followed the sampling criteria procedures as outlined above.  Table 1 
outlines the characteristics of the sample population including additional information 
such as their occupation and their employment status since based on analysis this 
appeared to affect one’s health condition. 
Table 1. Participant Bios 
Pseudonym  Case 
# 
Gender Diagnosis # of 
medications 
Occupation/employment 
status 
Abby 1 F  High blood pressure 
High cholesterol 
Type 2 diabetes 
Gastro-reflex 
Depression  
5 Office administrator  
(full-time) 
Monica  2 F Arthritis (multi-
joint) 
Neuropathy 
Partial paralysis 
 
9 Swimwear designer 
(part-time) 
Liz 3 F Type 2 diabetes 
Depression 
Anxiety  
7 Nurse 
(full-time) 
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James 4 M Type 2 diabetes 3 Customer representative 
(full-time) 
Nicole 5 F Hypothyroidism 
Type 2 diabetes 
Hypertension  
5 Coordinator  
(full-time) 
Galen 6 F Rheumatoid 
arthritis 
Osteoporosis 
Anxiety   
9 Office administrator 
(part-time) 
Lauren 7 F Type 2 diabetes 
High blood pressure 
4 Family home visitor 
(part-time) 
Krista 8 F  SI joint inverted 
Lower back pain 
Menopause 
3 Previous personal 
support worker 
(unemployed) 
Faye 9 F  Osteoarthritis 
Bipolar disorder 
Depression 
High cholesterol 
4 House wife 
(unemployed) 
Mikaela  10 F Reactive arthritis 
Anxiety 
6 Counts receivable clerk 
(full-time) 
David 11 M  Type 2 diabetes 
Depression  
3 Technologist 
(full-time) 
Simon  12 M Parkinson’s disease 
Crohn’s disease 
>3 Pro athlete 
(semi-retired) 
Julie 13 F  History of heart 
attacks 
Epilepsy  
Menopause 
9 Home visitor 
(part-time) 
Peter  14 M  Type 2 diabetes 
Diasyphlic epilepsy  
6 Sales  
(self-employed) 
 
Kelly  15 F  Thyroid disease 
Osteoporosis  
Acid reflex 
Type 2 diabetes 
High cholesterol  
5 Restaurant owner 
(full-time) 
 
Ethics:  
 
 The researcher reviewed in detail the Tri – Council Statement: Ethical Conduct 
for Research Involving Humans and conformed to these guidelines.  The researcher 
completed and submitted an application for ethical review of research involving human 
participants to Brock University’s Research Ethics Board (REB) and was granted 
clearance on March 30, 2013 (12-176-COSBY).  All REB protocols were followed to 
ensure confidentiality of the potential participants – all personal identifiers were removed 
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from the data and all identifying information was only known by the primary researcher.  
Numbers and pseudonyms were associated with each participant to ensure there were no 
linkages between the participant identifiers and interview data.  Pseudonyms were used if 
names were outlined within the data.  Participants were informed from the first 
conversation to when the interview took palace that all involvement was strictly 
voluntary and participants had the right to refuse participation at any time.  Before the 
interview took place this was also outlined in detail in the informed consent form. 
Data analysis: 
 
 According to Mills, Bonner, and Francis (2006) when using constructivist 
grounded theory the first step before analysis has taken place is conducting an extensive 
literature review.  The researcher conducted a literature review before data collection 
begun, which was extremely beneficial because there was a heightened awareness about 
what participants could discuss during the interviews and prepared the researcher for 
what participants may be sharing about their experiences living with often multiple 
chronic conditions.  The literature review also aided in determining questions to include 
as part of the interview guide to ensure there was a focus on participants’ experiences and 
best methods in asking questions regarding medication adherence or non-adherence in 
those with a chronic condition.  This was essential as based on time constraints, only one 
interview was conducted with participants and the researcher had to ensure that the 
appropriate questions were being asked and develop a rapport with participants in a short 
period of time.   
 Once a literature review is completed, recommended next steps for data analysis 
utilizing the methodology of constructivist grounded theory, include: line by ling coding, 
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focused coding, moving codes to concepts, moving concepts to categories, researcher 
engages in memo-writing, the analysis is built directly on the researcher’s interpretations 
of the data, and the analysis is compared to the literature (Charmaz, 1990; Charmaz, 
1995; Mills et al., 2006).  Transcripts were analyzed in chronological order with respect 
to the order the interviews were conducted and data collection and analysis occurred 
simultaneously to inform each other (Hesse-Biber & Leavy, 2008). 
 The first step of data analysis involved line by line coding.  The researcher 
defined the actions and events based on the words of participants (Charmaz, 1995; 
Denzin & Lincoln, 2011; Hesse-Biber & Leavy, 2008).  By using words directly from the 
interviews, this aided the researcher in distancing herself from participants’ experiences 
to maintain the authenticity of what the participant was saying.  This step helped to 
refrain from putting the researcher’s own motives and inputs into the collected data 
(Charmaz, 1995).  By going through the interviews in detail, the researcher started to 
build insight which helped to determine the data that still needed to be collected 
(Charmaz, 1995).  After coding the first transcript, the researcher went back to the 
interview guide and added areas to further pursue and deleted questions that did not add 
value to the overall project, with the intention of collecting data that was missed during 
the initial interviews (Charmaz, 1995; Creswell et al., 2007; Holstein & Gubrium, 2003).  
Finally, line by line coding allowed the researcher to go deeper into the phenomena and 
explicate the data; it gave the researcher the opportunity to interact with the data and gave 
direction on areas to pursue (Denzin & Lincoln, 2011; Hesse-Biber & Leavy, 2008).  
 The second step was very similar to the first step but coding became more 
focused.  The researcher took earlier codes that were reappearing and organized these 
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codes into larger pieces of data (Charmaz, 1995).  This allowed the researcher to 
determine what codes made the most analytical sense and led to concepts and eventually 
categorizing the data (Charmaz, 1995).  It should be noted that during this time, the 
researcher was very self-aware about why the data was being collected and realized that 
every participant had their own constructions of their health experiences despite all living 
with similar chronic conditions.  The researcher throughout the process respected each 
participant’s voice and looked at each transcript as if it had never been seen before. 
 Through line by line coding and focused coding, the researcher analyzed 
predominant codes and raised the codes to concept.  By raising a code to a concept a label 
was applied to certain data (Charmaz, 1995).  This step allowed the researcher to better 
organize the data instead of having long quotes of codes, key words were selected that 
kept prevailing in the stories of participants and made it more manageable when 
analyzing the data. 
 One of the most important steps was determining the categories.  Based on the 
researcher’s concepts, categories emerged in the data that were based on participants’ 
voices (Mills et al., 2006).  Categories were labelled with simple, direct, and vivid words 
to ensure the researcher knew exactly what the category meant.  To generate categories, 
the researcher compared participants who were diagnosed with similar conditions, 
compared the variations among all participants, compared data from the same individuals 
with themselves at different points in time, and finally the researcher considered 
individual’s experiences to what was said in the literature.  Categories were saturated by 
finding repeated evidence that supported the importance of moving a concept to a 
category (Charmaz, 1995).   
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During this step of the analysis, the researcher engaged in memo-writing.  The 
researcher would re-read transcripts over and over again while documenting her own 
ideas and thoughts.  This exercise was an integral part of the process because the 
researcher was able to organize the data easier, clarify what categories were major and 
what were minor, and captured what the researcher was thinking when reading 
participants’ personal accounts (Charmaz, 1990; Charmaz, 1995; Hesse-Biber & Leavy, 
2008).  The researcher was given the opportunity to elaborate on certain codes and this 
became a tool for engaging in on-going dialog with self (Charmaz, 1990).  Through 
memo-writing it created a heightened sense of awareness of predominant codes.  As data 
analysis progressed, the researcher went back to initial interviews and re-coded the data 
because at the time the researcher did not realize the importance in what the participant 
was sharing until the researcher heard similar accounts from others.  By writing memos it 
aided the researcher in examining one’s own thoughts that emerged with the data (Hesse-
Biber & Leavy, 2008; Starks & Trinidad, 2007).  This served as an ‘audit trail’ whereby 
the researcher reflected on emerging thoughts throughout the data, how it related to one 
another, and how engaging with the data shaped one’s understanding of the initial 
hypothesis (Starks & Trinidad, 2007).  Thus, clarity was established in what the 
participant was saying and the perceptions of the researcher.  
    Finally, during the analysis stage the researcher interpreted the data and 
presented detailed interview quotes.  By using data based on lived experiences, the 
researcher attended to how they constructed their own worlds (Charmaz, 1990; Charmaz, 
1995).  The researcher became immersed in the data and had a voice within the analysis 
but ensured the participant’s accounts were visible, so there was a connection between 
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the analytical findings and the data from which they were derived from (Charmaz, 1995; 
Mills et al., 2006).  Once the analysis was completed it was compared extensively to the 
literature.  This affirmed in some instances categories that were essential to include and 
also confirmed gaps within the literature.  As a result, the researcher focused on the 
categories that were not well supported within the literature, for example there was 
minimal research for why individuals with health coverage were not adhering to their 
medications; the researcher went back through the participants’ transcripts to find 
answers to the questions that were not consistent with the literature.   
 Furthermore, throughout the data analysis the researcher consistently met with the 
primary supervisor.  These meetings became essential as there was discussion after the 
first few interviews to modify the interview guide to address the purpose of the question.  
Furthermore, as interviews progressed there was constant discussion around themes that 
emerged throughout the interviews, with a realization of what the predominant themes 
meant, which impacted the overall analysis.  After the initial analysis, the primary 
supervisor provided extensive feedback that required the researcher to go back through 
participants’ transcripts with a more objective outlook on participants’ experiences.  By 
going through this process, themes and categories changed with a focus more on an 
overarching realization of a common theme of the meanings that participants associated 
with their medications.  By engaging in continual discussions and having the primary 
supervisor provide feedback on the initial analysis, it ensured the validity and reliability 
of the results.  
 By following the methodology of constructivist grounded theory, the results are 
presented in explicating participants’ meanings and actions associated with living with a 
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chronic condition.  Meanings were co-constructed between the researcher and the 
participant. Thus, when reading the results section there needs to be awareness of the 
voices of the participants; however, the researcher provided perceptions and descriptions 
of what was said.  
Chapter 4: Results 
 
 The purpose of this study was to develop a theory on the process of decision-
making regarding medication adherence in individuals between the ages of 40 to 55 who 
are required to take three or more prescribed medications.  Specific organizational factors 
from the literature (i.e. the costs of health care, individuality, patient-physician 
communication, and Canada’s health care system) were evaluated and served as a basis 
for the development of interview questions, which led to the discovery of predominant 
themes.  Based on the experiences of participants, themes emerged around ‘balance of 
medications with the rest of my life’, focusing on the key concepts that kept re-emerging 
throughout the interviews.  
The ability to self-manage one’s health, relative to balancing of multiple 
medications, led to variance of choices among participants. Self-management is not 
necessarily an indication of engaging in positive self-management strategies but is 
referring to how an individual manages their medications in relation to their life, leading 
to decisions of adherence or non-adherence.  Balance of medications with the rest of the 
person’s life emerged throughout the data with underlying themes of individuals referring 
to sacrifices in certain aspects of their lives, the inability to function because of their 
prescribed medications, and rationalizing not adhering to their medications.  This resulted 
in fear – fear of the future and fear of having to be dependent on one’s medications, 
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which was ironic because even when dependency was recognized this did not result in 
adherence.  Finally, by the individual having to manage their condition and even when 
the person felt ‘in control’, this never resulted in a sense of security.  Security was not 
possible because of the constant decisions individuals with a chronic condition have to 
make on a daily basis. 
The data serves to answer the original research questions of determining the 
factors that influence individuals decision to adhere to a drug regimen and understanding 
how specific factors affect the person’s ability to adhere or not adhere to their prescribed 
drug regimen. This project focused on giving a voice to participants and providing 
respondents the opportunity to share their experiences of living with a chronic condition, 
potentially for the rest of their lives. For a more comprehensive list of quotations to 
support the results outlined, refer to Appendix G. 
Ability to ‘self-manage’ chronic conditions and multiple medications 
 
The ability to manage a condition was multifaceted in those living with a chronic 
condition (often co-morbid conditions).  Some participants spoke of engaging in self-
management strategies while others spoke of their ‘excuses’ for not doing so.  For some, 
if they could continue to work (maintaining the privacy of their condition), became a 
method to self-manage their condition and medications.  While almost all individuals did 
not want to rely on their medications ‘I’m a failure because now I have to take pills, pills 
are for old people – I’m not an old person’ -P4(4) and almost all participants recognized 
that their medications only helped to a certain point and ‘[...] medicine that helps you 
cure something, hurts you in other ways’ -P2(7).   
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Origins of chronic condition(s):  
 
Those who believed that they could have prevented their condition blamed 
themselves for having to be on their medications because of their decision to ignore the 
deterioration of their health.  In their view, since their behaviors led to them becoming ill, 
changes in behaviour could also lead to controlling or even reversing their medical 
condition(s).  In other words, self-management created the problem, so it should also 
resolve the problem. 
Maybe it is my fault because when I hurt myself I took a few days off and I 
thought that was treating it.  I didn’t even dawn on me to go to physio or 
anything like that.  I just thought this is the job, you end up with a sore back 
and you suck it up […] I like to get up and I like my clients but now I can’t 
do anything.  And I don’t see it changing, I don’t see my back getting any 
better, it’s been a year and a half. -P8(1) 
 
Well I know exactly how I got mine [referring to Parkinson’s disease] it was 
from getting hit.  If you go to the CNE and ride the bumper cars for a couple 
minutes, banging into things, the buzzer goes off, you get off.  But if you do 
that all day long, 4-5 hours a day for 30/40 years something is going to 
happen and fall off the map, and that’s what happened. -P12(4) 
 
Those who did historically ignore their bodies’ spoke of adhering to their medications 
and wanting to do more to manage their condition because of the blame they already 
placed on themselves for having to be on multiple medications.  Some individuals were 
more likely to adhere because they thought their condition was ‘their fault’.  It was a 
prevalent theme of individuals aware that something ‘was not right’ before they went to 
see a healthcare professional. As James outlined, it was easier to make excuses then to 
face the reality of it.  This was very different from individuals who felt that their 
condition was not their fault but that due to genetics they were ‘predisposed’. 
I have something that’s genetic; actually he has it too, my doctor.  That 
makes me say you ate what I ate and we both ate the same thing.  I would 
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get sick and you wouldn’t.  I have a certain type of cell that predisposes me 
to get what I got. -P10(2) 
 
They said do the exercise and watch your carbs and all that stuff but 
honestly I think if it’s going to happen to people, it’s going to happen.  And 
I’m totally predisposed with my whole family. -P1(1-2) 
 
Those who felt they had no choice in their health because of being predisposed 
to their chronic condition, were less likely to engage in self-management 
strategies and despite their condition being viewed as inevitable, purposely did 
not always take medication or take any preventative action.  Individuals who 
were ‘genetically predisposed’ or viewed their condition as their ‘fault’ had a 
sense of awareness of their condition and the medication needed to manage their 
condition.     
This mind frame was very different for those who had a mental illness, 
who were often unaware of their behaviours and how it potentially impacted 
others, “I hadn’t realized what I was like and I think that’s it.  I think I’m totally 
normal”-P1(5).  It often took loved ones to let the person know how they were 
acting for the person to be aware of their own behaviours, as their lack of 
awareness of their behaviours was a result of making the decision to not adhere 
to their medications.   
The impact of others to self-manage condition and medication use: 
 
Loved ones also became a central role in many participants’ lives in managing their 
condition and medications through the support of helping the person integrate their ‘new’ 
self with their ‘old’ self.  This support came in the form of aiding the person in making 
the first steps in asking for help, in adhering to their medications, in engaging in self-
management strategies such as exercising and healthy eating, and potentially the most 
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important form of support – helping in tasks the person was once capable of doing but 
was no longer an option.  However, not all were fortunate enough to receive any form of 
support and at times had to manage alone. 
I have difficulties with the people in my house and my diabetes and finally 
my husband is a huge problem and I think I’ve finally got it through his 
head that we can’t do this I need to eat at 6 o’clock we cannot eat at 8:30 at 
night.  Like we’re workaholics in our house, all of us are and that’s not a 
good thing […] I don’t know he doesn’t care, he just ignores me […] How 
have I been supported?  I support myself. I come here, I do my exercises I 
do my work and I get no cooperation from anyone about anything so 
basically I just truck on.  -P5(6) 
 
[…] I grew up with the mentality ‘you’re fine, why can’t you be happy’?  
You know my parents used to be like ‘why are you so unhappy?  What’s 
wrong?  Why can’t you be just fine?  Just think nicer things’.  You try to do 
that but it still has that stigma…-P1(2) 
 
In the accounts outlined above, participants saw no other choice but to manage their 
condition themselves.  This led to an increase in non-medication engagement strategies, 
such as dieting and exercising, and these individuals were more likely to pay for 
additional treatments such as physiotherapy and counseling.  However, this did not 
predict medication adherence – all admitted at some point to non-adherence, questioning 
if there were support mechanisms in place, would they be more likely to adhere to their 
medications?    
Those who had support recognized the power of support in helping them manage 
the challenges they face every day. 
...a lot of time I can’t pull up my frigin pants or hold a fork or whatever.  He 
[referring to her husband] does it with stride.  I can’t open bottle – he does it 
for me, little things that are stupid.  I’m frigin 46 years old I should be able 
to open my own bottle. -P9(5) 
 
My husband is a great supporter.  Ken is really good and if I do ever get in 
anxiety attacks or anything he’ll just be like ‘you’re okay, you’re here…we 
don’t need to do anything, take some deep breaths, think of something else’.  
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He’s really good.  My kids know about it, they’re all good, they know I go 
up and down kind of thing. -P1(4) 
 
Individuals were able to manage their condition with the help of their partners, who often 
helped with their drug regimen.  The medication became something significant to their 
partner as well because they saw the value in their partner adhering to their medication, 
so would help if possible.  Other participants discussed a process of support that only 
developed when their partner also experienced a setback in their own health.  This helped 
their partner to fully conceptualize what they have had to endure and to justify having to 
be on multiple medications.  
I think Ken did and said I’m not sure if this is a good idea but you see at the 
time Ken wasn’t taking a lot of drugs either.  So he was like ‘why are you 
taking a lot of drugs’?  But now you see he has too, so he realizes that those 
drugs are keeping him alive while these ones are keeping me alive.  So I 
don’t think he was as supportive back then as he is now. -P1(5) 
 
This illustrates the lack of awareness regarding management of a chronic condition and 
how an individual with a chronic condition rely on their medications to help them 
manage their conditions.  The support from loved ones seems to influence a person’s 
decision-making regarding their own health.  Whether it is in the form of positive or 
negative support, the person with the health condition is aware of what they need from 
others.  However, in the end it is the person who is on multiple medications who decides 
to engage in self-management strategies. 
The ‘success’ and ‘failure’ associated with self-management: 
 
With some making the effort to engage in self-management strategies, some were 
confused as to why they were still diagnosed with a physical condition, “I exercise I don’t 
eat bad and I run now so there really isn’t any reason why I should have high blood 
pressure”-P10(4).  Others were aware that they should be engaging in some form of self-
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management strategies beyond taking their medications but still have been unable to do 
so.  This was attributed to age, stress at work, routines of everyday life, and not having 
the time.  All participants knew they were making excuses and placed blame on 
themselves for not being in more control of their health. 
I don’t know if it’s just the lifestyle we have now a days, it’s so readily 
available – you have a big TV, you have movies, sports, watching hockey.  I 
mean you get the exercise bike you can sit and watch it while doing it or 
take the dog for a walk.  Walk the dog a couple of blocks every day but you 
just make excuses and it’s easier to fail then to actually succeed. -P4(5) 
 
I got a hole in my stomach and the surgery was in April and it didn’t heal 
until September.  And that’s probably part of the diabetes, which is my fault.  
It is what it is; we stopped and never have gone back to it [referring to going 
swimming].  We want too but we have never seem to have gotten around to 
it. -P1(7) 
 
By not engaging in other strategies besides taking their medications, James and Abby 
spoke of blaming themselves and the fear of failing.  Despite Abby’s disinterest in doing 
more physically for her health, she has admitted to being a ‘pill popper’-P1(2) for her 
‘physical conditions’.  This shows the complex relationship people have with their 
chronic condition and the rationale behind selecting treatments, in that individuals are not 
following all suggestions but are determining what works within the context of their life. 
Those participants who have accepted that they may have their condition for the 
rest of their life, wanted to do more to manage their condition and wanted to have greater 
control in managing their medications. 
When I got injured I didn’t know the first thing about arthritis, it wasn’t in 
my family.  I didn’t know the first thing about disability, any of that stuff.  
Until it happens you just go on with your life but I’m not a passive 
personality.  Some of this I can control, some of it I cannot control.  I think 
it makes me feel a little more balanced; education is where that balance is 
and what’s for me to find out and to do my homework sort to speak and 
when to seek out answers. -P2(5) 
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Individuals became aware of what they had to do to manage their condition, recognizing 
that medication alone was not enough.  This was also reiterated by participants who 
wanted to self-manage their condition by being able to seek additional help but who were 
unable to do so because of many factors, including: the time it took to receive help when 
it was needed, the out-of-pocket expenses, and not ‘qualifying’ for help when requested. 
For example, Abby spoke of wanting to see a psychiatrist since she knew this could help 
her with her depression but she recognized that by the time she was able to see this 
specialist she would have already forgotten her problem.   
I had a really bad time and I went to see her [referring to family physician] 
and she asked if I wanted to see anyone else.  I said no because I go to see 
her I get the appointment the same day, right?  By the time I get an 
appointment with a psychiatrist, those feelings will be gone and I’ll sit there 
being like ‘I’m fine, how are you?’ -P1(3) 
 
For those with a mental illness, many spoke of wanting counselling but were unable to do 
so because they could not afford it or had to wait until they were at a ‘low’, which 
justified their out-of-pocket expenses.  This is a fault in the system since many 
recognized the need for treatment beyond medications. 
I think one thing that’s missing in all of this is some kind of counselling and 
how illness can impact your life because I called up the mental health 
people after I had the incident on the street and said I think I need to see 
somebody, this is really scary what happened here.  They asked me all of 
these questions ‘are you suicidal’?  No I’m not suicidal.  ‘Are you clinically 
depressed’? No but I’m in a tough situation and I think it would be best to 
talk to someone, to have a neutral third party that’s not involved. ‘No we 
can’t do that, it’s not available’. And I thought the stress that comes from 
having a chronic illness, the leg that’s not being addressed here is mental. -
P2(11) 
 
These feelings resonated with many participants – living with a chronic condition is not 
something that is short-term and there is a greater need beyond medication.  Participants 
felt there was something inherently wrong when medications were covered through 
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insurance plans but having the opportunity to speak to someone about their experiences 
due to their condition(s) was not.   
For individuals to be able to afford their medications and any additional out-of-
pocket expenses such as counselling, almost all participants spoke of having to be 
employed.  Being employed became a form of self-management as it allowed individuals 
to afford additional resources beyond medication.  Employment also played another 
important role for participants, as it provided a method to maintain a part of their life that 
gave them a sense of ‘normality’, in that they could resume the life they had before they 
were diagnosed with a chronic condition and having to take multiple medications. 
The ability to continue to work and maintain privacy:  
 
Many associated being employed with achieving a sense of normality and this was 
viewed as a reflection on their capacity to self-manage their condition.  This became 
related to the ability to maintain the privacy of their condition and their medication use; 
many spoke of the importance of wanting ‘no one’ to know ‘anything’. 
I’m surprised I’m saying all of this […] Because I’m so private with my 
medication, I mean nobody here knows anything [referring to workplace].-
P6(4) 
 
By maintaining privacy it allowed participants to continue to maintain elements of their 
‘old’ life before they had to take multiple medications.  For example, working affirmed 
that their condition(s) and medications were managed, as they were able to maintain that 
part of their old self who was able to work and keep their condition private because of the 
ability to maintain who they once were and avoid ‘being treated differently’-P13(9). 
Well I was diagnosed with Parkinson disease 14 years ago but I kept quiet 
about it for 13 years […] I ran into the problem that I had to hide it. I had 
to hide it from everybody and that became more of a problem for me 
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because if everyone found out I had Parkinson's disease I thought that they 
would shun me away from any TV or projects I wanted to do. -P12(1,3) 
 
Simon spoke of the need to ‘hide’ his condition to be able to continue to work because 
of the fear of what others would think if they knew he had Parkinson’s.  For Simon, his 
medication became pivotal because he had to be able to manage his condition to ensure 
the privacy of his condition.  Some participants went as far as not telling their family of 
their condition or that they had a heart attack to protect them, “you can’t talk to your 
family about that kind of stuff [referring to her personal health] because then I worry 
about them worrying about me” -P2(11).  Julie had a strong belief in self-management 
and made the decision to endure her condition alone because of her strong beliefs in 
privacy and not wanting to place stress on anyone else but herself. 
  For some they were unable to self-manage their condition, even with medications, 
and had no choice but to quit their job or were limited in their workplace and in one 
instance it also resulted in losing loved ones.  
I don’t want to continue like this. It’s affecting my work; I can’t be at work 
as long as I would like to be […] my grandkids for picking them up and 
stuff.  Going out and just doing regular activities and things, I’m limited for 
what I can do and for how long, so it’s difficult. -P15(4) 
 
[…] it was 4 years into the period [referring to not being diagnosed but ill] 
that I didn’t work she was tired of quote “of looking after me” quote.  We 
had a young child at the time I think her comment was “I don’t want to look 
after 2 babies”.  She had gotten a promotion and I had found out she had 
gotten a boyfriend. -P14(4) 
 
Being on medication only helped manage participants’ symptoms to some degree, but the 
side-effects still limited their ability to think clearly and they did not have the confidence 
in their ability to return to a working environment or could only work for a certain period 
of time and felt defeated because they wanted to be able to do more.  For Peter, his 
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inability to manage his condition with the proper medication caused loved ones around 
him to lose confidence in him and it resulted in him losing his wife and child. Julie also 
spoke of a similar experience of not being prescribed the proper medication and unlike 
previous examples where participants chose to quit their jobs due to their condition, Julie 
was fired from her job because of her medication. 
Then in December I passed out, well almost passed out but I didn’t pass out. 
My blood pressure was so low; my pulse was so low like it was at the 
general meeting.  So managers were all there, whatever, the OA here was 
serving my lay off paper the next day […] I was flipping.  I had to go to my 
union rep.  What had happen was the pharmacy screwed up; the name on 
the bottle was not the medication in the bottle.  I wasn’t supposed to take it 
in the morning; I was supposed to take it at night.  It was like 3 weeks, I was 
a zombie. -P13(3-4) 
 
Julie adhered to her medications and instead of resulting in an improvement in her life, it 
meant losing her job and losing the privacy she had tried so hard to maintain in her life.   
Thus, her medications became the culprit in her job loss, and she cultivated a complex 
rationalization of timing her decisions to consume or not consume her medications. 
The theme of ‘self-management’ demonstrates the variance in behaviours and 
choices between individuals who are diagnosed with a chronic condition (often 
overlapping conditions).  Engagement in self-management strategies that involved the 
person choosing to do more for their health was not an indication of medication 
adherence. For example, a person who exercises to control their blood pressure may not 
take their medications, whereas another participant may take their blood pressure 
medications but choose not to exercise. In the current study, the perceived origins of their 
medical conditions, support from loved ones, employment, and the ability to maintain 
privacy, all intertwine with perceptions of self-management to contribute to the choice of 
consumption of medications. 
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The choice of sacrificing medication use 
 
Despite the reliance on medications to function, which many experienced through 
non-adherence, this did not predict the decisions individuals were making to continue to 
live their life.  Almost all participants spoke of having to making sacrifices that affected 
their health because of the costs of their medication, the costs of additional treatment, and 
making the choice to provide for others versus themselves. 
‘Meds are very important but...’: 
 
The costs of medications can often limit a person’s decision to adhere to their 
medications.  This was expressed by some that because of the expenses already in their 
lives (i.e. car and house payments) and having minimal coverage, sacrifices were often 
made:  
They want to remove some of the tissue, they want to remove half of it so it 
releases the pain but they won’t cover it for this one [referring to her left 
breast].  So I have to pay $6 000 for this one [...] I was supposed to have 
surgery July 16
th
 but I cancelled because I didn’t have the money. -P13(2,9) 
 
I don’t go buy new clothes when I see it or I’ll have to do without […] I cut 
down on groceries, certain things I would’ve bought before.  $10 t-shirt 
even, I cut back because I know my prescriptions are $250 I have to back off 
on other things, so we did […] as long as I have my pills, I’m okay or I 
would be sitting her sweating. -P8(5)  
 
Sacrifices were made that resulted in individuals not taking the recommended doses to 
make their prescriptions last longer, limiting spending even for basic necessities.  Krista 
and Julie associated costs with their health.  For Krista this meant having to decide what 
medications were essential while not adhering to others in order to cover the costs of 
prescriptions that were viewed as a ‘necessity’.  Julie had to determine if medical 
treatments were deemed as ‘necessary’ if it meant out-of-pocket expenses that were not 
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feasible based on her current prescription costs and having already maxed out her 
benefits. 
Individuals also attempted to rationalize their medication consumption, and despite 
doing everything possible to provide for themselves and their family, it was often not 
enough.  This resulted in, “I would miss pills for a couple days because I didn’t have the 
money […] I mean meds are very important but I mean I have to feed the kids”-P7(6-7). 
For some, this meant rationalizing not taking lifesaving medication and losing function, 
however, there was more value in providing for others versus themselves.  Julie spoke of 
losing her coverage and being unable to afford her medications but decided to sacrifice 
her own health to aid her son in buying a new house, “I’m giving him my savings to buy it 
[referring to a house] for him and his girlfriend”-P13(9.)  Sacrifices were made because 
to some there was no other choice. Lauren and Julie associated greater meaning in being 
able to provide for their family as opposed to the value in their medications; recognizing 
that having to take multiple medications does not only impact the person but others as 
well.  
The fear of living with a chronic condition 
 
‘Fear’ was a feeling all participants were able to resonate with.  There was 
constant fear of the future with a focus on the fear of losing one’s medication coverage 
despite having medication coverage and fear from comparing themselves to others who 
had the same condition. Fear was also directly related to the increased dependency on 
medications and the fear of what this entailed – medications were essential for the person 
to live even if this meant having to live with the side-effects.  This required participants 
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constantly having to make decisions regarding their medications, which lead to the 
question of, ‘have I made the right decision?’    
The fear of the future: 
 
Individuals living with a chronic condition have to constantly make decisions 
regarding their health affecting their ability to ‘live’ their life.  Almost all participants 
spoke of having to be on their medications for the ‘rest of [their] lives’, which resonated 
with feelings of fear because of the implications of this.  The word ‘fear’ was not 
necessarily used but below the surface it was apparent that individuals were constantly 
thinking long-term of what could happen because of having to be on multiple 
medications. This led to discussions around medication coverage.  The majority of 
participants had some form of coverage but there were diverse views on ‘would I adhere 
if I did not have my coverage’? 
The costs are fine because Ken’s plan is really good.  If I had to pay for it 
on my own […] I’d probably still do it because what would the 
consequences be? So I’d probably have to find some way of doing it. -P1(6) 
 
I’m covered for everything right now and I have a really great pharmacist 
who doesn’t charge me the little bit extra […] I worry about when I retire 
though because I’m on already a slew of meds and as you get older you just 
get put on more meds, so this is going to be quite brutal, so I worry about 
that but then I think I’m not going to retire so it doesn’t matter. -P3(8) 
 
Participants hypothesized what would happen if they lost their coverage at retirement or 
from some other reason even though this question was never asked.  Abby outlined that 
she would have to find other strategies to cover her medications because she was not 
willing to experience the consequences of non-adherence and was aware of her 
dependency on her medications to function.  Participants considered the future and what 
being on medications entailed – how there is this deep realization that there is a 
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dependency on medication to live and thus on medication coverage to be able to afford to 
live. 
Many participants recognized how grateful they were for their coverage yet this 
also meant having to live below the poverty line to quality for medication compensation.  
Those who suffered from depression, anxiety, or were simply overwhelmed by having to 
live with a chronic condition every single day, outlined the need for better treatment 
beyond having to take multiple medications. 
[…] John’s work covers the cost of medication but it doesn’t cover the 
therapy.  So if I go in to see a psychologist, it comes out of my pocket or 
John’s pocket, that’s hard so I really pick and choose when I need it.  So if 
I’m really low then I’ll go see them […] it runs from $150 to $250 per hour 
and nothing is healed or fixed in an hour.  Right now I know I have to go to 
therapy and I have this lady on speed dial and I’m just waiting.  It’s like 
‘I’m okay, I’m okay I think I don’t need it, I’m okay today’ because all I 
have to do is call her and get in that day but I know one hour is not going to 
do enough so 5 hours at $200/hour. -P9(6) 
 
[…] for me to go see a therapist privately is a minimum $140 an hour, I 
don’t have that kind of money and the reason for that is I have to be so 
broke to get my meds covered. -P2(11)   
 
The costs of alternative treatments, such as counselling, effect an individual’s decision-
making by forcing them to only seek counselling when it is potentially too late.  
Individuals are then living in fear of the unknown because there is an awareness that 
individuals have to wait until there is no other choice, questioning whether those who 
suffer from a chronic condition could better manage their condition if the option of 
additional treatment was available.  The fear of the unknown was not limited to the costs 
of treatment and medications but the fear of what could happen due to their condition.  
This resulted in many individuals comparing their condition to others who were 
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diagnosed with the same condition and had experienced something negative due to their 
condition.  
Participants spoke of individuals they knew who had died because of health related 
issues.  This led to varying perceptions of their conditions, with some viewing death as 
inevitable while others were fearful of what could happen. 
I do know one guy who died in his sleep from a diabetic problem, he was 
insulin diabetic and he went to sleep one night and didn’t wake up.  So I 
think it’s’ fear that if I don’t take those ones, the physical ones that 
something is going to happen. -P1(5) 
 
My dad passed away from leukemia he didn’t know, he had gone for a 
checkup 5 months earlier then he passed away and then my brother just 
over a year later passed away and he was 51 at the time but he didn’t really 
take care of himself.  I mean heavy smoker and his eating habits weren’t the 
greatest.  I kind of was like when I’m 50 I have to go and see him [referring 
to his family physician]. -P4(2) 
 
In James’s case the fear of seeing his father and brother pass away, led him to see his 
family physician and get diagnosed with type 2 diabetes.  By witnessing the death of a 
family member, it seemed to put life in perspective.  For Abby, the fear of what could 
happen if she did not manage her condition resulted in an increase in adherence for the 
‘physical’ medications but this was not a consistent behaviour with her other 
medications. 
When outlining the impact of their conditions, there was often a comparison to 
others who were diagnosed with similar conditions.  Participants sought affirmation in 
knowing that they were not the only one who was ill, some went as far to outline that 
they were more in control of their condition compared to others. 
I’ve seen other people recently as recent as last summer that were playing 
with their medications and they were suffering from depression but they 
weren’t handling it, they were abusing it.  Where they would self-medicate 
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dosages, it would be like I’m going to meet people so I’m going to take a 
handful.  No, now you’re just high. -P11(4) 
 
Individuals would compare their experiences to others often in an attempt to figure out if 
what they were experiencing was ‘normal’.  Fear then became associated with what could 
happen if non-adherence took place and how dependency of medications can become an 
addiction.      
Despite the comparison to others, which resulted in fearing for the future because 
of the awareness of what living with a chronic condition could entail, this did not predict 
medication adherence.  Once again there was variance in adherence behaviours with 
some believing they needed certain medications over others (thus, choosing what 
medications they needed) and others having an increased dependency on their 
medications, with some fearful of what this meant. 
The fear of dependency on medications: 
 
 All participants recognized the need of their medications to live their life yet this 
was contradicted by almost all participants who, as interviews progressed, admitted to 
purposely not taking their medications.  However, for some there became a moment 
when they realized that despite not being able to have ‘tangible’ results with their 
medications, their experiences reaffirmed the value in adhering to their medications. 
Well I’ll tell ya, it’s an oxymoron, I’m a pill popper with the Metformin and 
that but I just get to the point where I’m like I’m taking way too many drugs 
and I would stop taking for something like that because depression I think 
for the last 10 years has never been realized as a disease and see I grew up 
with the mentality ‘you’re fine, why can’t you be happy’? I could lose that 
one and could be happy but I can’t lose the Metformin because that’s 
tangible, you can see it, the blood pressure. -P1(2) 
 
[…] we were on the water and I got one on the bike and I almost took him 
and me out on the bike. And I had stopped taking the medication because I 
had gone on it at first but I’m better now, everything is good.  When that 
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happened I was just beside myself and my doctor said ‘oh my god you never 
should’ve gone of that.  You might just need that, you might have to be on it 
for the rest of your life, you might just need that edge’. -P10(2-3) 
 
When people could not see the direct benefits of their medications or that their condition 
was not recognized as a ‘disease’, for them it was an indication that they no longer 
needed their medications.  However, participants associated that because they were 
‘taking too many drugs’ and the effects of their medications were not ‘tangible’ – the 
meaning in the medications altered because they no longer wanted to be dependent on 
something.   
 Those who suffered from depression or anxiety had a very different meaning 
associated with their medications than others.  There was a greater fear in these 
individuals because almost all recognized that certain situations would trigger a 
heightened awareness of the need for their medications and that they could not control 
their condition during these situations with self-management or their prescribed doses of 
their medication. 
Sure I’ve got the medication but the medication is okay but that’s not going 
to last me forever...if anything slight goes off in my family life. -P9(6) 
 
I’m a single parent. And I was briefly married […] I shouldn’t say briefly it 
was 7 years and he was a gambler and I found out about that after.  He 
disappeared a few years ago, I have a feeling people were after him but he 
left without saying anything to her either. -P3(7) 
 
Certain factors such as fear, having to care for others, relationships ending and 
becoming an empty nester were all linked to stress.  Stress was a factor that led 
certain individuals to perceive they had less control of their condition(s) and in 
some circumstances resulted in higher dosages of their medications.  
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 Many spoke of the dependency on their medications to function in everyday life.  
Some recognized that without their medications, they would not be able to live any type 
of normal life, resonating with feelings of fear because of the unknown, what would 
happen if their prescription ran out, if they lost their coverage, or if their medications no 
longer had the same effects.  For some, the fear of dependency could be addressed by 
reducing their consumption of medications.   They did not want to put ‘pills’ in their 
body because it would eventually increase their dependency on their medications. 
[...] and I said to Marcus if I don’t have my morphine tonight, I will be 
going through withdrawals in the morning and I’ll be  basket case – I won’t 
be able to do anything. -P9(4) 
 
I don’t want to take it but I can’t function, I have to take it.  Like the Celexa, 
the antidepressant thing there, no I can do good with that low dose I don’t 
want to be on anymore then I have to be on and that little bit is sustaining 
me.  So I’m good with that but the other medication I have to take it or else I 
won’t be walking down the street and for Estrogel if I didn’t take it I 
wouldn’t be sleeping.  So to function in life you need sleep and I need to 
walk so. -P10(8) 
 
Medication became a means for participants to ‘function’ in their life but this was not an 
indication of the person ‘living their life’.  Faye clearly outlined how many participants 
felt that adhering to prescribed medications was a contradiction – one needed their 
medications yet even when one took their medications this did not always mean one 
could live the life they wanted to.   
With my morphine I take, still today, it’s been 2 years; every morning when 
I take it I can’t function for about 2 hours.  Every night I take it, I’m a write 
off because you know my body is just and you know with the hydromorphine 
you should be able to work, still be able to drive a car and live a normal 
life, you’re body has come accustomed to it, my body wont, it refuses to 
become accustomed to it. -P9(4) 
 
Faye’s experiences spoke to many participants’ experiences that even with a dependency 
on medications this did not always equal functionality, yet participants would still 
84 
 
continue to take their medications even thought this did not allow the person to ‘live a 
normal life’.  Living a normal life was related to the person being able to perform tasks 
they were once capable of doing; however, due to restrictions of their condition and often 
the side-effects associated with their medications, this resulted in limitations and having 
to come to terms with their ‘new normal’. 
 Identity dilemma of the ‘old normal’ to the ‘new normal’  
 
For many living with a chronic condition it resonated with feelings of being 
‘disappointed’ in themselves and ‘too young’ to not only be diagnosed with a chronic 
condition but on multiple medications.  All participants spoke of the moment when they 
were diagnosed with a chronic condition and what this experience meant to them.  This 
became the pivotal moment for many having to shift from who they once were to moving 
to a ‘new normal’.  A new normal became “having something that is moving forward is 
really, really important […] if you have no sense of possibility you get stuck”-P2(13).  
Individuals had to find ways to move forward, which involved medications.  
Emotions associated with being first diagnosed:  
 
 When individuals first heard they were diagnosed with a condition, it became a 
pivotal moment in their life.  There was variance in emotion with some being ‘upset’ 
while others were in shock, almost in denial, because they perceived certain people to 
have certain conditions and they did not think they would ever be one of those people 
who were diagnosed with a chronic condition. 
I was really upset because I’m not a medication person and at the time the 
only thing I ever took was Tylenol when I had pain.  So when I first found 
out and I was put on medication because they also found out I had the 
osteoporosis as well so I had to go on medication for that and I cried and 
was really upset because I’m not a pill person.  So I felt a big huge setback 
kind of thing. -P15(1) 
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And the diabetes was a complete surprise to me […] I didn’t think I was the 
type of person for diabetes – there was no history in my family, I was not a 
heavy person at all until after I quit smoking and when I was younger I was 
pretty active but smoking and the job and lifestyle just slows you down.  But 
I really didn’t think I was a target for diabetes. -P11(2) 
 
Being upset and surprised with the diagnosis meant for many having to be on 
medications.  This to some was more upsetting than knowing they had a chronic 
condition because it entailed having to be on medication, which to them was viewed as 
‘failing’.  Others found solace in their diagnosis because for them it provided an 
explanation of what they were experiencing.    
I think it actually was kinda a relief that I could chalk this up to me not 
being an ass. -P11(3)   
 
Relieved […] because I had 10 years of symptomology with no diagnosis 
and I’ve been unable to work and I was fighting insurance companies and I 
had seen 27 specialists so finally someone put a name on it and the 
insurance companies get happy and life is good. -P14(1) 
 
By getting diagnosed this provided affirmation of what they were experiencing.  Before 
their diagnosis, both Peter and David had to deal with others, including health care 
professionals, questioning if they were sick.  Medication to them was viewed as a relief 
and became an opportunity to help them manage their diagnosed condition.  
 Another emotion that emerged with being diagnosed with a chronic condition was 
the realization of what the condition would entail and the severity of having that 
condition. 
I was furious.  I don’t need this on top of everything else.  Neuropathy is a 
very difficult thing to live with; it’s like having electrodes in your feet.  I 
know this sounds every dramatic but it feels like barbed wire being pulled 
through the feet and I have no feeling on the surface of the skin but 
internally you get this electric sensation. -P2(4) 
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For some, their ‘new normal’ was associated with heavy emotion and recognizing the 
impact of their condition on their lives.  Participants had different reactions and emotions 
associated with their initial chronic condition diagnosis.  For some it led to feelings of 
sorrow, shock, and anger, yet all were aware that being diagnosed also meant having to 
take prescribed medication.  This became the starting point of their ‘new normal’.   
Moving to a new ‘normal’: dependence vs. the imagery of a warrior: 
 
For those with a chronic condition making the transition to a life that involved 
having to take multiple medications on a daily basis became a challenge for all 
participants because of what their medications stood for.  For those with a mental illness, 
many spoke of specific experiences that have contributed to their reasoning of having to 
be on prescribed medications.  
It [anxiety] got triggered by my mother died 10 years ago and I was 
executor, what a nightmare […] when she died, they took us to court and 
wanted their share, which wasn’t much anyway.  You figure a house that’s 
worth $100 000, you’re dividing it by 3 and by the time you take the 
lawyer’s fees and everything, cremation, whatever there’s not much left.  
But they insisted they were going to do this, it was a big scandal.  The 
lawyer who handled the case did something wrong and in the end committed 
suicide, it just goes on I can’t even explain and they blame me. I’ve never 
hurt a flee and I think you know that.  And I took it to heart so I ended up 
getting these panic attacks so bad. -P10(2) 
 
I had post-partum with my daughter and that’s when I was diagnosed with 
the blood pressure, she was a year old.  And I wasn’t in a good relationship 
at the time with her father so it was a lot of stuff happening […] my son was 
demanding and stress with him and he lived out of the home for a while, at a 
treatment centre because of his issues and stuff. -P7(4-5) 
 
Drastic life events led to the diagnoses of certain mental conditions, which resulted in the 
person having to take prescribed medications, requiring the person to recognize that 
something was wrong and their life was no longer ‘normal’.  Having to take medications 
became a reminder that ‘normal’ was gone and medication was needed on a daily basis.   
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Other participants spoke of who they once were, not necessarily contributing their 
diagnosis to a life event, yet emphasized what they were once capable of doing and 
caused them to reflect on who they have become. 
I always thought I mean through my life you wouldn’t notice now but 
through my life I was always into weightlifting, I exercised like religiously 
every day up until after we had the kids and they start growing your lifestyle 
changes you don’t have that I mean when they got a little bigger I got back 
into it but then it fell by the waist side.  And I  thought I took care of myself 
and thought I ate very well I just was shocked that he said I had it, what the 
heck you know, I couldn’t understand why. -P4(2) 
 
My whole life has been about me, where I played, where I coached, the 
towns I’ve been in – it’s time for me to balance the scales a little bit. And I 
don’t mean to be selfish but everything evolved around me and now it 
doesn’t and I like it.  I can give back; balance the scales a little bit.  That’s 
the great thing about it and I feel like what I’m supposed to do.  I don’t want 
to be remembered as Simon the great hockey player, the great coach, the 
great TV guy, great writer I rather be remembered as the guy who raised a 
lot of money for Parkinson’s disease. -P12(5) 
 
The experiences above document the differences in how someone with a chronic 
condition can perceive themselves.  James had feelings of ‘shock’ and associated himself 
with being a ‘failure’ because of the person he once was while Simon recognized the 
changes in his life and what he could do as a result of his condition.  Simon was one of 
the very few participants who adhered to his medications, which may be contributed to 
his ability in wanting to be proactive about his condition and because of that engaged in 
self-management strategies and medication use. 
 Moving to a new normal and realizing the importance of medication also became 
a means to perform everyday functions.  Many participants were diagnosed with some 
form of arthritis, which meant for them having challenges every morning getting dressed, 
being unable to work because could no longer type, going to the bathroom, and “just 
simple little things”-P6(5).  Individuals felt frustrated, useless, and felt as if they lost 
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their independence because they had to rely on others for help; this was not limited to 
those with arthritis but with almost all participants.  For some this also meant losing 
control of areas they once were in complete control of.  
And then they tried to, Ashley and Dee, both knew about my diabetes so they 
tried to over control what I was eating.  And I did lose it on them and said 
you can’t control what I eat, I’m an adult and I will control it.  You guys can 
be aware of it but I can control it.  So then I slid backwards and started 
eating cookies a lot because you know my daughter is there and is 16 years 
old and she doesn’t have any issues so well we can’t cut her off because I 
can’t eat them.  So okay I’ll have a couple and Ashley is the same, she will 
bring in treats for herself and I told them I’ll eat what I want, when I want. -
P11(6) 
 
Living with a chronic condition, often co-morbid conditions, forced participants to figure 
out what they could and could not do, which was difficult for many because it often came 
back to individuals speaking of how young they were and this is not how they anticipated 
their life to be.  However, not all were willing to easily adjust to a new normal instead 
sought affirmation in knowing that they were still able to maintain the identities they 
previously had before being medicated. 
I mean I think I’m a good wife too, I cook and clean I do it all. -P10(9)   
 
If I can go, I can go until I drop.  That’s what I do. -P10(9)   
 
I think the nuns they always said ‘fight, fight, fight’.  So my attitude is totally 
different than my sisters.  My sisters are scared; they panic when they are in 
the city […] they’re not fighters or pushers.  I am. -P13(6) 
 
While Mikaela and Julie affirmed who they were in certain roles as being a ‘good wife’ 
and being a ‘fighter’, others focused on how strong they were, “I’ve battled back from 
anything” -P12(1), creating images of themselves as a warrior and being able to ‘battle’ 
their health, as if their health was the enemy. Others saw their condition(s) as another 
opportunity to prove that, “[…] then I thought this is just another thing in my box that I 
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have to tackle […] I can do it, I can get rid of anything, I can do anything”-P5(3).   
Nicole presented herself as being able to do ‘anything’, as if her health was just one more 
challenge she was capable of conquering.  The ironic thing in how participants 
viewed/represented themselves as being a ‘fighter’, being able to ‘do it all’, and ‘battling 
back from anything’, yet all spoke of the struggles they have had in managing their 
conditions and medications.  To some degree all spoke of, “…they [indicating health care 
professionals] told me none of them [referring to medications] I would be off of unless 
they will change to another one […] this is for the rest of my life.”-P13(3).  Medication 
became the means that allowed individuals to function and thus to have the belief in 
themselves to ‘battle back from anything’.  It also meant individuals creating routine to 
address concerns with their medications.   
For participants who had a greater sense of awareness of the effects of their 
medications, they realized the importance of incorporating their drug regimen in their 
everyday life.   
Every morning when I get up I have my breakfast first then I take it because 
I don’t want to have an empty stomach […] So I put my one right there 
when I have my supper then I take it right after I have my supper so that I 
know I’ve taken it. -P10(5) 
 
[…] what I do is I take my meds and then once weekly I set up a regimen so 
I have morning pills, evening pills in containers. -P14(2) 
 
When asked how the person incorporates their medications into their lives, some outlined 
creating a routine, emphasizing that the drugs were incorporated into ‘my day’.  Even 
with a routine and a sense of awareness, Monica clearly articulated the challenges of 
being on multiple medications and even with a system in place that was not always 
enough. 
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It was difficult and I wasn’t writing it down, which I should have but I didn’t 
have adequate pain management so I wasn’t sleeping well.  And when you 
don’t sleep well that makes you not think as clearly and I was making 
mistakes. Like I wear a fentanyl patch and in December I didn’t take the old 
one off before I put a new one on […] I was so tired and spacey. I wasn’t 
making sure I was taking it off and I was found at a corner in the dead of 
winter unconscious in my chair with my dog tied to my chair […]  I had no 
idea that this happened, I could’ve been going across the street and just 
stopped in the middle of traffic.  So I went in and talked to Mike 
[pharmacist] and Curtis [family physician] and said ‘we have to do 
something, this is really serious’.  I could’ve been killed, the dog could’ve 
been killed, whatever and that’s when they came up with this [referring to 
bubble pack med kit] and it’s worked like a charm.  I haven’t had any 
problems with it. -P2(3) 
 
It took a life-threatening experience for Monica to realize that being on multiple 
medications can be very challenging and a system that may have worked for others, did 
not work for her.  Having a drug regimen entails the person being conscious of the 
mixing of certain medications, when and how often to take a medication and the onus is 
on that person to follow their drug regimen.   
It was apparent that for all participants, a medication can only do so much to help 
the person live their lives.  What was outlined to some degree by all participants was the 
contradiction with medications – it is designed to help but results in failure.  Medication 
can only help to a certain point and this is assuming it helps to begin with, as Mikaela 
reiterated the medication she was on did not help her in anyway yet she was prescribed 
the medication.  This becomes dependent on the person to make a decision to continue to 
take a medication that has been prescribed by their doctor or go against their doctor’s 
recommendations because to the patient the benefits do not outweigh the side-effects.  
This becomes a difficult decision for a person to make and the communication of the 
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physician factors into the decisions that individuals are making to adhere to their 
medications.   
Prescribing experiences 
 
Creating routine: being prescribed a medication forces an individual to have to 
make daily decisions to adhere or not to adhere to their prescribed medications.  Even 
when participants made the decision to adhere to their medications, based on their 
physician’s recommendations, this resulted in serious side-effects.  While some 
participants were aware of the side-effects, others were not.  If the person experienced a 
side-effect from their medication, from then on it became a risk for the person to take any 
of their medications.  Individuals then had a heightened awareness of their medications 
because they did not feel confident in their medications based on their experiences with 
the negative side-effects.  In an attempt to avoid the consequences of their medications’ 
side-effects, individuals created a daily routine to incorporate their multiple medications 
into their life.  As a result, medications became more than having to put ‘pills’ in their 
bodies. 
The awareness of being on multiple medications: 
 
Many meanings were associated with the concept of ‘multiple medications’.  Some 
spoke of their prescribed medications in relation to their age, “I’m a failure because now 
I have to take pills, pills are for old people, I’m not an old person I don’t want to take 
pills”-P4(4), there was a stigma associated with taking medications and the constant 
challenge of individuals being relatively young to be on multiple medications. 
Participants still questioned the value in their medications: 
92 
 
 I hate being on the medicine for 20, 30 years because what happens is any 
medicine that helps you cure something, hurts you in other ways […] It 
really is heaven and hell. -P12(3) 
 
Simon outlined what was reiterated by many participants who have had no choice but to 
be on medication for quite a while and because of this their medication is less effective.  
A majority of participants spoke of the awareness they have because of the effects of 
their medications. 
I couldn’t figure out by the end of my career I broke my sternum, broke my 
shoulder, broke my collarbone, broke my wrist, broke my foot I couldn’t 
figure out why it was all happening because I had really been bullet proof 
for most of my career and they did a map out of my history and they said 
‘you were taking Prednisone for so long when you were 16 that it softened 
your bone mass’, so it became brittle at a certain age. -P12(3) 
 
They put me on a TB drug for 6 months and its’ a prophylactic for 6 months 
prior to going on Enbrel.  And it’s the same drug called Isoniazid, I took it 
as a child but when I took it a second time it caused this neuropathy 
reaction, which is very rare and caused permanent damage to my hands, 
mostly my fingertips and my feet are numb. It’s very painful. -P2(4) 
 
Simon’s experience, outlined above, documents how he had to deal with the long-term 
effects of taking a medication when he was younger that later would jeopardize his career 
but at one point that same medication allowed him to pursue his career.  One medication 
for Monica, which she thought would be her ‘magic bullet’, resulted in her having a 
reaction and developing neuropathy.  These experiences factored into the decisions these 
individuals made from that point on involving their medications because of the fear of 
knowing what could happen, resulting in an heightened awareness of their medications, 
which was not consistent among participants. 
While many have recognized their dependency on their medications to function in 
everyday life, for some their dependency on their medications resulted in serious 
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consequences.  Individuals reflected on their lack of awareness of their health and 
attributed this to their medications. 
I didn’t realize anything was wrong with me to the point I would come home 
from work lay on the couch and tell her to get her own meals. She was 12 
and I didn’t feel like cooking, ‘go make yourself something’ but I didn’t 
think that was wrong […] I didn’t sleep much and I thought that was okay 
too.  I was on it [referring to Champix] for 8 weeks and I don’t know.  One 
day I had all my pills lined up and then I got scared and called someone and 
said ‘I’m afraid I’m going to take these please come get me’. -P3(2) 
 
I get really frantic and everything has to be perfect.  I just go […] I go in 
overdrive, everything has to be perfect and everything has to be done right 
now and when I crash, I don’t care about nothing.  Those dishes who cares 
about dishes, those paintings that are waiting to be hung that I was so crazy 
about hanging them 2 days ago, they can sit there for another 2 years, I 
really don’t care.  My biggest thing is I’ll stay in bed; it’s easier to stay in 
bed.  I’ve taught John and my daughter, Lindsey, that it is better that I’m in 
bed then out because if I’m out then I think stupid thoughts.  So if I think 
stupid thoughts I just go to bed and have a sleep…-P9(7) 
 
When reflecting on this experience, Liz recognized how abnormal her behaviour was but 
how it took a suicide attempt for her to realize the severity of her own thoughts.  On the 
other end of the spectrum, Faye, who has bipolar disorder, was very aware how every day 
varied and was heavily reliant on others to help her through those days when she knew 
she had ‘stupid thoughts’.  However, both were adhering to their medications.  
Patient-physician communication 
 
Physicians are a highly trusted source for participants.  Almost all participants 
spoke of the value and trust they placed in their physician; however, despite this trust, 
this has not always resulted in positive experiences with their physician and the health 
care system in general.  When a physician is unable to address the needs of the patient, 
often not in a timely manner, this led participants to purposely not follow their 
physician’s recommendations because treatment was not catered specifically to their 
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individual needs.  Participants spoke of the varying roles they play as a ‘patient’ and how 
this has inadvertently affected the decisions they are making pertaining to their own 
health. 
The role of the patient and the physician: 
 
 When participants spoke of their experiences with health care professionals, it 
was apparent the varying roles patients took.  Depending on what point the person was at 
with regards to their health, they were more likely to show emotions of vulnerability and 
needing someone to believe in them because they still were not diagnosed but were 
suffering every day. 
I went to a gynecologist and he said you’re not going through menopause 
you’re too young and he sent me home […] the doctor just dismissed it […] 
he said ‘come back in 3 months or whatever we’ll do blood work’.  I come 
back, get blood work and he says ‘you’re full blown menopause’, and I said 
‘what have I been telling you’? He said ‘you’re too young, the average age 
is 53’. I was 39 turning 40. -P8(2) 
 
You know when you have someone coming every week saying something is 
just not right.  In the end I cried because I had been to him a few times and I 
said ‘something is wrong, I can’t walk, I’m so lethargic and fatigued’ and I 
had lots of the runs and it would come out of me and eat through my skin, it 
was horrible like the whole thing was a horrible, horrible thing.  And in the 
end I said ‘I can’t do this anymore’, I just cried and I said ‘you have to help 
me, YOU HAVE TO HELP ME’.  And he said ‘I’m going to help you’, he 
said ‘we know it’s something different’ but a lot of doctors they don’t know. 
-P10(10) 
 
If the person’s physician did not address their concerns, participants’ spoke of feeling 
dismissed, did not feel value in their role as a patient, and often was not diagnosed until 
much later because of the physician initially dismissing their symptoms.  However, other 
participants took ownership and recognized their role in their own health.  As a result, 
they were more assertive with their physician and knew precisely what they wanted for 
their health.  
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I require that and I would’ve kept looking for doctors that weren’t 
threatened by the patient’s next question and both of them are more than 
happy to answer a question.  I also realize they have no time, so I don’t ask 
them ridiculous questions.  I come to them with well-considered issues and 
it may take them a while to get back to me but it’s there […] I have to feel 
like I’m much as a participant as they are and how the hell can I go to a 
doctor and say ‘make me better’, if I’m not doing my end. -P2(10) 
 
[…] the doctor said the blood results are high and I said ‘we had a birthday 
and I had a piece of cake’ and I forgot I was getting blood testes right.  So 
he says ‘okay we can live with that’ […] then you start to look at the doctor 
and he’s just diagnosing you on symptoms that you have.  So you have to be 
upfront with him on what you are doing because if I went in there and my 
blood was 10 when I fasted for 18 hours and I didn’t say I had a piece of 
cake and ate something I wasn’t supposed to, now he’s going to say ‘well 
the medication isn’t strong enough so we are going to have to up your dose 
or put you on insulin’. -P4(3) 
 
Monica and James did not blame their physician when they had any health related issues 
but took responsibility for their own actions.  However, other participants were quick to 
place blame on their physician for any of their health problems.  
Dr. L is really good but I have to tell him what I want […] I find it as long 
as I have to push him for him to send me for example to do these tests.  I 
think that, I blame him a little bit that maybe it [referring to heart attack] 
would’ve been caught if he would’ve listened to me.  Like I tried to explain 
to them, how would I know it is my heart with this [referring to her right 
breast] being so painful? - P13(7) 
 
Instead of taking any form of ownership for their health, for some it became easier to 
place the blame on others.  Julie and Liz, both acted against their physicians’ 
recommendations, and decided to take a medication to help them quit smoking.  Both 
experienced severe side-effects and spoke of having no control over their thoughts and 
actions yet neither followed their physician’s recommendations because they did not 
respect their physician or place value in what their physician said.  Their relationship 
with their physician impacted their decision-making and as a result, both experienced 
serious consequences of not following their physician’s recommendations. 
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David realized that one negative experience with a walk-in physician resulted in 
him wanting to have a family physician for the first time in his life.   
So I went to see him [referring to the walk-in doctor] one day and he asked 
me ‘how I was doing’ and I said ‘oh I have a slight cold’ and he said ‘stay 
over there because I have 3 doctors out today and we can’t have anymore 
out’.  Well that’s not really the response I was expecting, so ya I was not 
impressed with that. -P11(5) 
 
This was a common theme of individuals having a negative experience with a health care 
professional, which led them to seek better care.   
So when I spoke to my family doctor I said ‘look if I’m going to talk to an 
infectious disease person, I’m going to talk to someone who at least knows 
what the hell is going on and spend some time’.  So they set me up with the 
head of infectious disease at Toronto Western or no Toronto General.  So I 
went down and met with him and he spent literally 2.5 hours with me doing 
a full workout.  By the time I got home, I had an appointment booked for a 
follow-up within 5 days to go for some tests within 5 days after that I had an 
appointment with a follow-up with him and he said this is it. -P14(6) 
 
I had a really poor doctor […] the lady who diagnosed me; she was more 
upset that I had a coffee in there.  I brought in a coffee and she said ‘how 
dare you drink coffee in my office’.  I was like ‘pardon me’?  She’s a 
neurologist doctor and she was balling me out for having a coffee, why?  I 
never heard anything like it and she said ‘because I said so’.  What kind of 
bedside manner is that?  This is going to go downhill from here […] she had 
no idea who I was or what I had.  ‘It’s possible that you have Parkinson’s’ 
and I said ‘I think I do’.  She did a test and was telling me ‘did anyone tell 
you, you are a handsome man’?  I said ‘no, not lately’.  She goes ‘you have 
Parkinson’s disease’, walked out of the room, and never came back.  I was 
waiting there, I figured she was going to come back and see me and nope, 
they said that’s it – that was it. -P12(3)  
 
In both situations it resulted in participants getting the care they needed and in Peter’s 
case it led him to getting diagnosed after seeing 27 specialists and 10 years of not 
knowing what was wrong. 
Patients can play varying roles regarding their health whether it is the patient who 
does not see a physician most of their life but feel by a certain age they should, the 
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patient who is in complete control of their appointment, or the person who does not take 
responsibility for their health and it becomes the physician’s fault.  Regardless of the 
experience, all participants’ emphasized the impact of communication.  If there is not 
active communication it results in patients purposely not adhering to their medications or 
following their physicians’ recommendations because they are unable to understand the 
need for the medications and do not place value in what is said because of their 
perceptions of their physician. These perceptions can often interfere with the person’s 
overall views of the health care system. 
Canada’s Health Care System 
 
 As already outlined to some degree under patient – physician communication, 
participants’ decisions regarding their medication is multi-faucet.  Participants spoke 
specifically of the challenges with Canada’s health care system and not receiving the care 
when needed.  A select few spoke of positive experiences; however, this was often 
related to direct communication with a health care professional.  Barriers to the health 
care system have impacted the decisions individuals are making regarding their health. 
Barriers and facilitators to care: 
 
 Participants were asked about their experiences regarding the health care system.  
Some asked for further elaboration and they were asked to share some of the barriers 
and/or facilitators they have experienced in relation to Canada’s health care system.  Very 
few touched upon any positive experiences they have had with the system besides direct 
patient-physician contact.  A barrier that was expressed by Mikaela was also supported 
by her physician and how taking one medication off the market drastically changed so 
many lives. 
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I was on great medication, well you’ve probably heard of Vioxx, which they 
took off the market which is the stupidest thing they ever did.  And now 
people are, my doctor says kids are in wheelchairs that walked.  People are 
crippled that could move and it was an amazing drug.  It did wonders for 
me too; I was like a totally different person. -P10(2) 
 
It was interesting that a question about the system resulted in touching upon the effects of 
the pharmaceutical industry and the TPD’s role in taking a certain drug off the market.  
This experience caused the person to have to take numerous other medications to 
determine another treatment that was just as effective as Vioxx, which led the person to 
experience numerous setbacks because of the trial and error process associated with 
taking other medications. 
Even when seeking basic care, some felt they were being ‘scammed’ by the system 
so made decisions without the benefit of a physician because they would have to wait 
hours in a waiting room to see their physician for a one minute procedure. 
Ya and I don’t like it, I really don’t.  I think it’s a bit of a scam myself.  You 
know try to get in to see them 2 months down the road.  You know they’re 
getting paid for you whether you come or not, so who benefits from this? -
P10(7) 
  
So I don’t absorb anything from food anymore so I give myself a shot.  The 
doctor used to do it but I didn’t like waiting there for a couple of hours.  So 
I said hell with that give it to me. -P10(9) 
 
In some capacity all participants recognized the faults with Canada’s current health care 
system – there was almost no possibility of receiving care when needed or individuals 
where limited in the type of care they received, which was not enough to help them 
manage their condition.   
The participants in this study all had a chronic condition (often multiple 
conditions), reflecting a group of individuals who rely on the services of Canada’s health 
care system.  Unfortunately, participants spoke of feeling limited because of the barriers 
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in Canada’s health care system and have had to factor these limitations into their 
decisions regarding their own health, often requiring individuals to make sacrifices.  This 
will be expanded upon in future implications.  
Chapter 5: Discussion 
 
The purpose of this study was to develop a theory on the process of decision-
making regarding medication adherence in individuals between the ages of 40 to 55, who 
were required to take three or more prescribed medications, and were diagnosed with a 
chronic condition.  Medication adherence can be defined as the ability of an individual to 
coincide with medical advice (Golay, 2011; Kaufman & Birks, 2009; McDonald et al., 
2002).  For the purpose of this study, this definition was used as basis for determining if 
participants’ engaged in adherence behaviours. Using purposive sampling strategy, 15 
individuals were interviewed who the met the inclusion criteria with the researcher 
collecting additional information on the person’s occupation and employment status, as 
after the first interview this was recognized as a factor affecting medication adherence.  
Results were analyzed using the methods of constructivist grounded theory with a 
cognitive awareness of the theoretical framework, symbolic interactionism.  Throughout 
the research process an interpretative and subjective perspective was utilized as a means 
to have a central focus on participants’ experiences and maintaining their voice 
throughout the results.    
The main themes in the literature included: the costs of health care, individuality, 
patient – physician communication, and Canada’s health care system.  The themes from 
the literature were only considered as single factors and not as co-existing factors.  Based 
on participants’ experiences predominant themes and categories emerged with a core 
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theme of ‘balance of medications with the rest of the person’s life and the meanings 
individuals associated with their medications’ becoming the centralized theme.  Other 
subthemes included: sense of security, inability to function, sacrifices, rationalizing non-
adherence, fear, and active communication with their physician.  It was evident the 
interconnection of the subthemes.  For example, some purposely engaged in self-
management strategies while others spoke of the need to do so but made ‘excuses’ for not 
doing more for their health; however this did not predict medication adherence 
behaviours.  Medication was sacrificed because of expenses and individuals placed more 
value in providing for others then themselves. This resulted in participants recognizing 
the challenges of not being able to take their medication yet the need for their 
medications to perform everyday tasks.  Even when participants were able to afford their 
medication and recognized the need for it, this did not equate to adherence.  For some, 
dependency on their medications resulted in ‘playing’ with their medications, with the 
person deciding on their doses despite their prescriber’s recommendations.   
Participants who chose to ‘play’ with their medications, who purposely sacrificed 
their health, and those who recognized their dependency on their medications to function, 
resulted in almost all participants having feelings of fear.  This included fear of the 
unknown and of not being able to control their condition even with prescribed 
medications.  Adherence to medications became a contradiction; all participants 
recognized the need for it yet also recognized that their medications could only do so 
much for their health and engaged in non-adherence, resulting in no sense of security. For 
some, in attempt to feel secure, participants engaged in self-management strategies. 
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Wagner and colleagues (2005) suggested that self-management was an active 
process that requires patients to make day-to-day decisions to manage their medical 
condition(s) and that these decisions play a vital role in managing chronic conditions.  
The effectiveness and quality of integrating self-management strategies into one’s life is a 
strong determinant of health outcomes (Wagner et al., 2005). This study supported these 
results but also had some contradictory findings.  Some participants recognized how 
engaging in self-management strategies contributed to their health.  This involved staying 
active, monitoring what they ate, and engaging in relaxation methods.  In some instances 
participants spoke of wanting to do more, however, due to financial limitations were 
unable to afford additional self-management strategies.  Participants recognized how 
engagement in self-management strategies reaffirmed to some extent that there was not a 
reliance on medications and medication only aided their management of their condition to 
a point since there was value in engaging in other strategies. 
Participants found it was challenging to maintain a balance with their life and 
their medications.  These individuals contradicted themselves because they were aware of 
what they had to do in terms of self-management strategies yet labeled themselves as a 
‘failure’ for being on multiple medications.  However, they were purposely not engaging 
in any other form of self-management.  This mentality of wanting to do more but 
choosing not to was very common among those who felt their condition was predisposed 
(i.e. genetic) and viewed their medications as ‘inevitable’.  This placed less value in self-
management as individuals did not attribute their health outcomes to not engaging in self-
management strategies, which was not consistent with the literature. 
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Some participants engaged in self-management strategies by making the 
additional effort to educate themselves on their condition(s) and medications.  This 
increased their ability to justify and understand the purpose of their medications, yet even 
with this increased knowledge, this did not predict medication adherence.  Unlike the 
literature that concluded that those with a chronic condition purposely limited their search 
for information about their condition because he/she did want to identify themselves as 
an ‘ill’ person (Audulv et al., 2012; Kralik, 2002; Townsend et al., 2003), this study 
found that participants conducted their own research about their conditions and found 
strategies on their own that they could use to help manage their condition beyond taking 
medications.  However, even with the increased knowledge around self-management 
strategies, this did not always equate to individuals taking action, reaffirming the 
complexity of this group of individuals.  
Participants also engaged in self-management strategies through support of others.  
The literature shows that chronic conditions places a different set of demands on a patient 
than does an acute condition – chronic conditions requires continual decision-making and 
adjustments to changing circumstances for both the patient and loved ones (Ledford et 
al., 2010; Tinetti et al., 2004; Wagner et al., 2005).  This study found that participants 
who had additional support were more likely to have a drug regimen in place and engage 
in self-management strategies because by having the additional support there was an 
emphasis placed on adherence for functionality.  That is, they wanted to be healthier not 
just for themselves, but to support and help others as well.  Not all participants had the 
option of support.  This study found that for those who did not have any form of support 
spoke of the importance of having to rely on themselves yet those who had support, were 
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not more likely to adhere their medications. The meanings of medications did not vary 
from those with no support versus those with supportive relationships.    
The results found that participants purposely engaged in self-management in an 
attempt to maintain their privacy, which was often reflected in one’s ability to continue to 
work.  The literature suggests that men face identity dilemmas such as preserving a 
public persona (i.e. maintaining their privacy) (Charmaz, 1994).  The findings of this 
study found that preserving a ‘public persona’ was not limited to males.  Regardless of 
gender, maintaining privacy was highly important to all participants and no one wanted to 
appear ‘ill’.  The ability to maintain a ‘public persona’ was an indication that the person 
was able to manage their condition with prescribed medications and could keep the need 
for multiple medications from their employers, achieving a level of privacy that they 
could not achieve at home.  Individuals were more likely to adhere to their medications if 
they wanted to maintain their privacy (primarily related to the workplace) to allow 
individuals to ‘function’ and maintain their life.  Not all placed importance in maintaining 
their life (directly related to medications) and were purposely sacrificing their prescribed 
medications.   
Sacrificing medications was justified due to financial limitations, for others, and 
for personal reasons.  Participants spoke of purposely limiting their adherence because of 
the costs of their medications.  This study found that the majority of participants were 
fortunate enough to have coverage through their own plan or in combination with their 
partner’s plan.  However, some were forced to evaluate the effectiveness of their 
medications because of affordability and limitations with their coverage.  Consistent with 
the literature, those who did not have any form of prescription coverage and with a lower 
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household income were more likely than those with health coverage to report cost related 
non-adherence (Golay, 2011; Kennedy & Morgan, 2006; Law et al., 2012; Schoen et al., 
2007; Schoen et al., 2010).  This study found that even with some form of prescription 
coverage, individuals were citing cost related non-adherence.  This was taking place to 
some extent because provincial drug plans are preventing individuals from taking their 
prescribed medication (Demers et al., 2008; Grootendorst, 2002; Schoen et al., 2010).  
Based on the limitations of provincial drug plans, individuals who would benefit from it 
do not qualify because of their income yet this is not considering the expenses individuals 
need to live.  Those who do qualify for it are sacrificing their medications because paying 
the deductible on their medication plan becomes less important than being able to provide 
for their family.   
 This study also found that individuals who had some form of coverage were 
purposely limiting their medication adherence to make their medications last longer to 
provide for others.  Individuals recognized their reliance on their medications yet found 
greater importance in providing for others versus themselves.  One may question if this 
relates to the generation under review who are having to care for their parents, their 
families, and are placing less precedence on their own health to provide for others.  
Finally, even with some form of coverage, it was often not enough to cover the price of 
all of their medications.  Almost all participants spoke of having to make out-of-pocket 
expenses if they engaged in any other form of treatment beyond their medications.  Not 
all were fortunate enough to have the financial means to do so and suffered from not 
being able to seek alternative care.  This resulted in a common emotion in almost all 
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participants of being fearful of their inability to manage their condition and as a result 
medication. 
A main finding from this study was an underlying feeling of fear that participants 
had.  Fear became associated with participants’ medications because of the dependency 
on their medications, with the realization that even with access to prescribed medications, 
this still did not improve their functionality.  Participants’ spoke of being fearful of the 
future because of not knowing what could happen next (i.e. if they lost their medication 
coverage or if a medication that was once effective no longer worked for them) due to 
their reliance on their medications.  For some, their dependency on their medications was 
affirmed through experiencing the effects of non-adherence, leading to fearful 
experiences and their inability to control their lives without their medication. This 
emotion of fear was not exemplified in the literature in relation to living with a chronic 
condition and medication adherence behaviours.  The results also demonstrated that 
participants had feelings of fear through comparison of others who were diagnosed with 
similar conditions.   
It should be noted that the term ‘dependency’ is used in various contexts 
throughout medication adherence literature.  In some contexts, ‘dependency’ is referring 
to an addiction to medication (Asmundson, Wright, Norton, & Veloso, 2001) while in 
other contexts it is used to describe individuals who are dependent on their medications to 
live, specifically pertaining to those diagnosed with a chronic condition (Ruppar, 
Dobbels, & Geest, 2012).  This research study focused on the foundation of constructivist 
grounded theory and focused on the words of participants, if participants used the word 
‘dependency’ the researcher presented it in the context used by the participant, with the 
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objective of maintaining the integrity of the data.  In some context the literature indicated 
that a patient’s commitment to their drug regimen was dependent on the patient’s beliefs 
and values including the patient’s views of themselves (Audulv et al., 2012).  The 
findings of this study support this to some degree.  Participants’ views of themselves 
involved comparing their condition and medication use to others, resulting in feelings of 
fear because participants were aware of what could happen due to their chronic condition 
and how a dependency on their medications could result in ‘playing’ with their 
medications.  Comparison to others did not necessarily affect a patient’s commitment to 
their drug regimen, as many spoke of not following their prescriptions, but comparison to 
others and knowing of the possibility of what could happen, affected their views of 
themselves.  In some way knowing that others who were similar in age and who were 
also having to take multiple medications, allowed participants to shift from who they 
were once were before being prescribed their medications to who they have become as a 
person taking multiple medications.   
While the literature outlined how a patient’s values and beliefs influence their 
commitment to their drug regimen, the literature was unable to provide evidence around 
how fear can influence a patient’s commitment to their drug regimen.  Fear was a 
predominant theme throughout this research study, with participants speculating their 
future and fearful of how this would affect their ability to adhere to multiple medications.  
Participants exemplified the complexity of their adherence behaviours and already spoke 
of the struggles even with provisions in place to help them succeed with medication 
adherence (i.e. medication coverage) yet there was still this worry of the fear of the future 
and adherence.  However, in very few instances fear of the future was a motivator for 
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adherence, when this did take place it was often in an attempt to try to be on fewer 
medications over time.  This was not consistent among participants and even with 
individuals speculating of the fear of their future, many spoke of experiences of non-
adherence as well as seeing themselves on more medications over time as to them their 
chronic condition(s) and medications were viewed as ‘inevitable’.  Once again, this 
demonstrates the complexity of this group in making decisions regarding their medication 
choices and how living with a chronic condition, often multiple chronic conditions, 
places a massive demand on individuals, requiring individuals to engage in various 
methods of long term decision-making.  
The literature on individuals with a chronic condition searching for normality 
outlined the loss of control individuals with a chronic condition feel over life 
circumstances and the need to retain their previous identity (Asbring, 2001; Charmaz, 
1994; Kralik, 2002).  This was consistent with the current study’s findings.  All 
participants spoke of the importance of being in control yet there were feelings of the loss 
of control, which happened due to individuals not knowing why they were ill and 
choosing not to adhere to their medications.  Individuals had to rediscover what they 
were capable of doing and for some they still represented themselves as being ‘strong’ 
and ‘able to do anything’, which was ironic because as interviews progressed, all 
participants spoke of the continual struggles they have in managing their condition with 
their medications as this required daily decisions.  Experiences of not being able to 
perform tasks individuals were once capable of doing, caused participants to realize that 
to attain some aspects of their previous identity, there was a need for their medications in 
order to live a ‘normal’ life.   
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A ‘normal’ life took on a new definition for participants as a new normal meant 
having to take medication on a daily basis and being unable to perform tasks the person 
was once capable of doing.  This study found that living with a chronic condition meant 
individuals taking risks and engaging in daily decisions to adhere or not adhere to their 
medications.  Asbring (2001) and Kralik (2002) found that women were more likely to 
embrace their medical condition and reconstruct their identity to gain a sense of 
empowerment and control versus men who struggled with their identity and having a 
chronic condition.  This was not consistent with the study’s findings.  Almost all 
participants spoke of the struggles of being on multiple medications at a relatively young 
age and associated having to take medication as being a ‘failure’ and being an ‘old 
person’.  Participants did attempt to gain some form of control through medication 
adherence and engaging in self-management strategies yet there was never any sense of 
security, so there could never be a true sense of control or feelings of empowerment.  
Prescribing experiences resulted in variance in what medications meant for 
participants and impacted their medication adherence decisions.  Even when individuals 
placed an importance on taking their medications, adherence did not always take place; 
once again highlighting the common theme of individuals contradicting themselves and 
their decisions.  Townsend and colleagues  (2003) outlined how prescribed medications 
play a key role in managing symptoms, allowing individuals to carry out everyday tasks 
that can become central to one’s identity.  All participants were aware of the need for 
their medications to function in everyday life.  The literature outlined that other factors 
do play a key role with patients choosing to adhere or not adhere to multiple medications 
based on the perceived need of their medications and the effectiveness of their 
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medication (Kreps et al., 2011; Ledford et al., 2010; Lewis et al., 2003; Townsend et al., 
2003; Zhao et al., 2011).  This study was consistent with the literature and found that 
participants were purposely not adhering to their medications because they did not 
understand why they had to take certain medication(s) or thought they were in control of 
their health, so there was no need for their medication(s).  Individuals then rationalized 
their non-adherent behaviours, as they were consciously making the decision to not 
adhere versus simply forgetting to take their medications.  
The literature also outlined that non-adherence was due to experiences associated 
with the side-effects of medications (Kreps et al., 2011; Ledford et al., 2010).  The results 
support this to some extent. Some participants purposely spoke of not adhering to their 
medications because they could not deal with the medication side-effects.  However, 
some spoke of the side-effects that have limited their ability to function and live a 
‘normal’ life yet still had a dependency and a reliance on their medications because the 
side-effects were more manageable then without their medications.  This could be 
contributed to the ability of the prescriber to communicate the effectiveness of the 
patient’s medications.   
The literature on patient-physician communication has found that patients are at a 
greater risk for non-adherence if they have minimal interactions with their physician 
(Kennedy & Morgan, 2006).  High quality and cost-effective treatments would be best 
achieved if there was a partnership between the patient and the health care provider 
(Kaufman & Brinks, 2003).  This was consistent with the study’s findings.  Participants 
placed an importance on the quality of care they have received from their health care 
providers and that there was value placed in their role as a patient.  The majority of 
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participants had a very proactive approach to their health and had no issues voicing their 
concerns with their physicians; however, some interactions with their physician led to 
non-adherence.  This was consistent with Nair and colleague’s (2008) study that 
concluded that non-adherence was attributed to the patient not receiving enough 
information about their medications and could not make an informed treatment decision.  
All participants spoke of the importance of making informed treatment decisions, which 
was not always reflected in participants’ final decisions. Participants in the current study 
took the necessary steps to become informed about their condition and medications, as 
many participants needed justification as to why they were on medications at a relatively 
young age.  Thus, there could be a significant age effect that future research should 
explore as more and more young adults are being prescribed chronic medications for the 
rest of their lives.  
The literature outlined the need for healthcare providers to focus on patient-
centred care, which is characterized by promoting a better understanding of the patient’s 
life, empowering patients, and tailoring treatment to the patient’s needs and preferences 
(Golay, 2011; Tinetti et al., 2004; Wagner et al., 2005).  This study found that this is 
highly important for physicians to do.  One participant highlighted that she did not want 
to see her specialist or follow her specialist’s recommendations because the prescribed 
treatment did not consider her values and beliefs and her concerns were often dismissed.  
Physicians that have played an active role and have addressed patients’ concerns have 
had better health outcomes (Wagner et al., 2005).  This finding was also consistent with 
the study.  Majority of participants did play a very active role in their health but 
participants who had health related goals (typically to be on less medications by a certain 
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age), spoke of the continual support from their physician.  Through physician support and 
participants having active communication with their physician; this affected individuals’ 
decision-making process, with individuals then more likely to share with their physician 
their choices related to adherence.  The results exemplified that patient-physician 
engagement can be very difficult as this age bracket does not have a need to see their 
physician unless identified need by the patient or for screening at the age of 50.  This 
becomes a challenge for a physician to develop a relationship and determine if adherence 
is taking place, which is also impacted if the patient is seeing numerous health care 
professionals and being prescribed medications from different sources. 
 The literature outlined typical barriers to the health care system, which included: 
long wait times, being unable to see a physician the same day care was needed, 
difficulties in scheduling appointments, contacting their physician via telephone, and 
getting prescriptions refilled (Ledford et al., 2010; Schoen et al., 2010).  The issue of 
‘time’ was a consistent finding throughout the study. This resulted in patients purposely 
not making an appointment with their physician despite needing care because by the time 
they got an appointment they would forget why they made it to begin with.  In one 
instance, long wait times resulted in one participant giving herself a needle every 2 weeks 
when her physician was technically required to do so.  There were also long wait times to 
see specialists when participants were in a moment of crisis and needed someone to talk 
to.  This meant individuals having to rely on their family physician for this type of care 
because by the time they would be able to speak to a specialist, the moment of crisis 
would have already lapsed.  Some individuals were fortunate enough that they could 
contact their family physician on demand but this only was available to very few 
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participants.  Thus, the main barrier to the healthcare system, and consistent with the 
literature, was time.  One may question if this barrier of time could be addressed if 
patients were more aware of community resources to address their needs and if patients 
had a realistic expectation of what they are asking of their health care professionals; this 
will be consider in greater detail under future implications. 
Strengths and Limitations: 
 
 One of the main limitations of this study was conducting only a single interview 
with each participant focusing on one point in time.  According to Charmaz (1990) given 
the nature of living with a chronic condition, multiple interviews are necessary to get 
through the basic information of the course of his or her health experiences. By 
conducting multiple interviews it may have contributed to the participant’s level of 
trustworthiness that was placed in the researcher.  Furthermore, by having multiple 
interviews over a longer period of time, this would have been beneficial to document the 
potential changes in participants’ adherence behaviours and if their meanings associated 
with their medications changed over time.  However, even with a single interview it was 
evident throughout the interview process that as interviews progressed and participants 
were able to get comfortable with the researcher, a certain depth of information was 
shared.  In many grounded theory studies, only a single interview is possible, but the 
studies are still considered robust and trustworthy (Creswell et al., 2007; Holstein & 
Gubrium, 2003; Schou & Hewison, 1998).  Participants did focus on the progression of 
their experiences, often rationalizing who they had become in relation to their 
medications and chronic conditions.  The literature suggests this is evidence of a valid, 
stable interview process (Corbin & Strauss, 2008; Patton, 2002; Strauss & Corbin, 1990). 
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Finally, participants were aware that there was only a single interview taking place, 
which could be speculated as to why a certain depth of information was shared with the 
researcher.  
After conducting the initial interview, the interview guide was altered for the 
remaining interviews. Based on the methodology of constructivist grounded theory, the 
researcher is encouraged to add areas to further pursue and delete questions that do not 
add value to the overall project, with the intention of collecting data that was missed 
during the initial interviews (Charmaz, 1995; Creswell et al., 2007; Holstein & Gubrium, 
2003).  However, this was only possible with participants that were interviewed later in 
the process since the researcher did not have the opportunity to conduct multiple 
interviews and pursue areas that could have been further elaborated on.  Although later 
interviews benefited from what was learned, the original interviews may have lacked 
some depth and focus. 
Another limitation was the researcher’s inexperience with grounded theory 
interviewing.  This was her first experience conducting interviews.  The researcher 
piloted the interview guide with family and friends.  It should be noted that the interview 
guide was not piloted on individuals who met the inclusion and exclusion criteria as it 
was immediately recognized the challenge in recruiting individuals who met all of the 
requirements of the inclusion and exclusion criteria (refer to Appendix B).  For the 
purpose of this research study, piloting the interview guide with five individuals allowed 
the researcher to practice the art of interviewing, focusing on conversation as opposed to 
following the guide word by word.  The researcher was aware of having only a single 
opportunity to interview participants and wanted to ensure that key questions were 
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included that allowed participants to speak to their experiences regarding their own 
health.  The interviewer also received significant training from Dr. Cosby, and was 
guided through a comprehensive list of readings from the qualitative literature by her 
supervisor.  However, even with piloting the interview guide, this is still not adequate 
preparation for what is needed for qualitative, in-depth interviews.  Charmaz (1990) 
touched upon a key limitation within this study that the quality of data earlier in the 
process differed from the later interviews because of the time it took to develop the 
confidence and skills in conducting interviews.  The researcher had to find a balance of 
not asking direct questions because of the comfort level of participants.  It took time for 
the researcher’s skills to develop and have an awareness of techniques that worked best in 
conducting interviews that were asking individuals to share very personal details of their 
life.   
 There were also challenges associated with collecting the sample required for the 
study.  The researcher found it difficult to recruit participants who met the age bracket of 
40 to 50.  This resulted in altering the sample criteria’s age requirement to 40 to 55.  In 
reality, by increasing the age bracket there was no dramatic difference in the variance of 
experiences of someone who was 40 versus someone who was 55.  The majority of 
participants were at similar stages in their lives and this did not appear to alter the data by 
changing the age group.  A strength of this research study was the focus around the 
‘sandwich generation’ (Do, Cohden, & Brown, 2014; Hammer & Neal, 2008; Hansen & 
Slagsvold, 2014; Townsend et al., 2003).  The sandwich generation is a very unique 
group who are more concerned with caring for others then themselves despite the posing 
threats to their health (Do et al., 2014; Hammer & Neal, 2008; Hansen & Slagsvold, 
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2014; Townsend et al., 2003).  Further investigation is needed around this age bracket to 
explore in-depth adherence factors outlined by participants (i.e. self-management, 
sacrificing medication, fear, and patient communication with health care professionals) as 
it still not fully understood the complexity of the decisions for those between the ages of 
40 to 55. 
A potential limitation of this study is the sample size, which consisted of 15 
participants.  A common misconception about sampling in qualitative research is that 
sample sizes that are too small are unable to support the claim of having achieved 
theoretical saturation (O’Reily & Parker, 2013; Sandelowski, 1995).  In qualitative 
research, there is no set number of participants; the sample size is reached when data is 
saturated and there are no new emerging themes or categories (Corbin & Strauss, 2008; 
Creswell et al., 2007; O’Reily & Parker, 2013; Patton, 1980; Sandelowski, 1995).  Based 
on the purpose of this research project, there were no new emerging themes or categories 
after 15 participants were interviewed, and the data was saturated with evidence.  To 
further iterate this, according to Strauss and Corbin (1990) theoretical sampling can be 
defined as: “If numbers are important for satisfying a committee, or oneself, then 
instances of occurrence of phenomena can certainly be counted” (p.191).  In other words, 
in grounded theory, the concern is not with the number of participants, but whether or not 
each participant experienced the phenomena.  In the current research study, each 
participant was consuming multiple medications and was able to explicate numerous 
important experiences with the said phenomena under study.  
 Taking into account the sample size, a potential limitation is the explication of 
divergent and convergent themes. With any qualitative research project, there is always a 
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concern with how to handle data that is not consistent with overarching themes.  Patton 
(1990) strongly urges that you seek out discriminate or divergent data to challenge the 
development of your categories and themes.  Strauss and Corbin (1990) suggest, ‘the flip-
flop technique’ be used to enhance one’s ability to find those pieces of data that negotiate 
or require significant changes to thematic development.  Strauss and Corbin (1990) 
further suggest this technique enhances overall theoretical sensitivity in grounded theory.  
In the current study, divergent data was reviewed, using these techniques to enhance 
theoretical sensitivity.  When this data was reviewed by both investigators, the remaining 
divergent data was determined to be insufficient to alter the final themes and categories 
of the grounded theory.  The final technique used was a systematic comparison (Strauss 
& Corbin, 1990), were one breaks away from custom forms of thinking.  This further 
sensitizes the researcher to speak out and attempt to incorporate all divergent data into the 
grounded theory.  Therefore, although some divergent data could not be included in the 
grounded theory, every possible mean was utilized to do so. 
 Despite having an adequate sample size and reviewing the divergent data, a 
limitation of the study was the methods utilized to recruit participants.  Participants were 
recruited through a primary care office in Niagara, a physiotherapy clinic in Halton, 
Niagara Region Public Health, and through word of mouth by the researcher.  A 
challenge with this method is that individuals are being recruited who are more likely to 
have access to health care than the average population, and are more likely to have 
medication coverage as well as having the means to afford additional treatment (i.e. 
physiotherapy).  This is not to say that participants in this study all had those luxuries but 
it is recognizing that future research should be considering other methods that are 
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representative of adults who are on multiple medications, who are still utilizing the health 
care system, but may not necessarily have a family physician.  Future research should 
consider recruiting in public places to ensure there is representation of the targeted 
sample.  
Chapter 6: Conclusion 
 
 Schou and Hewison (1998) outline how different explanations of health and 
illness may be experienced by the same people in different ways depending on the 
situation.  This piece of literature encompasses this research project perfectly.  This 
project aimed to answer the questions: what factors influenced individuals decision to 
adhere to a drug regimen?  How do specific factors affect the person’s ability to adhere or 
not adhere to their prescribed drug regimen?  Based on individuals willingness to share 
their experiences, it was apparent how multifaceted living with a chronic condition can be 
and the number of factors that impact individual’s ability to adhere or not adhere to their 
prescribed medications.  A core theme emerged in participants’ experiences that those 
with a chronic condition who are relatively young, associated meanings with their 
medications and this impacted their decisions to ‘live’ their life according to their 
medications. 
 Individuals spoke of the challenges of balancing their medications within the 
context of their life.  Some spoke of engaging in self-management strategies because 
there was value in wanting to do more for their health.  This included educating 
themselves on their conditions and their medications, as many spoke of not knowing the 
need for their medications.  Individuals also spoke of the value of others supporting them 
in self-management strategies and how this positively affected their ability to control 
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their condition and as a result medication.  However, all participants recognized the need 
to engage in self-management strategies but some were purposely choosing not to, often 
because they saw their medications as ‘inevitable’.  This was ironic because having to 
take multiple medications led individuals to view themselves as a ‘failure’ and having 
feelings of being disappointed as to whom they had become.  Regardless of engagement 
in self-management strategies, this minimally affected individuals’ ability to adhere to 
their medications.  The evidence suggest to some extent that those who placed blame on 
themselves for their condition, were the most likely to adhere to their medications as 
having to take prescribed medications became their fault.  Thus, to some extent there was 
more value in adherence. 
 Not all placed value in their medications and medications were sacrificed.  
Individuals spoke of purposely not adhering to their medications due to the restrictions of 
cost.  Many recognized they had other costs in their lives and they had to outweigh the 
benefits of being to afford their medications or being able to provide for their family.  
This meant individuals sacrificing their health for others.  Some participants were 
fortunate enough to have health care coverage; however, this was often not enough.  This 
meant for some having to live below the poverty line in order to qualify for provincial 
drug plans or having to decide what medications were more important.  Many 
participants spoke of the out-of-pocket payments they made to seek additional help, such 
as counselling, which not all could afford despite participants recognizing the serious 
need for this additional help.  If counselling became part of health care coverage, for 
many this would have made a dramatic difference in helping them manage their condition 
and possibly resulted in better management of their medications. Living with a chronic 
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condition is not something that is short-term and by not being able to afford the needed 
medications or treatments – the stress placed on the person is detrimental.   
 Individuals recognized that being on multiple medications, meant having to make 
decisions on a daily basis.  This resonated with feelings of fear because there was never 
any sense of security of the decisions they were making.  Individuals were fearful of the 
future because of the dependency on their medications yet even with a dependency this 
did not equal functionality.  With many participants sharing experiences of having to 
limit what they chose to do because of the effects of their medications.  In some 
instances, this was a form of rationalizing non-adherence.  Having feelings of fear also 
took place when individuals compared their condition and medications to others.  
Individuals became aware of what could happen due to their condition and even with this 
awareness, individuals were still struggling to manage their medications. 
 Being diagnosed with a chronic condition, often multiple conditions over time, 
and having to take multiple medications became associated with who the person was.  
Individuals spoke of the moment they were diagnosed with their condition, having 
feelings of sadness, anger, and some in disbelief that they were diagnosed with a chronic 
condition.  Being diagnosed with a chronic condition meant having to be on multiple 
medications, which for some reflected their inability to manage their life and failing to 
some extent.  Individuals recognized they had no choice but to shift to a ‘new normal’.  
This was very multi-faucet as some recognized a new normal in incorporating their 
medications into their daily routine and all spoke of attempting to maintain who they 
once were.  However, this was not without its’ limitations as many had to rely on others 
to perform tasks they were once capable of doing as medications only helped managed 
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their condition to a point.  Individuals had to find strategies to balance who they once 
were with who they have become, with their medications playing a central role in their 
lives despite some being unable to accept this fact.  
 It became challenging for individuals to recognize that there was a need to take 
their medications in order to live their lives.  All participants said they adhered to their 
drug regimen but as interviews progressed, all participants contradicted themselves and 
spoke of experiences with non-adherence.  These experiences reaffirmed individuals need 
for their medications as these experiences resulted in severe consequences as individuals 
spoke of losing complete control of their lives.  However, it became a contradiction, in 
some participants recognizing that their medications were designed to help them yet due 
to the side-effects of their medications, it resulted in severe setbacks.  Medications then 
became a risk because once again there was never any sense of security and individuals 
did not want to re-experience the severe side-effects of their medications.  For some, this 
was why they were choosing not to take their medications according to their prescription 
but a select few still continued to take their medications despite ‘being a write off’ and 
having limitations.   
This could be related to the ability of physicians to communicate the effectiveness 
of the prescribed medications, and in some instances that the benefits outweigh the risks.  
Participants spoke of their relationship with their physician and the importance of having 
a role in their own health.  Participants wanted to know about their condition and 
medications and be provided with additional treatment options besides prescribed 
medications.  However, not all participants had active communication with their 
physician.  This caused participants to devalue what their physician was recommending 
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and as a result going against their physician’s recommendation, often leading to non-
adherence or in two cases deciding to take a medication despite both participants’ 
physicians strongly recommending against it.  By having the person contribute to the 
decision-making process regarding their own health with their physician, this to some 
extent impacted individuals’ decisions to adhere to their medications. 
 Finally, all participants spoke of the barriers with the healthcare system.  This 
involved individuals not being able to see their physician when care was needed, having 
to wait in their physician’s office for long periods of time leading to feelings of 
frustrations, and the system not providing better mental health care.  Very few 
participants touched upon the strengths with Canada’s health care system and it leads one 
to question, if individuals received the care they needed, would their health be improved?  
This meant for many, receiving care that was holistic in nature that did not only address 
their physical symptoms but considered the overall impact of having to live with a 
chronic condition.   
Living with a chronic condition and having to take multiple medications is a 
challenging idea for those between the ages of 40 to 55.  This age bracket specifically 
spoke of the challenges of having to take multiple medications at a relatively young age 
and then how this impacted their views of themselves.  Individuals’ medications started 
to having meaning as this allowed individuals to live their life, however, there was 
recognition that living one’s life meant having limitations and shifting to a ‘new normal’.  
Prescribed medications did not become the ‘magic bullet’ for participants and there was 
never any sense of security as participants did not always have confidence in their 
prescribed medications.  This impacted individuals’ decisions to live their life with some 
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purposely choosing not to adhere to their medication. There is not one single answer as to 
why participants chose not to adhere to their medications.  This study provided evidence 
in how multifaceted individuals, who are between the ages of 40 to 55 and prescribed 
multiple medications, who are making very different choices pertaining to their health.  
Future Implications: 
 
Living with a chronic condition and adhering to multiple medications is very 
complex.  From the patient viewpoint, it becomes a challenge for patients to 
communicate if adherence is taking place when they are talking to their caregivers, 
especially the age bracket targeted for this research study who have different priorities 
and technically have no basis for seeing their physician unless for an emergency or for 
screening requirements based on their age.  The results of this study revealed the impact a 
family physician can have on the patient’s ability to adhere to their medication yet this 
study was not able to provide sufficient evidence in determining the impact of other 
health care professionals (i.e. specialists) who are also prescribing medications.  
 The findings of this study also suggest that patients may be continuing to 
consume medications that are no longer medically needed, and may also be harmful 
psychologically to a patient.  Participants in this study spoke of being on numerous 
medications and as a result, labelled themselves as a failure – this could potentially be 
minimized by caregivers reducing the number of medications prescribed to a patient.  Our 
study found that even one less medication can lead to a true sense of empowerment.  This 
could take place if a strategy were employed where an information platform was utilized 
that allowed health care professionals to store information regarding their patients, 
specifically around their prescribed medications and the purpose of their medications, and 
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this platform would permit other health care professionals to review the information as 
well as enter their information regarding the patient (Sellors et al., 2003).  This could 
benefit health care professionals in improving prescription practices as well as providing 
a more comprehensive understanding of the needs of their patients, as patients are not 
always transparent about their health with all of the health care professionals they are 
seeing (Golay, 2011; McDonald et al., 2002; Osterberg & Blaschke, 2005; Wagner et al., 
2005). 
With a focus on relationship building between the patient and physician, there 
should be an awareness of adherence in relation to the diagnosed condition(s) (M. 
Greenway, personal communication, June 16, 2014).  Relationship building may not be 
feasible for the patient who is diagnosed with a condition that is acute versus a patient 
with a condition who is routinely required to see their physician to monitor their chronic 
health condition(s) (Audulv et al., 2012; Gibson et al., 2005; Ledford et al., 2010; 
Osterberg & Blaschke, 2005; Tinetti et al., 2004; Zhao et al., 2011).  Relationships may 
also vary for individuals who are required to pick up their prescriptions from the same 
local pharmacist, who have an understanding of the patient’s individual needs and are 
able to provide guidance because the pharmacist also has active communication with the 
primary prescriber (Austin et al., 2005; Dolovich et al., 2008; Dolovich, 2012; Farrell et 
al., 2008; Kennie & Dolovich, 2008; M. Greenway, personal communication, July 8, 
2014; Pottie et al., 2009).  Some research even suggests that a trained pharmacist versus a 
pharmacist technician enhances adherence behaviours (Dolovich, 2012; Lau, Dolovich, & 
Austin, 2007).  Unlike a pharmacist technician, a trained pharmacist would be able to 
provide the patient with additional knowledge around their medications, and as this study 
124 
 
exemplified, individuals want to be educated about their prescription medications, which 
could then potentially influence their adherence behaviours.  Based on the misperceptions 
of medications that participants stated in this research study, patients appear to require 
additional education and support, which could be provided through a pharmacist who is 
able to understand the needs of the individual.   
This study suggests that to maintain active communication between a patient and 
health care professional, this may involve addressing health care professionals’ 
prescribing practices.  If less refills are provided to the patient, this would leave the 
patient no other choice but to see their physician to get a prescription refilled more often, 
resulting in also addressing adherence because there is less time in between appointments 
and more opportunity to address the concerns and commitments of the patient around 
their medication behaviours (Holbrook et al., 2011; Holbrook et al., 2012; Holbrook, 
Goldsmith, & Leung, 2008; Kreps et al., 2011; Randolph et al., 2008).  This may be a 
challenge for individuals who are citing cost-related non-adherence, as having one’s 
prescription refilled more often would equate to an increase in the number of 
copayments.  However, as expressed by participants in this study, when active 
communication with one’s local pharmacist and/or family physician is needed, it may be 
essential to have copayment fees waived or patients being offered drug samples, although 
some research suggests providing free samples can do more harm than good (Chimonas 
& Kassirer, 2009; Cosby & Houlden, 1996; Katz, Reid, & Chran, 2014; Limcangco, 
Stuart, & Briesacher, 2013; Reid, Alikhan, & Brodell, 2012).  Participants from this study 
were fortunate enough to have positive experiences with free samples, but it required 
them to be transparent with their local pharmacist and family physician to have their 
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individual needs met.  With that being said, this may become a routine question in that 
family physicians should begin asking their patients if they can afford their medications 
and documenting this as part of the patient’s record.  If this is immediately addressed then 
patients can be provided with the necessary resources and supports to prevent non-
adherence earlier in the process by determining what is needed for the person to be able 
to afford their medications and possible other non-medication treatments. 
To further address adherence behaviours, there may be value in conversations 
between a patient and health care professional around patient expectations (Miller & 
Rollnick, 2002; Rollnick, Mason, & Butler, 1999; Rollnick et al., 2010).  The results of 
this study demonstrated how time was a barrier for many to health care, leading to 
negative preconceptions of the health care system and indirectly affecting patient 
adherence choices.  There is value in future research investigating how patient 
expectations impact adherence behaviours as well as education for future family 
physicians in understanding the need to address patient expectations as a basis for 
addressing adherence behaviours.  
It may also benefit individuals who are living with a chronic condition and are 
prescribed multiple medications to address their own expectations of their health.  The 
results of this study exemplified how participants were comparing themselves to others, 
typically comparing to worst case scenarios.  There may be a benefit for patients who are 
relatively young and are diagnosed with a chronic condition to meet individuals who 
have done more to manage their condition and as a result are on fewer medications, as 
this was recognized by many as being a personal goal.  This was an interesting finding 
and exemplifies how the group selected for this research study are highly influenced by 
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others, specifically others who they can relate to.  By providing them with best case 
scenarios regarding their health, this may be a motivator in adherence to medication and 
self-management strategies.   
This study also found that family physicians should be documenting if their 
patients are engaging in non-medication strategies to manage their condition.  This could 
provide family physicians with the opportunity to determine realistic strategies that their 
patients could utilize besides medications.  As this study exemplified, individuals are 
interested in self-management strategies but are not engaging in them.  If this is 
encouraged by someone who is a trusted source (i.e. family physician) it may result in an 
increase in self-management strategies, which has been demonstrated in the literature to 
result in an increase in adherence behaviours.   
Finally, participants also had expectations of how long they would be on their 
medications for, with many assuming that they would be on their medications for 
potentially the rest of their lives.  The evidence from the current study has shown that it 
becomes important for prescribers to have conversations around this expectation as this 
would be an opportunity for the prescriber to address this unrealistic expectation, provide 
other strategies besides prescription medications, and to educate patients that over time 
they may gradually be on less prescription medications – once again providing the patient 
with options and supporting their role in their own health. 
Due to the focus on chronic conditions in this study the majority of participants 
were being prescribed medications for primary prevention.  Future research is needed to 
determine if adherence behaviours vary for someone who is on a medication for 
preventative purposes versus someone who is on medication for reactive purposes.  One 
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may speculate that medications used for secondary prevention would result in greater 
adherence behaviour, as the benefits of being on these types of medications are more 
tangible and do not require individuals to adhere to medications over a longer period of 
time.  As this study exemplified, individuals’ chose to not always adhere to their 
medications that did not provide immediate, tangible results as participants assumed that 
certain medications were only intended for short-term use.  However, in reality these 
medications were prescribed as a preventative method, which entailed the person having 
to adhere to their medication for a longer period of time.  
Based on the outlined implications, a key recommendation proposed would be for 
policy makers to take into account this age group who are being prescribed multiple 
medications at a relatively young age.  By addressing the unique health needs of this age 
group, it would result in economical savings as fewer health care resources are then being 
utilized by this group.  However, for this to take place, changes need to be made.  First, 
there needs to be consideration of the costs of medications.  Individuals are purposely 
sacrificing their health because they are unable to afford their medications.  These 
individuals are making slightly more than $20 000 per year so are not qualifying for the 
Ontario drug savings plan yet when one takes into account the additional expenses in 
these individuals’ lives, they are in fact making significantly less than $20 000.  Second, 
it was apparent how influential peers can be for this group in not only adhering to their 
medications but engaging in self-management strategies.  As previously outlined, this 
group often relates to individuals who are in the worst case scenario.  With that being 
said, there may be a benefit to provide funding to chronic disease organizations that can 
provide peer support groups to allow individuals who are experiencing similar conditions 
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to discuss methods they are using to manage their condition(s) as well as their 
medications.  However, for this to be successful it needs to be promoted as a 
‘prescription’.   
All participants spoke of viewing their family physician as a trusted source – this 
must be capitalized on.  A first step could be providing family physicians with the 
resources that they can then ‘prescribe’ to their patients to seek additional treatments 
besides their medication, with the physician purposely following up with their patient to 
determine if they followed their recommendations.  This would hold the family physician 
accountable to make an appointment with their patients to follow-up on the preventative 
strategies being recommended and to focus on relationship building between the patient 
and the physician.  There also becomes an opportunity for family physicians to start 
documenting the ability of their patients to afford their medications, determine if they are 
engaging in self-management strategies, and if they are being prescribed medications.  By 
family physicians documenting this, possibly included as part of their EMR, then there 
becomes a more comprehensive approach to health as individuals in the current study 
were citing numerous and often complex reasons for non-adherence (Holbrook et al., 
2011a; Holbrook et al., 2011b) .  If policy is not possible, there still needs to be a focus 
on small changes, whether it is the patient who is able to have copayments waived or who 
has a family physician that addresses preventative methods; these are the potential 
opportunities with the results of this study. 
Summary Conclusions 
 
This study found that individuals living with a chronic condition (often more than 
one) and who are required to take multiple medications have a very complex relationship 
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with their medications and consequently with their care providers, loved ones, and the 
health care system.  This research was able to identify that adhering to one’s medications 
are very multifaceted and there are certain factors that are influencing individual’s 
conscious decisions to adhere or not adhere to their prescribed drug regimen.  Individuals 
are purposely sacrificing their medication by placing less merit in their own health and 
more merit to support others.  Even with an awareness of the need of their medications to 
function, this still does not equate to adherence.  This group requires increased education 
and support as individuals spoke of non-adherence because there was not a recognized 
need for their medications and the results of their medications were not ‘tangible’.  If the 
importance of medications was discussed between the patient and the prescriber, it may 
minimize the feelings of fear.   
This study found that many multi-medication users are fearful of having to be on 
multiple medications, often believing that it will only get worse with age, resulting in 
feelings of fear of the future.  This is the expectation that many have of themselves yet 
this is a group of individuals who recognize that they are relatively young to be on 
multiple medications.  There becomes a contradiction when expectations are not 
matching with participants’ personal experiences.  Prescribers are in an interesting 
position to address patients’ expectations, possibly helping the patient devise realistic 
expectations and provide the person with the hope of being on fewer medications over 
time.   
However, this also requires the prescriber to address self-management strategies.  
While this study found that very few engaged in self-management, but those individuals 
who did were more likely to adhere to their medications.  The majority of participants 
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had an awareness of wanting to do more for their health but purposely chose not to.  By 
engaging in self-management strategies this may address the challenges this group is 
experiencing with regards to being on multiple medications.  This research is able to 
exemplify how individuals associated meanings with their medications and this age group 
is very unique from most in that they have an awareness of what they need to do but are 
constantly rationalizing every decision made, reaffirming the importance of increased 
education and support.  For this age group to successfully adhere to their medications 
there needs to be a balance between living their life and taking their prescribed 
medication.  This study has shown that the use of multiple medications is not a linear 
process of simply adding more medications consumed each day by an individual.  
Instead, this study has shown that multiple medication management requires an increased 
understanding of complex interrelated factors that impact adherence and non-adherence 
behaviours. 
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Chapter 8: Appendices 
Appendix A: Semi-structured interview guide 
 
Tell me a little bit about yourself (icebreaker to start building trust with participants). 
What do you do for a living?  If indicate yes, are you full or part time? Tell me about the 
medications you are currently taking.  What health conditions are these medications 
prescribed for? 
Interview Questions Probe Questions 
1. How many of those medications 
do you take according to the 
prescription? 
Interesting, why is that? 
 
2. If you would like to share with me 
how you felt when you were first 
diagnosed with your health 
condition? 
How did this affect how you feel 
about yourself? 
3. How does your condition affect 
your life? 
Depending on the answer, ask 
participants to consider specifically 
personal relationships, their 
workplace, and them as an 
individual 
4. Tell me about any experiences 
you’ve had with your medications 
(i.e., side-effects, benefits, 
incorporating your drug regimen 
into your daily routine, etc.). 
How has this affected your decision 
in taking your medications?  Do 
you feel you were able to make an 
informed decision? 
If yes Why so?If no Why not? 
Has anything else in your life 
affected your decisions to take your 
medications or not to take your 
medications? 
5. What steps have you taken to 
manage your conditions? (i.e., 
exercise, eating healthy, 
alternative medicine, etc.). 
If you would like to share with me 
any experiences you’ve had that 
have caused you to take these 
specific steps. 
Where you recommended any self-
management strategies or treatment 
options by your physician? 
6. Tell me about your relationship 
with your family physician. 
If they are seeing more than 1 
physician, ask if there is a different 
relationship with each person. 
7. Have you had any difficulties 
with the healthcare system? 
Yes Tell me more about it. 
No Why do you think this is?  
8. Do you feel you are supported in 
the decisions you have made? 
Why is that? 
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The questions were based on the sequential steps reflected in Figure 1 that lead a 
patient to the final decision in their medication adherence.  If patients are adhering to 
their medications, is it because of the patient’s ability to self-manage their condition or is 
it due to other factors that were not outlined in the literature?  For patients who choose 
not to adhere to their medications, the interview will reveal if barriers outlined in the 
literature (i.e., structural and personal) are consistent with participant experiences. 
According to Figure 1, patients choose to continue to take their medications based upon 
the strategies the patient is personally able to implement as well as active communication 
between the patient and their physician; while patients who choose not to continue to 
adhere to their medications base this decision on the inability to control their condition(s) 
and/or poor patient-physician communication.   
Figure 1 focuses broadly on the factors affecting medication adherence but Figure 
2, 3, and 4 address specific factors participants will be asked to speak about.  Figure 2 is 
reflected in question 4, where participants are asked to share any experiences they’ve had 
with their medications; specifically how does their drug regimen affects their life?  It will 
be interesting to see if participants speak of the need to substitute their medications, the 
choices they are provided with, and if their knowledge and perceptions of their health 
affect their decisions.  Figure 3 is reflected in questions 2 and 3 where participants are 
asked about how they felt when they were initially diagnosed and how their medical 
condition has impacted their lives.  Figure 3 is also considering the effects of gender.  As 
previously outlined, females were more likely to feel a sense of empowerment when 
searching for a balance between their multiple conditions and their personal lives, while 
men were more likely to feel a loss of control because of the fear of being dependent on a 
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medication for a long period of time and being unable to live a ‘normal’ life (Asbring, 
2001; Charmaz, 1994; Kralik, 2002; Lewis et al., 2003).  Finally, Figure 4 considers 
more in-depth the importance of communication between the patient and physician.  This 
is reflected in questions 6 and 8, which is based on Figure 4 that considers the impact a 
physician can have on the ability of a patient to adhere to their medication.  The questions 
pertaining to patient-physician communication will aid in supporting the figure, thus the 
literature, or disapprove what has been said in the literature.           
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Appendix B: Inclusion and exclusion criteria 
 
Inclusion criteria: 
 Participants are between the ages of 40 to 55 when data is being collected 
 Male or female 
 Diagnosed with a chronic condition; not limited to a single chronic condition 
o According to the Centre for Chronic Disease Control and Prevention in 
Canada (2010) the most commonly diagnosed chronic conditions in 2010 
were heart disease, stroke, cancer, diabetes, and arthritis 
 Required to take three or more prescribed medications to manage diagnosed 
condition(s) 
o However, participants will be asked to indicate if taking any other 
medications that were not prescribed by their healthcare practitioner or 
engaging in other treatment options (i.e. alternative medicine) 
 There will be no restrictions for health coverage; participants will have to indicate 
their available health coverage but this will not exclude individuals if one does 
not have any form of coverage 
 Engaged in communication with a physician or specialist that gave 
recommendations to improve health  
 
Exclusion criteria: 
 Under or over the preferred age bracket 
 Not diagnosed with a chronic condition 
 Prescribed less than 3 medications 
 Does not actively engage in communication with a physician pertaining to the 
participant’s personal health 
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Appendix C: Summary of research project 
 
 
 
April, 2013 
Title: ‘Multiple medication use in adults: A qualitative study’ 
 
The purpose of this research project is to develop a theory of the process of decision-
making in medication adherence in adults between the ages of 40 to 55 who are required 
to take multiple prescribed medications.  Specific organizational and individual factors 
(i.e. the costs of healthcare, individuality, patient- physician communication, and 
Canada’s healthcare system) will be analyzed while investigating the influence these 
factors has on a patient’s ability to follow their physician’s recommendations.   
 
Based upon data collection with a focal point around individual experiences it will aid in 
developing a framework for healthcare providers in understanding the context and the 
rationale behind a lay person’s decisions in adhering to their prescribed medications.  
Once a rationale has been provided for adherent or non-adherent behaviors, a hierarchy 
will be created exemplifying what factors are most affecting individuals while 
considering the demographic of the person. 
 
There is a need for research in understanding the decisions in multiple medication use 
since over half of prescribed medications for patients with chronic conditions are not 
taken as prescribed, resulting in health and economical consequences (Golay, 2011; 
Osterberg & Blaschke, 2005).  Furthermore, those between the ages of 40 to 50 are more 
likely to exhibit non-adherence behaviors due to the costs of medications and personal 
factors (i.e. not accepting being labelled with a chronic condition) (Audulv et al., 2012; 
Law et al., 2012).  However, research has been unable to exemplify why this specific age 
bracket is exhibiting non-adherence and what specific factors are causing a patient to take 
certain medications while choosing not to take others.   
 
To recruit participants we are looking to place advertisements within local pharmacies 
were individuals have the option to contact the principle student investigator or faculty 
supervisor.  We believe this will be the most ideal method to recruit individuals who meet 
the required demographics of this project, which will be outlined on the advertisement.  I 
have attached a copy of the advertisement.  If you have any further questions please 
contact: 
 
Carolyn Dyer, Graduate Student         Dr. Jarold Cosby, Faculty Supervisor 
Department of Kinesiology          Department of Kinesiology 
Brock University                                 Brock University 
905-246-1966 or cd06xq@brocku.ca        905-688-5550 ext. 5340 or jcosby@brocku.ca   
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This project was approved by Brock University’s Research Ethics Board (12-176).  For 
further questions please contact the Research Ethics Office at 905-688-5550 ext.3035 or 
reb@brocku.ca.            
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Appendix D: Telephone script 1 
 
P = Potential participant;  I=Interviewer 
 
I – Hello, may I please speak to [insert name of potential participant]? 
 
P – Hello, may I ask who I am speaking to? 
 
I – Yes, my name is Carolyn Dyer and I am a Masters student within the Faculty of 
Applied Health Sciences at Brock University.  I am currently conducting research under 
the supervision of Dr. Jarold Cosby on multiple medication use; I received your e-mail 
regarding your interest in possibly participating in my research project.  Would you be 
interested in learning more about the study? 
 
P – No. (Thank them for their time and say goodbye) 
 
OR 
 
P – Yes.  
 
I – Terrific, as part of my research project I will be conducting one on one interviews 
with individuals who have been diagnosed with a chronic condition and are prescribed 3 
or more medications to treat their condition.  The purpose of this project is develop a 
framework for policy and decision makers within the healthcare industry in 
understanding the decisions individuals are making in adhering or not adhering to their 
prescribed medications.  Before we proceed any further, I need to ask you a few 
questions to verify specific demographic factors: 
1.  Are you male or female? (P answers) 
2. Are you between the ages of 40 to 55? (P answers) 
3. Have you been diagnosed with a chronic condition? (P answers) 
4. Are you currently required to take 3 or more prescribed medications? (P 
answers)  Thank you for answering my questions. 
 
(If P does not fit the inclusion criteria) – Unfortunately this study is looking for certain 
demographics factors and you do not meet the criteria.  I apologize for the inconvenience 
and would like to thank you for taking the time to speak with me.  Goodbye.   
 
OR 
 
(If P does meet the inclusion criteria) – Excellent, I would like to speak to you about your 
experiences you have had regarding your personal health.   Do you have a few more 
minutes so I can give you some additional information regarding the interview process? 
 
P – No, could you call back later? (Arrange a time that would be best convenient for you 
to call back). 
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OR 
 
P – Yes I would be interested in hearing additional information regarding the interview 
process. 
 
I – Perfect, here is some background information: 
 I will be conducting one on one interviews starting this winter. 
 The interviews will be conducted at the Health Decisions Lab at Brock University 
located on 500 Glenridge Ave, St. Catharines, ON. 
 The interview will last anywhere from 45 minutes to an hour and an interview 
time will be selected based upon whenever is most convenient for you. 
 Participation in this study is strictly voluntary and you can choose to withdraw 
from this study at any point in time. 
 The interview questions are quite general (i.e. tell me about the medications you 
are currently taking).  Interview questions will be open-ended and allow you to be 
as detailed as you would like in your response.  I want to inform you that this is 
not a medical study and there will be no advice given on your medical 
conditions. 
 You may decline to answer any of the questions you do not wish to answer. 
 With your permission, the interview will be audio recorded to allow for 
transcription and analysis at a later time. 
 All information you provided will be considered confidential; I will be using a 
randomized number system and personal characteristics that would identify who 
you are will not be used to protect your privacy. 
 Two weeks after the study is completed you will be mailed a copy of the results 
and if you wish to have a copy of your personal transcript, this will be mailed or 
e-mailed to you within forty-eight hours of when you requested your transcripts.  
 The data collected will be kept in a secure location and disposed of one year after 
the study has been completed. 
 With your permission I would like to mail or e-mail you an information package 
which has all of these details along with contact names and numbers to help you 
assist in making a decision to participate in this study. 
 
P – No thank you, I am not interested. (Thank them for their time and wish them 
goodbye). 
 
OR 
 
P – Yes (decide on a method of mailing and obtain contact information from the potential 
participant, i.e. e-mail or mailing address). 
 
I – Thank you very much! 
 If you have any questions or need additional information about this research 
project, please feel free to contact my supervisor, Dr. Jarold Cosby at 905-688-
5550 ext. 5340 or jcosby@brocku.ca  
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 I would like to assure you that this study has been reviewed and has received 
ethics clearance through the Office of Research Ethics.  Should you have any 
questions or concerns regarding your participation within this study, please 
contact the Office of Research Ethics at 905-688-5550 ext. 3035 or 
reb@brocku.ca  
 I will follow up with you in 3 to 5 days to see if you are interested (or still 
interested) in being interviewed and we can arrange a time to meet.  Thank you 
for taking the time to talk with me and once again if you have any questions 
please do not hesitate to contact me at cd06xq@brocku.ca  
  
P – Goodbye. 
 
I – Goodbye.  
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Appendix E: Letter of invitation  
April, 2013 
 
Title of Study: Multiple medication use in adults: A qualitative study 
Principal Student Investigator: Carolyn Dyer, Graduate Student, Department of 
Kinesiology, Brock University 
Faculty Supervisor: Dr. Jarold Cosby, Associate Professor, Department of Kinesiology, 
Brock University 
 
I, Carolyn Dyer, Graduate Student, from the Department of Kinesiology, Brock 
University, invite you to participate in a research project entitled, ‘Multiple medication 
use in adults: A qualitative study’. 
 
The purpose of this research study is to provide health care professionals with a 
framework in understanding how decisions are made regarding medication adherence for 
individuals who are taking three or more prescribed medications.  This is not a medical 
study and at no point in time will medical advice be given.  Should you choose to 
participate, you will be asked to participate in a one to one interview and share your 
experiences regarding the decisions you have made regarding medication adherence.  The 
interview will last approximately 45 minutes.  
 
Your participation will provide data that will contribute to an overall increased 
understanding of the rationale and context behind the decision-making process regarding 
medication adherence.  This will help us in creating a framework for healthcare 
professionals in understanding the decisions made by patients and how medication 
adherence can be improved.   
 
This is a single-site project as all interviews will be conducted at Brock University at 500 
Glenridge Avenue, St. Catharines, ON.  Your involvement in this study is strictly 
voluntary and you have the right to refuse participation at any time.   
 
If you have any questions about your rights as a research participant, please contact the 
Brock University Research Ethics Officer (905-688-5550 ext. 3035 or reb@brocku.ca). 
 
If you have any questions regarding the research study, please feel free to contact Dr. 
Jarold Cosby or I at any time (see below for contact information). 
 
Thank you, 
 
Carolyn Dyer, Graduate Student         Dr. Jarold Cosby, Faculty Supervisor 
Department of Kinesiology          Department of Kinesiology 
Brock University                                 Brock University 
905-246-1966 or cd06xq@brocku.ca        905-688-5550 ext. 5340 or jcosby@brocku.ca   
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This project was approved by Brock University’s Research Ethics Board (12-176).  For 
further questions please contact the Research Ethics Office at 905-688-5550 ext.3035 or 
reb@brocku.ca.           
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Appendix F: Informed consent form 
Date: April, 2013 
Project Title: Multiple medication use in adults: A qualitative study 
 
Principal Student Investigator:   
Carolyn Dyer, Graduate Student 
Department of Kinesiology   
Brock University 
905-246-1966; cd06xq@brocku.ca 
 
Faculty Supervisor: 
Dr. Jarold Cosby; Associate Professor 
Department of Kinesiology 
Brock University 
905-688-5550 Ext. 5340; jcosby@brocku.ca 
 
INVITATION  
Brock University’s Health Decision Lab would like to invite you to participate in a research study about 
medication adherence.  The purpose of this research is to provide health care professionals with a 
framework in understanding how decisions are made regarding medication adherence for individuals who 
are taking three or more prescribed medications. 
 
WHAT’S INVOVLED 
As a participant you will be asked to share your experiences with the researcher.  Interviews will be audio 
digitally recorded and transcribed verbatim.  Interviews will take place at Brock University on 500 
Glenridge Avenue in St. Catharines, ON.  Interviews will be conducted one on one in a conversational 
manner and will allow you to share your personal experiences of adhering to a prescribed drug regimen 
specifically how certain organizational and individual factors have affected your decisions (i.e. the cost of 
medications, individual factors, patient-physician communication, and Canada’s healthcare system).  This 
is not a medical study, therefore, no medical advice will be provided.  Participation will take 
approximately 45 minutes to an hour of your time in addition to travel time to and from the interview.     
 
POTENTIAL BENEFITS AND RISKS 
Possible benefits of participation include the opportunity to tell your story about your experiences about 
your personal health, the opportunity to see the interpretation of your experiences, and to understand your 
experiences in relation to other participants with similar health dilemmas.  You will also contribute to an 
increased understanding of the decision-making process regarding medication adherence.  Thus, you are 
contributing to the development of a framework for healthcare providers in understanding the context and 
rationale behind medication adherence choices.  However, there are some associated risks with 
participation.  Sharing your personal experiences regarding your health may result in increased feelings of 
emotional distress yet you are given the opportunity to not answer any questions you do not feel 
comfortable with.  Furthermore, the principal student investigator has formal training in qualitative 
interviewing and is well prepared to manage any such risks. 
 
CONFIDENTIALITY  
The information you provide will be kept strictly confidential.  Your name will not appear in any thesis or 
publications from this study.  However, anonymous quotations may be used, which will be done through 
the use of a randomized number system.  Data collected during this study will be stored electronically on a 
computer hard drive, which is user name and password protected.  Data will be kept until the study is 
completed after which all hard copies of the data will be shredded and electronic copies will be erased.  
Access to the data will be restricted to the principal student investigator, Carolyn Dyer, and the faculty 
supervisor, Dr. Jarold Cosby.  However, at any time if you wish to access your interview transcript you 
may do so by contacting either Carolyn Dyer or Dr. Jarold Cobsy via telephone or e-mail.  All requested 
transcripts will be delivered within forty-eight hours of the request however once the study is completed 
156 
 
transcripts will not be available since all interview transcripts will be destroyed once the study is 
completed.   
 
VOLUNTARY PARTICIPATION 
Participation in this study is strictly voluntary.  If you wish, you may decline to answer any questions or 
participate in any component of the study.  Further, you may decide to withdraw from the study at any time 
and may do so without any penalty or loss of benefits to which you are entitled.  To withdraw from the 
study please contact the principal student investigator via telephone or e-mail before the study has been 
completed and submitted for publication.  After the study has been submitted for publication you will no 
longer be able to withdraw from the study.   
 
PUBLICATION OF RESULTS 
Results of this study may be published in professional journals and presented at conferences.  Feedback 
about this study will be available one week after the study has been completed and you may request a copy 
from either the principal student investigator or the faculty supervisor via telephone or e-mail.  All 
academic papers will be mailed within one week of the request. 
 
CONTACT INFORMATION AND ETHICS CLEARANCE  
If you have any questions about this study or require further information, please contact the principal 
student investigator or the faculty supervisor using the contact information provided above.  This study has 
been reviewed and received ethics clearance through the Research Ethics Board at Brock University (12-
176).  If you have any comments or concerns about your rights as a research participant, please contact the 
Research Ethics Office at 905-688-5550 Ext. 3035, reb@brocku.ca.  Thank you for assistance in this 
research project.  Please keep a copy of this form for your records.  
 
CONSENT FORM 
I agree to participate in this study described above; I have made this decision based on the information I 
have read in the Informed-Consent Letter.  I have had the opportunity to receive any additional details I 
wanted about the study and understand I may ask questions in the future.  I understand that I may withdraw 
this consent at any time. 
 
Name: 
  
Signature: 
 
Date: 
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Appendix G: Supporting quotations 
 
Categories Supporting quotations 
Origins of medical 
condition(s) 
I had a hard time too controlling my anger- I first chopped it up 
to getting married, having a family, her daughter/my daughter, 
that was a big change for me to so I chopped it up my mood 
swings to that.  But then I was like I don’t know they’re not that 
tough to get along with.  So that’s when I talked to Dr. K. -
P11(3) 
The impact of others to 
self-manage condition 
and medication use 
 
My parents don’t deal with things head on so there like it’s all 
you, you need to cut down on your eating, and at times I was 
eating okay like it wasn’t always is was eating.  And I told them 
how much sugar I was eating and the diabetes centre for 
example said that’s […] your pancreas isn’t working the way it 
should.  Then I would explain it to my family because my dad 
diabetic but he was diagnosed at the 13 and I was diagnosed at 
the 27.  So I said to them my parents aren’t supportive they were 
saying it’s your diet, you need to change I wasn’t always. -P7(6) 
 
He’s a great husband.  He knew if I was struggling, he knew it.  
He could tell, he would say you’re tired, you’re struggling, he’d 
know that…you need to quit now or could do whatever […] If I 
couldn’t do it, he would do it. -P10(9) 
The ‘success’ and 
‘failure’ associated with 
self-management 
So I started learning a bit more about that [depression] and 
started understanding some of the stuff I was doing, wasn’t 
really good for myself […] But then I was like I don’t know 
they’re not that tough to get along with.  So that’s when I talked 
to Dr. K. -P11(3) 
 
[…] so what I do is, don’t laugh, I count.  So if it happens at 
night and I’m lying in bed I’ll try to count how many days til’ 
Christmas, how many days until somebody’s birthday so like a 
counting strategy kind of thing.  -P1(4) 
 
We’re lucky, really lucky because Todd’s work covers the cost of 
medication but it doesn’t cover therapy […] if I go see a 
psychologist it comes out of my pocket […] that’s hard so I 
really pick and choose when I need it.  So if I’m really low then 
I’ll go see them. - P9(6) 
 
The ability to maintain 
privacy 
[…] this is a rarity for me I don’t usually share […] Ya I don’t 
tell people very much like I said I told my supervisor at work 
because I get along with him, I told my youngest brother 
because he knows what it’s like.  And of course my wife and 
daughter. -P11(7-8) 
 
I don’t trust anyone here [referring to her workplace], not the 
management, I don’t.  If my co-workers say you need to go I will 
say no I will lie through my teeth, I will not tell.  I’m part-time so 
I’m able to hide it so I can take a day and say oh I have an 
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appointment or whatever but I don’t want nobody to know.  I 
will not tell anyone. -P13(9) 
The ability to work And now you know I have little nobbles and my hands are 
starting to turn.  So it got to the point, I was a banker and 
on the computer all the time, it got to the point I couldn’t 
even type.  So I have to do voice recognition and you can’t 
do that at the bank. -P9(2-3) 
 
I have some energy, like it was getting to the point where I 
didn’t want to go to work and I normally the one up at 6 
the sun shining and I’m out the door walking the dog and 
now I feel I don’t want to do anything. -P8(3) 
 
[…] so my cardiac output at the most severe was 7% of 
normal so I pretty much flat on my back, I couldn’t do 
anything and I was off work for 10 years. -P14(2) 
Fear of the future I’m covered 100% but if it wasn’t for it I would probably 
be skipping out on a lot of the drugs because let’s face it, 
they are expensive. -P11(5)  
 
I have a friend he died of cancer and they are the most 
holistic people, they even made their own frigin dog food.  
Both of their dogs died of cancer and he died of cancer.  
So I don’t necessarily say ‘hey it’s in our food’, I get some 
of it is in our food but I’m sure it’s the air, in the earth, it’s 
around and I think if you’re genetically prone to it there’s 
nothing you can do to stop it. And most people die of old 
age from cancer anyways. -P10(8) 
 
I know you’re going to think I’m crazy now but I know a 
girl that’s bipolar that was taking the same medication 
and I kept hearing this ‘swwwiiishhh, swwwiiishhh, 
swwwiiishhh, swwwiiishhh’ I kept thinking what the frig, is 
there something wrong with my ears?  And she told me 
that’s what happens when you cold turkey it even though I 
was taking mega, mega stuff. -P10(3) 
The fear of the 
dependency on 
medications 
But I went off it for a while.  And my next door neighbour 
at the time was a nurse and I didn’t really tell her that I’ve 
been off it for a few days.  And I started to twitch and 2 
days later she goes ‘what is wrong with you?’  ‘Oh you 
know I went off my medications’.  I’d be super high and 
super low kinda thing and she was like ‘get back on your 
medications or otherwise I will never talk to you again’.  
So apparently it works. -P1(2) 
 
I know if I don’t take my panic attack pill I know I have 
problems because I tried to go off of it on my own which I 
guess you’re not supposed to […] I was just getting panic 
attacks and for no reason like just watching TV and say 
‘Cops’ or something was on then the fire was coming from 
feet right through my body and I was constantly shaking, I 
159 
 
couldn’t even drive a car. -P6(3,5) 
 
[…] then I think everything is over and settled now with 
the estate, things have moved on I think I’m going to do 
better, I’m going to do and I was doing okay but it 
something that I had a fear of to trigger it. -P10(3) 
The need for 
medications 
Okay, work can get to me, right? Definitely but at the point 
Katie [participant’s daughter] moved out to Alberta, took 
the kids […] My parents are moving in well have moved in 
now.  My mother has Alzheimer’s, a lot of stress. It’s a lot 
so I’m trying to handle everything there and then seeing 
her and the kids go, it was bad.  So she [referring to her 
family physician] actually put up my Celexa a little bit and 
I went down and said you know I’m going crazy kinda 
thing and she said okay we’ll bring it up. -P1(3) 
 
[…] that I don’t have the anxiety and depression, that I 
can sleep because I wasn’t sleeping without the 
medications because I’ve tried to go off because the 
sleeping pill is addictive, I’m addicted to it now.  So she 
has to wean me off of it but she hasn’t yet because she said 
sleep is more important but it’s been a year, so I’m 
thinking we need to start cutting the dose back. -P3(10) 
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Emotions associated 
with being first 
diagnosed 
 
I was very, very, very upset but at the time they said I 
could look after it with just diet but I did that for a bit then 
I when I went back it wasn’t getting any better so they put 
me on pills. -P1(1) 
 
So when I did go and see him that’s when we find out, 
Lynda [his wife] went with me and he told me I have type 2 
diabetes and high blood pressure.  I kind of questioned 
him because I drink water, I don’t drink pop, I don’t eat a 
lot candy and Lynda is the total opposite and I thought did 
you get the blood samples mixed up because the first is 
denial. -P4(2) 
Moving to a new 
‘normal’: dependence vs. 
the imagery of a warrior 
 
[…] from my stepfather passing away it was really hard 
and that’s where it basically started. -P6(3) 
 
My whole life has been about me, where I played, where I 
coached, the towns I’ve been in – it’s time for me to 
balance the scales a little bit. And I don’t mean to be 
selfish but everything evolved around me and now it 
doesn’t and I like it.  I can give back; balance the scales a 
little bit.  That’s the great thing about it and I feel like 
what I’m supposed to do.  I don’t want to be remembered 
as Simon the great hockey player, the great coach, the 
great TV guy, great writer I rather be remembered as the 
guy who raised a lot of money for Parkinson’s disease. -
P12(5) 
The awareness of being 
on multiple medications 
 
[…] they put me on Prednisone that was the fix all.  Of 
course I just got fat and a big head or whatever you want 
to call it, it was horrible.  I hated it; I will never go on it 
again unless if I have too, my doctor said I will never go 
on it again unless I have too.  It altered my mind; it made 
me a totally different person. -P10(1) 
 
I think it was because of the Champix.  I mean I was 
starting to not feel great but I’ve never had thoughts like 
that.  Even through all those years when I started to get 
depressed again – I never, never, never did.  So I’m pretty 
sure it was the Champix and they say that is one of the 
side-effects. -P3(3) 
 
 
 
 
 
